{
    "url": "https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231x10k.htm",
    "report_type": "10-K",
    "context": [
        {
            "id": 0,
            "context": "Item 1. Business\n\u200b\nOverview\n\u200b We are a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. Our proprietary KINect drug discovery platform combined with our preclinical development capabilities allows us to identify and advance potential drug candidates that we may develop independently or in collaboration with third parties. In addition to identifying and developing our novel drug candidates, we are pursuing strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our novel drug candidates. We also provide contract research services to third parties enabled by our early-stage research and development expertise. In January 2024, we announced that we are undertaking a strategic review of our business.",
            "type": "paragraph"
        },
        {
            "id": 1,
            "context": "\u200b\nOur Approach\n\u200b\nWe are dedicated to developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. Our approach to achieve this goal includes the following key elements:\n\u200b\n4\n\n| Drug Candidate / Program | Target | Route of Administration | Indication | Development Phase |\n| Immuno-Inflammatory |\n| ATI-1777 | \u201cSoft\u201d JAK 1/3 inhibitor | Topical | Atopic dermatitis | Phase 2b Complete |\n| ATI-2138 | ITK/JAK3 inhibitor | Oral | T cell-mediated autoimmune diseases | Phase 1 Complete |\n| Oncology |\n| Zunsemetinib | MK2 inhibitor | Oral | Metastatic breast cancer | Phase 1* |\n| Pancreatic cancer |",
            "type": "table"
        },
        {
            "id": 2,
            "context": "ATI-2138, an Investigational Oral Covalent ITK/JAK3 InhibitorATI-2138 is an investigational oral covalent inhibitor of interleukin-2-inducible T cell kinase, or ITK, and JAK3 for the potential treatment of T cell-mediated autoimmune diseases. The ITK/JAK3 compound interrupts T cell signaling through the combined inhibition of ITK/JAK3 pathways in lymphocytes.In September 2023, we announced positive results from our Phase 1 multiple ascending dose, or MAD, trial of ATI-2138 (ATI-2138-PKPD-102). ATI-2138-PKPD-201 was a two-week Phase 1 placebo-controlled, randomized, MAD trial to investigate the safety, tolerability, PK, and pharmacodynamics of ATI-2138 in healthy volunteers. The study enrolled 60 healthy subjects across 6 dosing cohorts ranging from 10 to 80 mg of total daily doses, with eight active and two placebo controlled per arm. Data from the trial demonstrated that ATI-2138 was generally well tolerated at all doses tested in the trial and had dose proportional PK. Additionally, ATI-2138 demonstrated a dose-dependent inhibition of both ITK and JAK3 exploratory pharmacodynamic biomarkers, with near maximal inhibition achieved at the 30 mg total daily dose. No serious adverse events were reported.We are assessing the most effective development pathway, including the lead indication, for ATI-2138.Zunsemetinib, an Investigational Oral MK2 Inhibitor\u200bZunsemetinib, or ATI-450, is an investigational oral, novel, small molecule selective inhibitor of the mitogen-activated protein kinase-activated protein kinase 2, or MK2, signaling pathway for the potential treatment of metastatic breast cancer, or MBC, and pancreatic ductal adenocarcinoma, or PDAC. \u200bMBC: Phosphorylated MK2 is upregulated in primary tumors and metastatic bone lesions from MBC patients. MK2 is responsible for the production of a subset of critical pro-tumorigenic factors secreted by the stromal microenvironment to support tumor growth and metastasis. Additionally, MK2 drives both metastatic and chemotherapy induced bone loss in MBC patients through, at least in part, its role in RANKL biology and osteoclast production and activation. In preclinical studies, zunsemetinib has been demonstrated to impact murine models of MBC through inhibition of tumor growth and metastasis along with bone preservation.\u200bPDAC: Phosphorylated MK2 is highly expressed in PDAC tissue and expression levels are directly associated with poor outcomes in patients with PDAC. The current first and second line standard of care for PDAC patients is FOLFIRINOX combination chemotherapy. Irinotecan and its metabolite, SN-38, are the main drivers of cancer cell apoptosis associated with FOLFIRINOX. The effectiveness of FOLFIRINOX is limited by pro-survival resistance mechanisms that are driven through SN-38 activation of the MK2 pathway and phosphorylation of two direct MK2 substrates, HSP-27 and Beclin-1. In both patient derived xenografts and in the autochthonous genetic KPPC model of PDAC in mice, zunsemetinib has demonstrated that it blocks phosphorylation and activation of HSP-27, induces tumor cell killing and enhances the efficacy of FIRINOX (a version of FOLFIRINOX used in murine models).\u200bWe plan to support Washington University in St. Louis in its investigator-initiated Phase 1b/2 trials of zunsemetinib in patients with MBC and PDAC.\u200bDiscovery Programs and KINect Drug Discovery Platform\u200bWe conduct small molecule drug discovery and preclinical development research through KINect, our proprietary drug discovery platform, which we acquired as part of our acquisition of Confluence Life Sciences, Inc. (now known as Aclaris Life Sciences, Inc.), or Confluence, in 2017. Our KINect platform enables us to identify potential drug candidates through a unique combination of our proprietary chemical library of kinase inhibitors, our novel approaches to inhibitor modalities, our expertise in SBDD, and our custom kinase assays. \u200bOur focus has been on difficult to drug kinase targets that exhibit some level of clinical, genetic and/or pharmacological disease validation. Our approach involves the following mechanisms: (1) reversible and irreversible covalent inhibitors, (2) molecular glue/complex targeted inhibitors and (3) targeted protein degraders. These novel approaches are currently being utilized to prosecute additional validated, difficult to drug kinase targets with the goal of demonstrating potential platform utility.\u200b6",
            "type": "paragraph"
        },
        {
            "id": 3,
            "context": "Reversible and Irreversible Covalent Inhibitors: Central to the KINect platform is our novel chemical library of several hundred compounds specifically designed to target non-catalytic cysteine residues near the adenosine triphosphate, or ATP, binding site of more than 300 kinases. Furthermore, using state-of-the-art drug modeling software, we are able to elaborate the structure of viable drug-like compounds culled from our library and extensive in silico libraries to optimize reversible binding to the target kinase and allow them to selectively form a covalent bond with the cysteine residue near the ATP site on the specific kinase target. This approach delivers inhibitors exhibiting enhanced potency, selectivity and biochemical efficiency thereby allowing pharmacological access to \u2018hard to drug\u2019 kinases. We then assess the function of the newly created compounds with physiologically relevant custom assays that effectively translate to human diseases.\u200bMolecular Glue/Complex Targeted Inhibitors: In cells, protein kinases function in the context of multicomponent signalosome complexes. Targeting kinase complexes with small molecule drugs designed to either stabilize (molecular glue) and/or generate inactive complexes provides several potential advantages over those designed against a single protein target including: (1) utilizing a more physiological translatable complex as the target, (2) providing novel protein interfaces devoid of competing endogenous ligands to target, and (3) identifying new chemical matter and modalities for difficult to drug kinase targets. As such, we have identified target complexes of interest and have initiated discovery programs against these targets.\u200bTargeted Protein Degraders: We believe targeted protein degraders represent a powerful approach to develop drugs against biologically important but difficult to drug proteins including kinases. This approach harnesses cellular protein clearing machinery to selectively remove proteins from the cell in contrast to inhibiting their function. This approach is particularly useful for kinases that have both catalytic and scaffolding functions for which inhibitors will only partially impact biology. We are exploring selective degraders of kinase targets with multiple biological functions in addition to the catalytic activity.\u200bThis integrated drug discovery engine allows us to rapidly progress potential drug candidates from idea to Investigational New Drug, or IND. We believe this platform can generate inhibitors with fit-for purpose mechanisms ranging from reversible, to reversible-covalent to irreversible-covalent kinase and kinase complex inhibitors along with targeted protein degraders.\u200bWe are actively progressing several discovery programs focused on delivering the next wave of drug candidates from our KINect platform. Our discovery efforts center on targeting kinases that play pivotal roles in various inflammatory, autoimmune, and oncology pathways. We intend to evaluate both internal and external development options, including strategic partnerships, for these assets.\u200bDiscontinued Programs\u200bWe were previously developing zunsemetinib as a potential treatment for various immuno-inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and rheumatoid arthritis. In March 2023, we announced that our Phase 2a study of zunsemetinib in patients with hidradenitis suppurativa did not meet its primary or second efficacy endpoints, and in November 2023, we announced that our Phase 2b study of zunsemetinib in patients with rheumatoid arthritis did not meet its primary or second efficacy endpoints. Following the results of these trials, in 2023 we discontinued further development of our MK2 inhibitor programs in immuno-inflammatory diseases, including halting enrollment in our Phase 2a study of zunsemetinib in patients with psoriatic arthritis.\u200bManufacturing and Supply \u200bWe do not have any manufacturing facilities. We rely on third parties for the manufacture of preclinical and clinical supplies for our drug candidates.\u200bCompetition\u200bThe pharmaceutical industry is characterized by rapidly advancing technologies, intense competition and a strong emphasis on proprietary drugs. While we believe that our knowledge, experience and scientific resources provide us with competitive advantages, we face potential competition from many different sources, including major pharmaceutical, biotechnology and specialty pharmaceutical companies, academic institutions and governmental agencies and public and private research institutions. Our drug candidates, if approved, will compete with existing treatments and new treatments that may become available in the future.7",
            "type": "paragraph"
        },
        {
            "id": 4,
            "context": "\u200bWith respect to ATI-1777 as a potential treatment for atopic dermatitis, there are several different types of therapies in the atopic dermatitis market, such as biologics, oral and topical corticosteroids, oral and topical calcineurin inhibitors, oral mycophenolate products, other JAK inhibitors, other oral antibiotics and antihistamines and phototherapy. There are also several prescription, non-prescription and over-the-counter, or OTC, topical products, including PDE4 inhibitors, utilized to treat atopic dermatitis. These types of drugs are produced and sold, or are approved for marketing, by large pharmaceutical companies, including AbbVie, Incyte, LEO Pharma A/S, Pfizer, and Regeneron Pharmaceuticals and Sanofi. In addition, we are aware of a number of companies including large pharmaceutical companies, such as Amgen, Dermavant Sciences, Eli Lilly, LEO Pharma A/S and Pfizer, developing and conducting clinical trials for investigational drug candidates that could compete with ATI-1777, in each case if approved, for the treatment of atopic dermatitis.\u200bThe commercial opportunity for our drug candidates, if approved, could be reduced or eliminated if our competitors develop and commercialize drugs that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any drug we may develop. Our competitors also may obtain FDA or other regulatory approval for their drug candidates more rapidly than our potential third-party partners may obtain approval for our drug candidates, which could result in our competitors establishing a strong market position before our drug candidates are able to enter the market. \u200bMany of the companies against which we are competing, or against which we may compete in the future, have significantly greater financial resources and expertise in research and development, manufacturing, and preclinical and clinical development than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and subject registration for clinical trials, as well as in acquiring technologies complementary to, or that may be necessary for, our development programs. \u200bIntellectual Property\u200bOur success depends in large part upon our ability to obtain and maintain proprietary protection for our drug candidates and to operate without infringing the proprietary rights of others. We seek to avoid the latter by monitoring patents and publications that may affect our business, and to the extent we identify such developments, evaluating and taking appropriate courses of action. Our policy is to protect our proprietary position by, among other methods, filing patent applications on inventions that are important to the development and conduct of our business with the U.S. Patent and Trademark Office, or USPTO, and its foreign counterparts.\u200bWith respect to our \u201csoft\u201d JAK inhibitor development program, we own numerous issued patents and pending applications in the United States and foreign countries to novel \u201csoft\u201d JAK inhibitors and various methods of use that expire, or would expire, between 2038 and 2042, subject to any applicable patent term adjustment or extension that may be available in a particular country. For example, we own issued patents in the United States and other foreign countries, as well as pending applications in the United States and foreign countries directed to various novel inhibitors of JAK1 and/or JAK3, including ATI-1777, and methods of using the same, which, if issued, would expire in 2038, subject to any applicable adjustment or extension. We also own pending applications in the United States and foreign countries directed to crystal forms of ATI-1777 and directed to methods of using ATI-1777 and topical formulations, which, if issued, would expire in 2041 and 2042, respectively, subject to any applicable adjustment or extension.\u200bWith respect to our ITK inhibitor development program, we own numerous issued U.S. patents and pending applications in the United States and foreign countries directed to novel inhibitors of ITK and methods of use that expire, or would expire, between 2035 and 2039, subject to any applicable patent term adjustment or extension that may be available in a particular country. For example, we own one U.S. patent and pending U.S., European Union and other foreign country applications directed to ATI-2138 and analogs thereof and methods of using the same, which, if issued, would expire in 2039, subject to any applicable adjustment or extension. We also own a pending PCT application directed to methods of using ATI-2138, which if issued, would expire in 2043, subject to any applicable adjustment or extension.\u200bWith respect to our MK2 signaling pathway inhibitor development program, we own numerous issued patents and pending applications to novel MK2 pathway inhibitors, including zunsemetinib, and various methods of use that expire, or would expire, between 2031 and 2041, subject to any applicable patent term adjustment or extension that may 8",
            "type": "paragraph"
        },
        {
            "id": 5,
            "context": "be available in a particular country. For example, we own two issued U.S. patents and issued patents and pending applications in the European Union and other foreign countries directed to zunsemetinib and analogs thereof and certain methods of using the same. The U.S. patents expire in 2034 and any claims that may issue from the pending applications expire in 2034, subject to any applicable adjustment or extension. We own pending patent applications in the United States, European Union and other foreign countries directed to methods of treating various cancers, such as breast cancer and pancreatic cancer, by orally administering zunsemetinib, which, if issued, would each expire in 2041, subject to any applicable adjustment or extension. Further, we own one U.S. patent and numerous pending patent applications in the United States, European Union and other foreign countries directed to certain methods of manufacturing zunsemetinib and crystal forms of zunsemetinib, which, if issued, would each expire in 2041, subject to any applicable adjustment or extension. We also exclusively license from Washington University pending applications in the United States and the European Union directed to methods of treating pancreatic cancer with MK2 inhibitors, including zunsemetinib, which, if issued, would expire in 2041, subject to any applicable adjustment or extension.\u200bPatents extend for varying periods according to the date of patent filing or grant and the legal term of patents in various countries where patent protection is obtained. The actual protection afforded by a patent, which can vary from country to country, depends on the type of patent, the scope of its coverage and the availability of legal remedies in the country. In most countries in which we file, the patent term is 20 years from the earliest date of filing a non-provisional patent application. In the United States, a patent term may be shortened if a patent is terminally disclaimed over another patent or as a result of delays in patent prosecution by the patentee, and a patent\u2019s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in granting a patent or by patent term extension, which compensates a patentee for delays at the FDA. The patent term of a European patent is 20 years from its filing date; however, unlike in the United States, the European patent does not grant patent term adjustments. The European Union does have a compensation program similar to patent term extension called supplementary patent certificate that would effectively extend patent protection for up to five years.\u200bWe also use other forms of protection, such as trademark, copyright, and/or trade secret protection, to protect our intellectual property, particularly where we do not believe patent protection is appropriate or obtainable. We aim to take advantage of all of the intellectual property rights that are available to us and believe that this comprehensive approach will provide us with proprietary positions for our drug candidates, where available.\u200bWe also protect our proprietary information by requiring our employees, consultants, contractors and other advisors to execute nondisclosure and assignment of invention agreements upon commencement of their respective employment or engagement. Agreements with our employees also prevent them from bringing the proprietary rights of third parties to us. In addition, we also require confidentiality or service agreements from third parties that receive our confidential information or materials.\u200bAcquisition and License Agreements \u200bAgreement and Plan of Merger with Confluence\u200bIn August 2017, we entered into an Agreement and Plan of Merger, or the Confluence Agreement, with Confluence, Aclaris Life Sciences, Inc., our wholly-owned subsidiary, or Merger Sub, and Fortis Advisors LLC, as representative of the former equity holders of Confluence. Pursuant to the terms of the Confluence Agreement, the Merger Sub merged with and into Confluence, with Confluence surviving as our wholly-owned subsidiary, resulting in our acquisition of 100% of the outstanding shares of Confluence. As part of the Confluence acquisition we acquired our investigational drug candidates zunsemetinib, ATI-1777 and ATI-2138. \u200bUnder the Confluence Agreement, we agreed to pay the former Confluence equity holders aggregate remaining contingent consideration of up to $75.0 million based upon the achievement of specified regulatory and commercial milestones set forth in the Confluence Agreement. In addition, we have agreed to pay the former Confluence equity holders future royalty payments calculated as a low single-digit percentage of annual net sales, subject to specified reductions, limitations and other adjustments, until the date that all of the patent rights for that product have expired, as determined on a country-by-country and product-by-product basis or, in specified circumstances, ten years from the first commercial sale of such product. In addition to the payments described above, if we sell, license or transfer any of the intellectual property acquired from Confluence pursuant to the Confluence Agreement to a third party, we will be obligated to pay the former Confluence equity holders a portion of any consideration received from such sale, license or transfer in specified circumstances. 9",
            "type": "paragraph"
        },
        {
            "id": 6,
            "context": "| \u25cf | completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the FDA\u2019s good laboratory practice regulations; |\n| \u25cf | submission to the FDA of an IND which must take effect before clinical trials may begin; |\n| \u25cf | approval by an independent institutional review board, or IRB, representing each clinical site before clinical testing may be initiated at the clinical site; |\n| \u25cf | performance of adequate and well-controlled clinical trials in accordance with good clinical practice, or GCP, regulations to establish the safety and efficacy of the proposed drug product for each indication; |\n| \u25cf | preparation and submission to the FDA of an NDA; |\n| \u25cf | review of the NDA by an FDA advisory committee, if applicable; |\n| \u25cf | satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product or its components are produced to assess compliance with current good manufacturing practices, or cGMP, and regulations to assure that the facilities, methods and controls are adequate to preserve the product\u2019s identity, strength, quality and purity; |\n| \u25cf | payment of user fees and securing FDA approval of the NDA; and |\n| \u25cf | compliance with any post-approval requirements, including potential requirements for a risk evaluation and mitigation strategy and post-approval studies required by the FDA. |",
            "type": "table"
        },
        {
            "id": 7,
            "context": "| \u25cf | Phase 1. The drug is initially introduced into healthy human subjects and tested for safety, dosage tolerance, absorption, metabolism, distribution and elimination. In the case of some products for severe or life-threatening diseases, such as cancer, and especially when the product may be inherently too toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients who already have the condition. |\n| \u25cf | Phase 2. Clinical trials are performed on a limited patient population intended to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage. |\n| \u25cf | Phase 3. If a drug candidate is found to be potentially effective and to have an acceptable safety profile in Phase 2 clinical trials, the clinical trial program will be expanded to Phase 3 clinical trials to further evaluate dosage, clinical efficacy and safety in an expanded patient population at geographically dispersed clinical trial sites. These trials are intended to establish the overall risk-benefit ratio of the product and provide an adequate basis for product approval and labeling claims. |",
            "type": "table"
        },
        {
            "id": 8,
            "context": "are submitted to the FDA as part of an NDA requesting approval to market the product. The submission of an NDA is subject to the payment of user fees, but a waiver of such fees may be obtained under specified circumstances. The FDA reviews all NDAs submitted for a period of 60 days to ensure that they are sufficiently complete for substantive review before it accepts them for filing. It may request additional information rather than accept an NDA for filing. In this event, the NDA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing. \u200bDuring the approval process, the FDA also will determine whether a risk evaluation and mitigation strategy, or REMS, is necessary to assure the safe use of the product. If the FDA concludes a REMS is needed, the sponsor of the NDA must submit a proposed REMS, and the FDA will not approve the application without an approved REMS, if required. A REMS can substantially increase the costs of obtaining approval. The FDA could also require a special warning, known as a boxed warning, to be included in the product label in order to highlight a particular safety risk. \u200bOnce the submission is accepted for filing, the FDA begins an in-depth review. The FDA reviews an NDA to determine, among other things, whether a product is safe and effective for its intended use and whether its manufacturing is cGMP-compliant. The FDA may refer the NDA to an advisory committee for review and recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendation of an advisory committee, but it generally follows such recommendations. NDAs receive either standard or priority review. A drug representing a significant improvement in treatment, prevention or diagnosis of disease may receive priority review. A priority review designation is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA\u2019s goal for taking action on the NDA from ten months to six months from filing of the NDA. After the FDA evaluates the NDA and conducts inspections of manufacturing facilities where the drug product and/or its active pharmaceutical ingredient will be produced, it may issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete, and the application is not ready for approval. A Complete Response Letter may require additional clinical data and/or an additional pivotal Phase 3 clinical trial(s), and/or other significant, expensive and time-consuming requirements related to clinical trials, preclinical studies or manufacturing. Even if such data and information are submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. \u200bPost-approval Requirements\u200bDrugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA and other governmental agencies, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion, and reporting of adverse experiences with the product. Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product may result in restrictions on the product or even complete withdrawal of the product from the market. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further FDA review and approval. There are also continuing annual user fee requirements for products, as well as new application fees for certain supplemental applications. In addition, the FDA may require testing and surveillance programs to monitor the effect of approved products that have been commercialized, and the FDA has the power to prevent or limit further marketing of a product based on the results of these post-marketing programs. \u200bDrug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and some state agencies for compliance with GMP regulations and other laws. The FDA has promulgated specific requirements for drug cGMPs. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance.\u200b12",
            "type": "paragraph"
        },
        {
            "id": 9,
            "context": "| \u25cf | refusal to approve pending applications; |\n| \u25cf | withdrawal of an approval; |\n| \u25cf | imposition of a clinical hold; |\n| \u25cf | warning letters; |\n| \u25cf | product seizures or detention, or refusal to permit the import or export of products; |\n| \u25cf | restrictions on the marketing or manufacturing of the product; |\n| \u25cf | total or partial suspension of production or distribution or product recalls; or |\n| \u25cf | injunctions, fines, disgorgement, or civil or criminal penalties. |",
            "type": "table"
        },
        {
            "id": 10,
            "context": "regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute\u2019s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal health care covered business, the Anti-Kickback Statute has been violated. Violations of this law are punishable by up to ten years in prison, and can also result in criminal fines, civil monetary penalties, administrative penalties and exclusion from participation in federal health care programs. \u200bAdditionally, the intent standard under the Anti-Kickback Statute was amended by the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the Affordable Care Act, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the Affordable Care Act codified case law that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. \u200bFederal false claims and false statement laws, including the federal civil False Claims Act, prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, for payment to, or approval by, federal programs, including Medicare and Medicaid, claims for items or services, including drugs, that are false or fraudulent or not provided as claimed. Entities can be held liable under these laws if they are deemed to \u201ccause\u201d the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers, promoting a product off-label, or for providing medically unnecessary services or items. In addition, activities relating to the sale and marketing of products are subject to scrutiny under this law. Penalties for federal civil False Claims Act violations may include up to three times the actual damages sustained by the government, plus mandatory civil penalties for each separate false claim, the potential for exclusion from participation in federal health care programs, and, although the federal civil False Claims Act is a civil statute, False Claims Act violations may also implicate various federal criminal statutes. \u200bThe federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, prohibits among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any health care benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a health care benefit program, willfully obstructing a criminal investigation of a health care offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for health care benefits, items or services. Like the Anti-Kickback Statute, the Affordable Care Act amended the intent standard for the health care fraud statute under HIPAA such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. \u200bThe civil monetary penalties statute imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent. \u200bAlso, many states have similar fraud and abuse statutes or regulations that may be broader in scope and may apply regardless of payor, in addition to items and services reimbursed under Medicaid and other state programs. Additionally, to the extent that a product is sold in a foreign country, the seller may be subject to similar foreign laws. \u200bIn addition, legislation imposing marketing restrictions and transparency requirements on pharmaceutical manufacturers has been enacted at the state and federal levels. For example, the Affordable Care Act imposed, among other things, annual reporting requirements to the Centers for Medicare & Medicaid Services, or CMS, for covered manufacturers for certain payments and other transfers of value provided to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other health care professionals (such as physician assistants and nurse practitioners) and teaching hospitals, as well as information regarding ownership and investment interests held by physicians and their immediate family members. Failure to submit timely, accurately and completely the required information for all payments, transfers of value and ownership or investment interests may result in civil monetary penalties for \u201cknowing failures.\u201d Certain states also mandate implementation of compliance programs, impose restrictions on drug manufacturer marketing practices, require registration of certain employees engaged in marketing activities in the 15",
            "type": "paragraph"
        },
        {
            "id": 11,
            "context": "location, and/or require the tracking and reporting of gifts, compensation and other remuneration to health care professionals, including physicians.\u200bWe have developed a comprehensive compliance program that establishes internal controls to facilitate adherence to the rules and program requirements to which we are subject. Although the development and implementation of compliance programs designed to establish internal controls and facilitate compliance can mitigate the risk of investigation, prosecution, and penalties assessed for violations of these laws, or any other laws that may apply to us, the risks cannot be entirely eliminated. If our operations are found to be in violation of any such laws or any other governmental regulations, we may be subject to significant penalties, including, without limitation, administrative, civil, and criminal penalties, damages, fines, disgorgement, imprisonment, contractual damages, reputational harm, diminished profits and future earnings, the curtailment or restructuring of our operations, exclusion from participation in federal and state health care programs, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and individual imprisonment, any of which could adversely affect our ability to operate our business and our financial results. \u200bWe may also be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, including the final omnibus rule published on January 25, 2013, mandates, among other things, the adoption of uniform standards for the electronic exchange of information in common health care transactions, as well as standards relating to the privacy and security of individually identifiable health information, which require the adoption of administrative, physical and technical safeguards to protect such information. Among other things, HITECH makes HIPAA\u2019s security standards directly applicable to \u201cbusiness associates\u201d, namely independent contractors or agents of HIPAA covered entities that create, receive or obtain protected health information in connection with providing a service for or on behalf of a covered entity and their subcontractors that use, disclose, access, or otherwise process protected health information. HITECH also increased the civil and criminal penalties that may be imposed against covered entities and business associates and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys\u2019 fees and costs associated with pursuing federal civil actions. In addition, certain state laws govern the privacy and security of health information in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and/or criminal penalties. \u200bHealth Care Reform \u200bIn the United States, there have been and continue to be a number of significant legislative initiatives to contain health care costs. For example, in March 2010, the Affordable Care Act was passed, which has had, and is expected to continue to have, a significant impact on the health care industry. The Affordable Care Act was designed to expand coverage for the uninsured and at the same time contain overall health care costs. With regard to pharmaceutical products, among other things, the Affordable Care Act expanded and increased industry rebates for drugs covered under Medicaid programs; addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; extended the rebate program to individuals enrolled in Medicaid managed care organizations; established annual fees and taxes on manufacturers of certain branded prescription drugs; made changes to the coverage requirements under the Medicare prescription drug benefit; and established a new Medicare Part D coverage gap discount program, in which manufacturers, as a condition for their outpatient drugs to be covered under Medicare Part D, must agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period. Moreover, the Affordable Care Act provided incentives to programs that increase the federal government\u2019s comparative effectiveness research and implemented payment system reforms including a national pilot program on payment bundling meant to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain health care services. \u200bThere have been executive branch, judicial and Congressional challenges to certain aspects of the Affordable Care Act. While Congress has not passed comprehensive repeal legislation, several bills affecting the implementation of certain taxes under the Affordable Care Act have been signed into law. On June 17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the Affordable Care Act is unconstitutional in its entirety because the \u201cindividual mandate\u201d was repealed by Congress. Prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the Affordable Care Act marketplace. The executive order also instructed certain governmental agencies 16",
            "type": "paragraph"
        },
        {
            "id": 12,
            "context": "to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the Affordable Care Act. Further, on August 16, 2022, President Biden signed the Inflation Reduction Act of 2022, or IRA, into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The IRA also eliminates the \u201cdonut hole\u201d under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and through a newly established manufacturer discount program. It is possible that the Affordable Care Act will be subject to judicial or Congressional challenges in the future. It is unclear how such challenges and any additional health care reform measures of the Biden administration will impact the Affordable Care Act and our business.\u200bIn addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. For example, in August 2011, President Obama signed into law the Budget Control Act of 2011, which, among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals in spending reductions. The Joint Select Committee on Deficit Reduction did not achieve a targeted deficit reduction of at least $1.2 trillion for fiscal years 2012 through 2021, triggering the legislation\u2019s automatic reduction to several government programs. This includes aggregate reductions in Medicare payments to providers of 2% per fiscal year, which went into effect beginning on April 1, 2013 and, due to subsequent legislative amendments to the statute, including the Bipartisan Budget Act of 2018, or the BBA, and the Infrastructure Investment and Jobs Act, will stay in effect through 2032 unless additional Congressional action is taken. Additionally, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals, cancer treatment centers and imaging centers. Moreover, the Drug Supply Chain Security Act imposes new obligations on manufacturers of pharmaceutical products related to product tracking and tracing. Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. \u200bThere has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Such scrutiny has resulted in several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. In July 2021, the Biden administration released an executive order, \u201cPromoting Competition in the American Economy,\u201d with multiple provisions aimed at prescription drugs. In response to Biden\u2019s executive order, on September 9, 2021, the Department of Health and Human Services, or HHS, released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. In addition, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs and biologics covered under Medicare and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. It is unclear how the IRA will be implemented in the future, but it is likely to have a significant impact on the pharmaceutical industry. Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. It is unclear whether this executive order or similar policy initiatives will be implemented in the future. On December 7, 2023, the Biden administration announced an initiative to control the price of prescription drugs through the use of march-in rights under the Bayh-Dole Act. On December 8, 2023, the National Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an agency can use when deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that will continue under the new framework. The effect of reducing prices and reimbursement for certain of our drug candidates, if approved, could significantly impact our business and consolidated results of operations. In addition, the IRA may meaningfully influence our pharmaceutical industry business strategies. In particular, it may reduce the attractiveness of investment in small molecule and biologic innovation. \u200bAt the state level, legislatures have become increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. For example, on January 5, 2024, the FDA approved Florida\u2019s proposal to import certain drugs from Canada for specific state healthcare programs. It is unclear if and how this program will be implemented and whether it will be subject challenges in the United States or 17",
            "type": "paragraph"
        },
        {
            "id": 13,
            "context": "Canada. Other states have also submitted proposals that are pending review by the FDA. Any such approved importation plans, if implemented, may result in lower drug prices for products covered by those programs.\u200bThe Affordable Care Act, the IRA, as well as other federal and state health care reform measures that have been and may be adopted in the future, could harm our future revenue. Additional legislative actions may be taken in the future which may change current regulations, guidance and interpretations. The impact of such actions on our business, if any, cannot presently be determined. \u200bThe Hatch Waxman Amendments to the FDCA \u200bOrange Book Listing \u200bIn seeking approval for a drug through an NDA, applicants are required to list with the FDA each patent whose claims cover the applicant\u2019s product or a method of using the product. Upon approval of a drug, each of the patents listed in the application for the drug is then published in the FDA\u2019s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Drugs listed in the Orange Book can, in turn, be cited by potential competitors in support of approval of an ANDA or an application covered by Section 505(b)(2) of the FDCA. An ANDA provides for marketing of a drug product that has the same active ingredients, generally in the same strengths and dosage form, as the listed drug and has been shown through pharmacokinetic, or PK, testing to be bioequivalent to the listed drug. Drugs approved in this way are commonly referred to as \u201cgeneric equivalents\u201d to the listed drug and can often be substituted by pharmacists under prescriptions written for the original listed drug. Other than the requirement for bioequivalence testing, ANDA applicants are generally not required to conduct, or submit results of, preclinical studies or clinical tests to prove the safety or effectiveness of their drug product. Section 505(b)(2) applications provide for marketing of a drug product that may have the same active ingredients as the listed drug and contains full safety and effectiveness data as an NDA, but at least some of this information comes from studies not conducted by or for the applicant. This alternate regulatory pathway enables the applicant to rely, in part, on the FDA\u2019s findings of safety and efficacy for an existing product, or published literature, in support of its application. The FDA may then approve the new drug candidate for all or some of the labeled indications for which the referenced product has been approved, as well as for any new indication sought by the 505(b)(2) applicant. \u200bThe ANDA or Section 505(b)(2) applicant is required to certify to the FDA concerning any patents listed for the approved product in the FDA\u2019s Orange Book. Specifically, the applicant must certify that: (i) the required patent information has not been filed; (ii) the listed patent has expired; (iii) the listed patent has not expired, but will expire on a particular date and approval is sought after patent expiration; or (iv) the listed patent is invalid or will not be infringed by the new product. The ANDA or Section 505(b)(2) applicant may also elect to submit a statement certifying that its proposed ANDA label does not contain, or carves out, any language regarding a patented method of use rather than certify to such listed method of use patent. If the applicant does not challenge the listed patents by filing a certification that the listed patent is invalid or will not be infringed by the new product, the ANDA or Section 505(b)(2) application will not be approved until all the listed patents claiming the referenced product have expired. \u200bA certification that the new product will not infringe the already approved product\u2019s listed patents, or that such patents are invalid, is called a Paragraph IV certification. If the ANDA or Section 505(b)(2) applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification to the NDA and patent holders once the ANDA or Section 505(b)(2) application has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the Paragraph IV certification. The filing of a patent infringement lawsuit within 45 days of the receipt of a Paragraph IV certification automatically prevents the FDA from approving the ANDA or Section 505(b)(2) application until the earliest of 30 months, expiration of the patent, settlement of the lawsuit, and a decision in the infringement case that is favorable to the ANDA or Section 505(b)(2) applicant. This prohibition is generally referred to as the 30-month stay. Thus, approval of an ANDA or 505(b)(2) NDA could be delayed for a significant period of time depending on the patent certification the applicant makes and the reference drug sponsor\u2019s decision to initiate patent litigation. \u200bThe ANDA or Section 505(b)(2) application also will not be approved until any applicable non-patent exclusivity listed in the Orange Book for the referenced product has expired. \u200b18",
            "type": "paragraph"
        },
        {
            "id": 14,
            "context": "Patent Term Extension \u200bIn the United States, after NDA approval, owners of relevant drug patents may apply for up to a five-year patent extension, which provides patent term restoration as compensation for the patent term lost during the FDA regulatory review process for the first permitted commercial marketing of a drug product. The Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, permits a patent term extension of up to five years beyond the expiration of the patent. The allowable patent term extension is calculated as half of the drug\u2019s testing phase, which is the time between the IND submission becoming effective and the NDA submission, and all of the review phase, which is the time between NDA submission and approval, up to a maximum extension of five years. The time can be shortened if the FDA determines that the applicant did not pursue approval with due diligence. Patent extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only one patent applicable to an approved drug may be extended. \u200bSimilar provisions are available in the European Union and other foreign jurisdictions to extend the term of a patent that covers an approved drug. For example, in Japan, it may be possible to extend the patent term for up to five years and in the European Union, it may be possible to obtain a supplementary patent certificate that would effectively extend patent protection for up to five years. \u200bCoverage and Reimbursement \u200bWe believe the success of our drug candidates, if approved, will depend on obtaining and maintaining coverage and adequate reimbursement as a prescription treatment or in the absence of coverage and adequate reimbursement, on the extent to which patients will be willing to pay out of pocket for our prescription drug products.\u200bThird-party payors determine which prescription drug products they will cover and establish reimbursement levels. Reimbursement by a third-party payor may depend upon a number of factors, including: the third-party payor\u2019s determination that a product is safe, effective, and medically necessary; appropriate for the specific patient; cost-effective; supported by peer-reviewed medical journals or current clinical practice guidelines; and whether there are competitive products, either branded or generic, and the pricing of those products. Many private third-party payors, such as managed care plans, manage access to drug products\u2019 coverage partly to control costs for their plans, and may use drug formularies and medical policies to limit their exposure. Obtaining and maintaining favorable reimbursement can be a time-consuming and expensive process, and our potential third-party partners may not be able to negotiate or continue to negotiate reimbursement or pricing terms for our drug candidates, if approved, with third-party payors at levels that are profitable to us, or at all. Further coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products which receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. \u200bIn addition to uncertainties surrounding coverage policies, there are periodic changes to reimbursement. Third-party payors regularly update reimbursement amounts and also from time to time revise the methodologies used to determine reimbursement amounts. Accordingly, these updates could impact the demand for our drug candidates, if approved. Our drug candidates, if approved, may not be considered cost effective, and government and third-party private health insurance coverage and reimbursement may not be available to patients or sufficient to allow our potential third-party partners to sell our drug candidates, if approved, on a competitive and profitable basis. Our results of operations could be adversely affected by the Affordable Care Act, the IRA and by other health care reforms that may be enacted or adopted in the future. In addition, increasing emphasis on managed care in the United States will continue to put pressure on the pricing of pharmaceutical products. Cost control initiatives could decrease the price that our potential third-party partners could receive for any of our drug candidates, if approved, and could adversely affect our profitability. We cannot predict how pending and future health care legislation will impact our business, and any changes in coverage and reimbursement that further restricts coverage of our drug candidates could harm our business. \u200bForeign governments also have their own health care reimbursement systems, which vary significantly by country and region, and we cannot be sure that coverage and adequate reimbursement will be made available with respect to our drug candidates, if approved, under any foreign reimbursement system. In some foreign countries, including major markets in the European Union and Japan, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take up to 12 months or longer after the receipt of regulatory marketing approval for a product. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a pharmacoeconomic study that compares the cost-effectiveness of our drug candidate to other available therapies. Such pharmacoeconomic studies can be costly and the results uncertain. Our business could be harmed 19",
            "type": "paragraph"
        },
        {
            "id": 15,
            "context": "if reimbursement of our drug candidates, if approved, is unavailable or limited in scope or amount or if pricing is set at unsatisfactory levels.\u200bEmployees and Human Capital Resources\u200bAs of December 31, 2023, we had 91 total employees, of which 86 were full-time employees. On December 19, 2023, we announced a plan to reduce our workforce, which we anticipate to be substantially complete by June 2024. All of our employees are located in the United States. None of our employees are represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with our employees to be good.\u200bOur human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity incentive plans are to attract, retain and reward personnel through the granting of stock-based compensation awards in order to increase stockholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.\u200bCorporate Information \u200bWe were incorporated under the laws of the State of Delaware in July 2012. Our principal executive offices are located at 701 Lee Road, Suite 103, Wayne, PA 19087. Our telephone number is (484) 324-7933. Our common stock is listed on the Nasdaq Global Select Market under the symbol \u201cACRS.\u201d\u200bAvailable Information \u200bOur internet website address is www.aclaristx.com. In addition to the information contained in this Annual Report, information about us can be found on our website. Our website and information included in or linked to our website are not part of this Annual Report. \u200bOur annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available free of charge through our website as soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission, or SEC. The SEC also maintains a website that contains our reports, proxy and information statements and other information. The address of the SEC\u2019s website is www.sec.gov.\u200b20",
            "type": "paragraph"
        },
        {
            "id": 16,
            "context": "Item 1A. Risk Factors\n\u200b Our business is subject to numerous risks. You should carefully consider the following risks and all other information contained in this Annual Report, as well as general economic and business risks, together with any other documents we file with the SEC. If any of the following events actually occur or risks actually materialize, it could have a material adverse effect on our business, operating results and financial condition and cause the trading price of our common stock to decline.",
            "type": "paragraph"
        },
        {
            "id": 17,
            "context": "\u200b\nSummary of Risk Factors\n\n\u200b\nRisks Related to Our Business, Our Financial Position and Capital Needs\n\u200b\nWe have incurred significant losses since our inception. We expect to incur losses over the next several years and may never achieve or maintain profitability.\n\u200b Since inception, we have incurred significant net losses. We incurred net losses of $88.5 million and $86.9 million for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, we had an accumulated deficit of $770.8 million. We have financed our operations over the last several years primarily from sales of equity securities and incurring indebtedness in the form of loans from commercial lenders.",
            "type": "paragraph"
        },
        {
            "id": 18,
            "context": "\u200b We have devoted substantially all of our financial resources and efforts to the development of our drug candidates, including preclinical studies and clinical trials. Our net losses may fluctuate significantly from quarter to quarter and year to year. We expect to continue to incur significant expenses and operating losses in the near term as we:",
            "type": "paragraph"
        },
        {
            "id": 19,
            "context": "\u200b\n21\n\n| \u25cf | the scope, progress, results and costs of preclinical development, laboratory testing and conducting preclinical and clinical trials for our drug candidates; |\n| \u25cf | the costs, timing and outcome of regulatory review of our drug candidates; |\n| \u25cf | the extent to which we in-license or acquire drug candidates and technologies; |\n| \u25cf | the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; |\n| \u25cf | our ability to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates; and |\n| \u25cf | our ability to earn revenue from licenses to, or partnerships or other arrangements with, third parties. |",
            "type": "table"
        },
        {
            "id": 20,
            "context": "| \u25cf | our drug discovery methods and our KINect platform may not be successful in identifying additional drug candidates; |\n| \u25cf | our discovery programs may initially show promise in identifying potential drug candidates, yet fail to yield drug candidates for clinical development; and |\n| \u25cf | potential drug candidates may, on further study, be shown to have harmful side effects or other characteristics that indicate that they are unlikely to be drug candidates that will receive marketing approval and achieve market acceptance. |\n| \u25cf | successful completion of preclinical studies and our clinical trials; |\n| \u25cf | successful development of manufacturing processes; |\n| \u25cf | receipt of timely approvals from applicable regulatory authorities; |\n| \u25cf | the identification and consummation of transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates; |\n| \u25cf | the commercial launch of our drug candidates, if approved, by a potential third-party partner; |\n| \u25cf | our potential third-party partners\u2019 ability to achieve acceptance of our drug candidates, if approved, by patients, the medical community and third-party payors, and willingness of patients to pay out of pocket for our drug candidates when third-party payor coverage and reimbursement is limited or unavailable; |\n| \u25cf | our potential third-party partners\u2019 ability to achieve success in educating physicians and patients about the benefits, administration and use of our drug candidates, if approved; |\n| \u25cf | the prevalence and severity of adverse events experienced with our drug candidates; |\n| \u25cf | the availability, perceived advantages, cost, safety and efficacy of alternative treatments for the proposed indications of our drug candidates; |\n| \u25cf | obtaining and maintaining patent, trademark and trade secret protection and regulatory exclusivity for our drug candidates and otherwise protecting the intellectual property portfolio; |\n| \u25cf | maintaining compliance with regulatory requirements, including current good manufacturing practices, or cGMPs; |\n| \u25cf | our potential third-party partners\u2019 ability to compete effectively with other treatment procedures; and |\n| \u25cf | our potential third-party partners\u2019 ability to maintain a continued acceptable safety, tolerability and efficacy profile of our drug candidates following marketing approval. |",
            "type": "table"
        },
        {
            "id": 21,
            "context": "| \u25cf | regulators or IRBs may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; |\n| \u25cf | we may experience delays in reaching, or fail to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites or prospective contract research organizations, or CROs, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; |\n| \u25cf | clinical trials of our drug candidates may produce negative or inconclusive results, including failure to demonstrate statistical significance, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon drug development programs; |\n| \u25cf | the number of patients required for clinical trials of our drug candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate; |\n| \u25cf | our drug candidates may have undesirable side effects or other unexpected characteristics, causing us or our investigators, regulators or IRBs to suspend or terminate the trials; |\n| \u25cf | our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all; |",
            "type": "table"
        },
        {
            "id": 22,
            "context": "| \u25cf | regulators or IRBs may require that we or our investigators suspend or terminate clinical development for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks; |\n| \u25cf | the cost of clinical trials of our drug candidates may be greater than we anticipate; and |\n| \u25cf | the supply or quality of our drug candidates or other materials necessary to conduct clinical trials of our drug candidates may be insufficient or inadequate. |\n| \u25cf | be delayed in obtaining marketing approval for our drug candidates; |\n| \u25cf | not obtain marketing approval at all; |\n| \u25cf | obtain marketing approval for indications or patient populations that are not as broad as intended or desired; |\n| \u25cf | obtain marketing approval with labeling that includes significant use or distribution restrictions or safety warnings; |\n| \u25cf | be subject to additional post-marketing testing requirements; or |\n| \u25cf | have the drug removed from the market after obtaining marketing approval. |",
            "type": "table"
        },
        {
            "id": 23,
            "context": "| \u25cf | the eligibility criteria for the trial in question; |\n| \u25cf | the perceived risks and benefits of the drug candidate in the trial; |\n| \u25cf | the availability of drugs approved to treat the disease in the trial; |\n| \u25cf | the efforts to facilitate timely enrollment in clinical trials; |\n| \u25cf | the patient referral practices of physicians; |\n| \u25cf | the ability to monitor patients adequately during and after treatment; and |\n| \u25cf | the proximity and availability of clinical trial sites for prospective patients. |\n| \u25cf | we may need to abandon the development or limit the further development of our drug candidates, including in various populations and for certain indications; |\n| \u25cf | regulatory authorities may withdraw approval to market such product; |\n| \u25cf | regulatory authorities may require additional warnings on the labels; |\n| \u25cf | a medication guide outlining the risks of such side effects for distribution to patients may be required; |\n| \u25cf | we could be sued and held liable for harm caused to patients; |\n| \u25cf | our reputation and physician or patient acceptance of our drug candidates, if approved, may suffer; and |\n| \u25cf | our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates would be harmed. |",
            "type": "table"
        },
        {
            "id": 24,
            "context": "Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more subject data become available and are subject to audit and verification procedures that could result in material changes in the final data.\u200bFrom time to time, we may publicly disclose interim, topline or preliminary data from our clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a full analysis of all data related to the particular trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. In addition, we may report preliminary analyses of only certain endpoints rather than all endpoints. As a result, the interim, topline or preliminary results that we report may differ from future results of the same trials, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim, topline and preliminary data should be viewed with caution until the final data are available. We may also disclose interim data from our clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as subject enrollment continues and more subject data become available. Adverse differences between interim, topline or preliminary data and final data could significantly harm our reputation and business prospects. Further, disclosure of interim, topline or preliminary data by us or by our competitors could result in volatility in the price of our common stock.\u200bFurther, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the potential of the particular program, the likelihood of marketing approval or commercialization of the particular drug candidate, any approved product, and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is derived from information that is typically extensive, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular program, drug candidate or our business.\u200bIf the interim, topline or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates may be harmed, which could harm our business, operating results, prospects or financial condition.\u200bChanges in methods of drug candidate manufacturing or formulation may result in additional costs or delay.\u200bAs drug candidates are developed through preclinical studies to late-stage clinical trials towards approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize processes and results. Such changes carry the risk that they will not achieve these intended objectives, and may also require additional testing, FDA notification or FDA approval. Any of these changes could cause our drug candidates to perform differently and affect the results of planned clinical trials or other future clinical trials conducted with the altered materials. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our drug candidates and jeopardize our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates.\u200bWe have conducted and may in the future conduct clinical trials for our drug candidates outside the United States. The FDA, EMA or comparable foreign regulatory authorities may not accept data from such trials.\u200bWe have conducted and may in the future conduct clinical trials for our drug candidates outside the United States. The acceptance of trial data from clinical trials conducted outside the United States or another jurisdiction by the FDA or comparable foreign regulatory authorities may be subject to certain conditions or may not be accepted at all. Such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, EMA or any comparable foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA, EMA or any comparable regulatory authority does 28",
            "type": "paragraph"
        },
        {
            "id": 25,
            "context": "| \u25cf | the efficacy, safety and potential advantages compared to alternative treatments; |\n| \u25cf | our potential third-party partners\u2019 ability to offer the products for sale at competitive prices; |\n| \u25cf | the convenience and ease of administration compared to alternative treatments; |\n| \u25cf | the willingness of the target patient population to try new treatments and of physicians to prescribe these treatments; |\n| \u25cf | the ability of our potential third-party partners to retain a sales force; |\n| \u25cf | the strength of our potential third-party partners\u2019 marketing and distribution support; |\n| \u25cf | the availability of third-party payor coverage and adequate reimbursement or the willingness of patients to pay for these products; |\n| \u25cf | the prevalence and severity of any side effects; and |\n| \u25cf | any restrictions on the use of our products together with other medications. |",
            "type": "table"
        },
        {
            "id": 26,
            "context": "We face substantial competition, which may result in others discovering, developing or commercializing drugs before or more successfully than we do.\u200bThe development and commercialization of new drugs is highly competitive. We will face competition with respect to any drug candidates that we may seek to develop or through our potential third-party partners, commercialize, in the future, from many different sources, including major pharmaceutical, biotechnology and specialty pharmaceutical companies, academic institutions and governmental agencies and public and private research institutions.\u200bWith respect to ATI-1777 as a potential treatment for atopic dermatitis, there are several different types of therapies in the atopic dermatitis market, such as biologics, oral and topical corticosteroids, oral and topical calcineurin inhibitors, oral mycophenolate products, other JAK inhibitors, other oral antibiotics and antihistamines and phototherapy. There are also several prescription, non-prescription and OTC topical products, including PDE4 inhibitors, utilized to treat atopic dermatitis. These types of drugs are produced and sold, or are approved for marketing, by large pharmaceutical companies, including AbbVie, Incyte, LEO Pharma A/S, Pfizer, and Regeneron Pharmaceuticals and Sanofi. In addition, we are aware of a number of companies including large pharmaceutical companies, such as Amgen, Dermavant Sciences, Eli Lilly, LEO Pharma A/S and Pfizer, developing and conducting clinical trials for investigational drug candidates that could compete with ATI-1777, in each case if approved, for the treatment of atopic dermatitis.\u200bThe commercial opportunity for our drug candidates, if approved, could be reduced or eliminated if our competitors develop and commercialize drugs that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than a drug that we may develop. Our competitors also may obtain FDA or other regulatory approval for their drugs more rapidly than our potential third-party partners\u2019 may obtain approval for our drug candidates, which could result in our competitors establishing a strong market position before our drug candidates are able to enter the market.\u200bMany of the companies against which we are competing, or against which we may compete in the future, have significantly greater financial resources and expertise in research and development, manufacturing, and preclinical and clinical development than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or that may be necessary for, our development programs.\u200bThe success of our drug candidates, if approved, will depend significantly on coverage and adequate reimbursement or the willingness of patients to pay for these products.\u200bWe believe the success of our drug candidates, if approved, will depend on obtaining and maintaining coverage and adequate reimbursement as a prescription treatment or in the absence of coverage and adequate reimbursement, on the extent to which patients will be willing to pay out of pocket for these prescription drug products.\u200bThird-party payors determine which prescription drug products they will cover and establish reimbursement levels. Reimbursement by a third-party payor may depend upon a number of factors, including: the third-party payor\u2019s determination that a product is safe, effective, and medically necessary; appropriate for the specific patient; cost-effective; supported by peer-reviewed medical journals or current clinical practice guidelines; and whether there are competitive products, either branded or generic, and the pricing of those products. Many private third-party payors, such as managed care plans, manage access to drug products\u2019 coverage partly to control costs for their plans, and may use drug formularies and medical policies to limit their exposure. Obtaining and maintaining favorable reimbursement can be a time-consuming and expensive process, and our potential third-party partners may not be able to negotiate or continue to negotiate reimbursement or pricing terms for our products with third-party payors at levels that are profitable to us, or at all. Further, coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products which receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. \u200bIn addition to uncertainties surrounding coverage policies, there are periodic changes to reimbursement. Third-party payors regularly update reimbursement amounts and also from time to time revise the methodologies used to determine reimbursement amounts. Accordingly, these updates could impact the demand for our drug candidates, if 30",
            "type": "paragraph"
        },
        {
            "id": 27,
            "context": "| \u25cf | decreased demand for any drug candidates that we may develop and, if approved, are commercialized by our potential third-party partners; |\n| \u25cf | injury to our reputation and significant negative media attention; |\n| \u25cf | withdrawal of clinical trial participants; |\n| \u25cf | significant costs to defend the related litigation; |\n| \u25cf | substantial monetary awards paid to trial participants or patients; |\n| \u25cf | loss of revenue; |\n| \u25cf | reduced resources of our management to pursue our business strategy; and |\n| \u25cf | our inability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates. |",
            "type": "table"
        },
        {
            "id": 28,
            "context": "our clinical trials will not be our employees, and except for remedies available to us under our agreements with such third parties, we cannot control whether or not they devote sufficient time and resources to our clinical programs. If these third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates. Consequently, our results of operations and the commercial prospects for our drug candidates would be harmed, our costs could increase substantially and our ability to earn revenue from those partnerships could be delayed significantly.\u200bSwitching or adding CROs involves substantial cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. Though we intend to carefully manage our relationships with our CROs, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects.\u200bWe rely on these parties for execution of our preclinical studies and clinical trials, and generally do not control their activities. Our reliance on these third parties for research and development activities will reduce our control over these activities but will not relieve us of our responsibilities. For example, we will remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with standards, commonly referred to as good clinical practices, or GCPs, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. We also are required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within specified timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. If we or any of our CROs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials complies with GCP regulations. In addition, our clinical trials must be conducted with drug product produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the marketing approval process for our potential third-party partners.\u200bWe also rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of our drug candidates or commercialization of our drug candidates, if approved, producing additional losses and depriving us of potential revenue.\u200bWe contract with third parties for the manufacture and supply of our drug candidates for preclinical and clinical testing. This reliance on third parties increases the risk that we will not have sufficient quantities of our drug candidates or such quantities at an acceptable cost, which could delay, prevent or impair our development efforts.\u200bWe do not have any manufacturing facilities. We currently rely, and expect to continue to rely, on third parties for the manufacture and supply of our drug candidates for preclinical and clinical testing. This reliance on third parties increases the risk that we will not have sufficient quantities of our drug candidates at an acceptable cost and/or quality, which could delay, prevent or impair our ability to timely conduct our clinical trials or our other development efforts.\u200bThe facilities used by our contract manufacturers to manufacture our drug candidates must be approved by the FDA or comparable foreign regulatory authorities pursuant to inspections that will be conducted after the NDA or comparable marketing application is submitted to the FDA or other regulatory authority. We do not have control over a supplier\u2019s or manufacturer\u2019s compliance with laws, regulations and applicable cGMP standards and other laws and regulations, such as those related to environmental health and safety matters. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, they will not be able to secure and maintain regulatory approval for their manufacturing facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our drug candidates or if it withdraws any such approval in the future, we may need to find alternative 32",
            "type": "paragraph"
        },
        {
            "id": 29,
            "context": "| \u25cf | reliance on the third party for regulatory compliance and quality assurance; |\n| \u25cf | the possible breach of the manufacturing agreement by the third party; |\n| \u25cf | the possible misappropriation of our proprietary information, including our trade secrets and know-how; |\n| \u25cf | the possible increase in costs by our third-party suppliers for the active pharmaceutical ingredients for our drug candidates; and |\n| \u25cf | the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us. |\n| \u25cf | partners have significant discretion in determining the efforts and resources that they will apply to these arrangements; |\n| \u25cf | partners may not perform their obligations as expected; |\n| \u25cf | partners may not pursue development, marketing approval or commercialization of any drug candidates that achieve marketing approval or may elect not to continue or renew development or commercialization |",
            "type": "table"
        },
        {
            "id": 30,
            "context": "| programs based on clinical trial results, changes in the partners\u2019 strategic focus or available funding, or external factors, such as an acquisition, that divert resources or create competing priorities; |\n| \u25cf | partners may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a drug candidate, repeat or conduct new clinical trials or require a new formulation of a drug candidate for clinical testing; |\n| \u25cf | partners could independently develop, or develop with third parties, products that compete directly or indirectly with our drug candidates if the partners believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours; |\n| \u25cf | drug candidates discovered in collaboration with us may be viewed by our collaborators as competitive with their own products or drug candidates, which may cause our partners to cease to devote resources to the development and/or commercialization of our drug candidates, if approved; |\n| \u25cf | a partner with marketing and distribution rights to one or more of our drug candidates that achieve marketing approval may not commit sufficient resources to the marketing and distribution of such drug candidates; |\n| \u25cf | disagreements with partners, including disagreements over proprietary rights, contract interpretation or the preferred course of development or commercialization, might cause delays or termination of the research, development or commercialization of drug candidates, might lead to additional responsibilities for us with respect to drug candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive; |\n| \u25cf | partners may not properly maintain or defend our or their intellectual property rights or may use our or their proprietary information in such a way as to invite litigation that could jeopardize or invalidate such intellectual property or proprietary information or expose us to potential litigation; |\n| \u25cf | partners may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; and |\n| \u25cf | partnerships may be terminated for the convenience of the partner and, if terminated, we could be required to raise additional capital to pursue further development and/or commercialization of the applicable drug candidates. |",
            "type": "table"
        },
        {
            "id": 31,
            "context": "on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our drug candidates or bring them to market and generate revenue.We may not have access to all information regarding our drug candidates that are subject to partnership agreements. Consequently, our ability to inform our stockholders about the status of our drug candidates that are subject to these agreements, and our ability to make business and operational decisions, may be limited. We may not have access to all information regarding our drug candidates that may become subject to agreements with partners, including potentially material information about clinical trial design, execution and timing, safety and efficacy, clinical trial results, regulatory affairs, manufacturing, marketing, sales and other areas known by our potential partners. In addition, we may have confidentiality obligations under our agreements with such partners. Therefore, our ability to keep our stockholders informed about the status of our drug candidates will be limited by the degree to which our partners keep us informed and by the degree to which our partners allow us to disclose information to the public or provide such information to the public themselves. If our partners do not timely inform us about the status of our drug candidates that are the subject of the partnership, we may make operational and investment decisions that we would not have made had we been fully informed, which may have an adverse impact on our business, prospects, financial condition and results of operations. \u200bRisks Related to Our Intellectual Property\u200bIf we are unable to obtain and maintain patent protection for our drug candidates, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and drugs similar or identical to ours, and ability to successfully identify a potential third-party partner to commercialize our technology and drug candidates may be impaired.\u200bOur success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect to our drug candidates. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our drug candidates. \u200bThe patent prosecution process is expensive and time-consuming, however, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our development output before it is too late to obtain patent protection. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents licensed to third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.\u200bThe patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States or vice versa. For example, European patent law restricts the patentability of methods of treatment of the human body more than U.S. law does. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we or our licensors were the first to make the inventions claimed in our patents or pending patent applications, or that we or our licensors were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our technology or drug candidates, in whole or in part, or which effectively prevent others from commercializing competitive technologies and drug candidates. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.\u200bMoreover, we may be subject to a third-party preissuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or other foreign patent office, or become involved in opposition, central revocation, derivation, reexamination, inter partes review, post-grant review or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or drug candidates and compete directly with us, without payment to us, or result in the inability of our potential third-party partners to manufacture or 35",
            "type": "paragraph"
        },
        {
            "id": 32,
            "context": "commercialize our drug candidates without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications that we own or license is threatened, it could dissuade companies from partnering with us to license, develop and/or commercialize our drug candidates. \u200bEven if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us or our potential third-party partners or otherwise provide us or our potential third-party partners with any competitive advantage. Competitors may be able to circumvent our patents by developing similar or alternative technologies or drugs in a non-infringing manner.\u200bIn addition, the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit the ability to stop others from using or commercializing similar or identical technology and drug candidates, or limit the duration of the patent protection of our technology and drug candidates. Our issued U.S. patents covering zunsemetinib expire in 2034. Our issued U.S. patent covering ATI-1777 expires in 2038. Our issued U.S. patent directed to ATI-2138 expires in 2039. We are pursuing patent protection for methods of use, polymorphs and methods of manufacture for our drug candidates that may extend the term of patent protection. Given the amount of time required for the development, testing and regulatory review of new drug candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our patent portfolio may not provide us or our potential third-party partners with sufficient rights to exclude others from commercializing drugs similar or identical to ours.\u200bWe may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful. Further, our issued patents could be found invalid or unenforceable if challenged in court.\u200bCompetitors may infringe our issued patents or other intellectual property. Our pending applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents or that our patents are invalid or unenforceable. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, non-enablement or insufficient written description, or similar requirements outside of the United States. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution. Third parties may also raise similar claims before the USPTO, in post-grant proceedings such as ex parte reexaminations, inter partes review, or post-grant review, or oppositions or similar administrative proceedings outside the United States, in parallel with litigation or, even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our drug candidates. Such a loss of patent protection would harm our business. \u200bIn such a proceeding, a court or administrative board may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent\u2019s claims narrowly or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology. An adverse result in any such proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. We may find it impractical or undesirable to enforce our intellectual property against some third parties. \u200bInterference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. \u200bFurthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.36",
            "type": "paragraph"
        },
        {
            "id": 33,
            "context": "\u200bWe may not be able to protect our intellectual property rights throughout the world.\u200bFiling, prosecuting and defending patents on our drug candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. For example, zunsemetinib is currently covered by patents and applications in the United States, European Union and other foreign markets. While we have issued U.S. patents directed to ATI-1777 and ATI-2138, we do not currently have any patents for such drug candidates in the European Union or other foreign markets; rather, we have pending applications in the European Union and other foreign markets directed to each of ATI-1777 and ATI-2138.\u200bMany companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of some countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. \u200bMany countries, including European Union countries, India, Japan and China, have compulsory licensing laws under which a patent owner may be compelled under specified circumstances to grant licenses to third parties. In those countries, we may have limited remedies if patents are infringed or if we are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit our ability to pursue strategic alternatives, including identifying and consummating transactions with potential third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates, and consequently our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.\u200bWe may need to license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.\u200bA third party may hold intellectual property, including patent rights, that are important or necessary to the development and/or commercialization of our drug candidates. It may be necessary for us or our potential third-party partners to use the patented or proprietary technology of third parties to further develop and/or commercialize our drug candidates. If we or our potential third-party partners are not able to obtain a license from these third parties on commercially reasonable terms, our business could be harmed, possibly materially, and even if we or they are able to, it may result in the reduction of revenue we earn from such partner as a result of payment obligations to the licensor. \u200bThird parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business.\u200bOur success depends upon our ability to pursue strategic alternatives, including identifying and consummating transactions with potential third-party partners, to develop, obtain marketing approval for and/or commercialize our drug candidates and earn revenue from those partnerships, and for our proprietary technologies to be used without infringing the proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our drug candidates and technologies, including interference or derivation proceedings before the USPTO. Numerous U.S. and foreign issued patents and pending patent applications owned by third parties exist in the fields in which we are developing our drug candidates. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future.\u200bIf we or our potential third-party partners are found to infringe a third party\u2019s intellectual property rights, we or such partners could be required to obtain a license from such third party to continue developing or commercializing our drug candidates and technology. However, we or our potential third-party partners may not be able to obtain any required license on commercially reasonable terms or at all. Even if we or our potential third-party partner were able to obtain a license, it could be non-exclusive, thereby giving competitors access to the same technologies licensed to us or our partner. Consequently, we or our potential third-party partner could be forced, including by court order, to cease developing or 37",
            "type": "paragraph"
        },
        {
            "id": 34,
            "context": "commercializing the infringing technology or drug candidate. In addition, we or our potential third-party partner could be found liable for monetary damages, including treble damages and attorneys\u2019 fees if we or such partner are found to have willfully infringed a patent. A finding of infringement could prevent our potential third-party partners from commercializing our drug candidates, if approved, or force such partners to cease some of their business operations. In the event of a successful claim of infringement against us or our potential third-party partners, we or our potential third-party partners may have to pay substantial damages, including treble damages and attorneys\u2019 fees for willful infringement, pay royalties, redesign our infringing drug candidate or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business.\u200bWe may be subject to claims by third parties asserting that we, our employees or our licensors have misappropriated their intellectual property, or claiming ownership of what we regard as our own intellectual property.\u200bMany of our employees and our licensors\u2019 employees were previously employed at other biotechnology or pharmaceutical companies. Although we and our licensors try to ensure that our employees and our licensors\u2019 employees do not use the proprietary information or know-how of others in their work for us, we or our licensors may be subject to claims that these employees, our licensors or we have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such employee\u2019s former employer. Litigation may be necessary to defend against these claims. \u200bIn addition, while it is our policy to require our employees and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own. Our and their assignment agreements may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims they may bring against us, to determine the ownership of what we regard as our intellectual property.\u200bIf we or our licensors fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we and our licensors are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to management. \u200bIntellectual property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities.\u200bEven if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Some of our competitors are larger than we are and have substantially greater resources. They are, therefore, likely to be able to sustain the costs of complex patent litigation longer than we could. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing upon or misappropriating our intellectual property. Litigation could result in substantial costs and diversion of management resources, which could harm our business. In addition, the uncertainties associated with litigation could compromise our ability to compete in the marketplace, including compromising our ability to raise the funds necessary to continue our clinical trials, continue our internal research programs, or pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates.\u200bIf we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.\u200bIn addition to seeking and maintaining patents for our drug candidates, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have 38",
            "type": "paragraph"
        },
        {
            "id": 35,
            "context": "access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed. \u200bThe validity, scope and enforceability of any of our patents that cover any of our drug candidates can be challenged by competitors.\u200bIf any of our drug candidates advance through development or are approved by the FDA or foreign regulatory authority, one or more third parties may challenge the current patents, or patents that may issue in the future, within our portfolio covering these drug candidates. The challenge may come in the form of a patent office proceeding, such as an inter partes review challenging the validity of the patents, or a district court proceeding such as a paragraph IV litigation arising out of the filing of an ANDA. Litigation or other proceedings to enforce or defend intellectual property rights are often very complex in nature, may be expensive and time-consuming, may divert our management's attention from our core business, and may result in unfavorable results that could limit our ability to prevent third parties from competing with our drug candidates, if approved. Any such challenge could result in the invalidation of, or render unenforceable, some or all of the relevant patent claims or a finding of non-infringement, which would harm our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates, and earn revenue from such arrangements. In addition, any such challenge on any divested product could harm our ability to earn revenue from the arrangements for such product. \u200bIf we do not obtain protection under the Hatch-Waxman Act by extending the patent term and obtaining data exclusivity for our drug candidates, our business may be materially harmed.\u200bOur success will largely depend on our ability to obtain and maintain patent and other intellectual property in the United States and other countries with respect to our proprietary technology, drug candidates and our target indications. Our issued U.S. patents covering zunsemetinib expire in 2034. Our issued U.S. patent covering ATI-1777 expires in 2038. Our issued U.S. patent directed to ATI-2138 expires in 2039. Given the amount of time required for the development, testing and regulatory review of new drug candidates, patents protecting our drug candidates might expire before or shortly after such candidates begin to be commercialized. We expect to seek extensions of patent terms in the United States and, if available, in other countries where we are prosecuting patents.\u200bDepending upon the timing, duration and specifics of FDA marketing approval of our drug candidates, one or more of our U.S. patents may be eligible for limited patent term extension under The Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, for a drug candidate. The Hatch-Waxman Act permits a patent extension term of up to five years beyond the normal expiration of the patent as compensation for patent term lost during development and the FDA regulatory review process, which is limited to the approved indication (or any additional indications approved during the period of extension). However, the total patent term including the period of extension cannot exceed 14 years from the product\u2019s approval date. Furthermore, this extension is limited to only one patent per regulatory review period that covers the approved product. However, the applicable authorities, including the FDA and the USPTO in the United States, and any equivalent regulatory authority in other countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. We may not be granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. Similar provisions are available in certain foreign countries, such as the European Union and Japan.\u200bIf we are unable to extend the expiration date of our existing patents or obtain new patents with longer expiry dates, our competitors may be able to take advantage of our investment in development and clinical trials by referencing 39",
            "type": "paragraph"
        },
        {
            "id": 36,
            "context": "| \u25cf | we, our licensors or any potential third-party partners might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own; |\n| \u25cf | we, our licensors or any potential third-party partners might not have been the first to file patent applications covering certain of our inventions; |\n| \u25cf | others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights; |\n| \u25cf | it is possible that our pending patent applications will not lead to issued patents; |\n| \u25cf | issued patents that we own or exclusively license may not provide us with any competitive advantages, or may be held invalid or unenforceable as a result of legal challenges; |\n| \u25cf | our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, |",
            "type": "table"
        },
        {
            "id": 37,
            "context": "| \u25cf | differing regulatory requirements in foreign countries; |\n| \u25cf | the potential for so-called parallel importing, which is what happens when a local seller, faced with high or higher local prices, opts to import goods from a foreign market (with low or lower prices) rather than buying them locally; |\n| \u25cf | unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements; |\n| \u25cf | economic weakness, including inflation, or political instability in particular foreign economies and markets; |\n| \u25cf | foreign reimbursement, pricing and insurance regimes; |\n| \u25cf | compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; |\n| \u25cf | foreign taxes, including withholding of payroll taxes; |\n| \u25cf | foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; |\n| \u25cf | difficulties staffing and managing foreign operations; |\n| \u25cf | workforce uncertainty in countries where labor unrest is more common than in the United States; |\n| \u25cf | potential liability under the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, or comparable foreign regulations; |\n| \u25cf | challenges enforcing contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States; |\n| \u25cf | production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; |\n| \u25cf | logistical challenges resulting from distributing our drug candidates to foreign countries; and |\n| \u25cf | business interruptions resulting from geo-political actions, including war and terrorism. |",
            "type": "table"
        },
        {
            "id": 38,
            "context": "| \u25cf | restrictions on such drugs, manufacturers or manufacturing processes; |\n| \u25cf | restrictions on the labeling or marketing of a drug; |\n| \u25cf | restrictions on drug distribution or use; |\n| \u25cf | requirements to conduct post-marketing studies or clinical trials; |\n| \u25cf | warning letters; |\n| \u25cf | recall or withdrawal of the drugs from the market; |\n| \u25cf | refusal to approve pending applications or supplements to approved applications; |\n| \u25cf | clinical holds; |\n| \u25cf | fines, restitution or disgorgement of profits or revenue; |\n| \u25cf | suspension or withdrawal of marketing approvals; |\n| \u25cf | refusal to permit the import or export of our drugs; |\n| \u25cf | drug seizure; or |\n| \u25cf | injunctions or the imposition of civil or criminal penalties. |\n| \u25cf | the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under federal and state health care programs such as Medicare and Medicaid. Further, several courts have interpreted the statute\u2019s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal health care covered business, the Anti-Kickback Statute has been violated. The intent standard was further amended by the Affordable Care Act, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a |",
            "type": "table"
        },
        {
            "id": 39,
            "context": "| violation. Moreover, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; |\n| \u25cf | federal civil and criminal false claims laws, including, without limitation, the federal civil False Claims Act (that can be enforced through civil whistleblower or qui tam actions), and the civil monetary penalties law, which impose criminal and civil penalties, against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, including the Medicare and Medicaid programs, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government; |\n| \u25cf | federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes criminal and civil liability for, among other things, executing a scheme to defraud any health care benefit program or making false statements relating to health care matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation; |\n| \u25cf | HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their respective implementing regulations, which impose obligations on covered health care providers, health plans, and health care clearinghouses, as well as their business associates that create, receive, maintain or transmit individually identifiable health information for or on behalf of a covered entity and their subcontractors that use, disclose, access, or otherwise process protected health information, with respect to safeguarding the privacy, security and transmission of individually identifiable health information; |\n| \u25cf | the federal Open Payments program, created under Section 6002 of the Affordable Care Act (commonly known as the Physician Payments Sunshine Act) and its implementing regulations, which requires specified manufacturers of drugs, devices, biologics or medical supplies for which payment is available under Medicare, Medicaid or the Children\u2019s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare & Medicaid Services, or CMS, information related to \u201cpayments or other transfers of value\u201d made to physicians, which is defined to include doctors, dentists, optometrists, podiatrists and chiropractors, other health care professionals (such as physician assistants and nurse practitioners), and teaching hospitals, and for applicable manufacturers to report annually to CMS information regarding ownership and investment interests held by physicians and their immediate family members; and |\n| \u25cf | analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving health care items or services reimbursed by non-governmental third-party payors, including private insurers; state and foreign laws that require pharmaceutical companies to comply with the pharmaceutical industry\u2019s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to health care providers; state, local and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other health care providers or marketing expenditures; state laws that require drug manufacturers to report pricing information regarding certain drugs; and/or that require registration of certain employees engaged in marketing activities in the location; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. |",
            "type": "table"
        },
        {
            "id": 40,
            "context": "additional reporting requirements and oversight if we or they become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our or their operations, which could have a material adverse effect on our ability to earn revenue from arrangements with such third-party partners for our drug candidates. If any physician or other health care provider or entity with whom we or our potential third-party partners expect to do business is found not to be in compliance with applicable laws, it may be subject to significant criminal, civil or administrative sanctions, including exclusions from participation in government health care programs, which could also materially affect our ability to earn revenue from arrangements with such third-party partners for our drug candidates.\u200bRecently enacted and future legislation may increase the difficulty and cost for our potential third-party partners to obtain marketing approval of our drug candidates and commercialize our drug candidates, if approved, and affect the prices our potential third-party partners may obtain.\u200bIn the United States, and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the health care system that could prevent or delay marketing approval of our drug candidates, restrict or regulate post-approval activities and affect our potential third-party partners\u2019 ability to profitably sell any of our drug candidates for which our potential third-party partners obtain marketing approval, and consequently affect our ability to earn revenue from arrangements with such third-party partners for our drug candidates.\u200bAmong policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in health care systems with the stated goals of containing health care costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. The Affordable Care Act, which was signed into law in 2010, is a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of health care spending, enhance remedies against fraud and abuse, add new transparency requirements for the health care and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms.\u200bAmong the provisions of the Affordable Care Act of importance to commercial products are the following: expanded and increased industry rebates for drugs covered under Medicaid programs; addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; extended the rebate program to individuals enrolled in Medicaid managed care organizations; established annual fees and taxes on manufacturers of certain branded prescription drugs; made changes to the coverage requirements under the Medicare prescription drug benefit; and established a new Medicare Part D coverage gap discount program, in which manufacturers, as a condition for their outpatient drugs to be covered under Medicare Part D, must agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period. Moreover, the Affordable Care Act provided incentives to programs that increase the federal government\u2019s comparative effectiveness research and implemented payment system reforms including a national pilot program on payment bundling meant to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain health care services.\u200bThere have been executive branch, judicial and Congressional challenges to certain aspects of the Affordable Care Act. While Congress has not passed comprehensive repeal legislation, several bills affecting the implementation of certain taxes under the Affordable Care Act have been signed into law. On June 17, 2021 the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the Affordable Care Act is unconstitutional in its entirety because the \u201cindividual mandate\u201d was repealed by Congress. Prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the Affordable Care Act marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the Affordable Care Act. Further, on August 16, 2022, President Biden signed the IRA into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The IRA also eliminates the \u201cdonut hole\u201d under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and through a newly established manufacturer discount program. It is possible that the Affordable Care Act will be subject to judicial or Congressional challenges in the future. It is unclear how such challenges and any additional health care reform measures of the Biden administration will impact the Affordable Care Act and our business.45",
            "type": "paragraph"
        },
        {
            "id": 41,
            "context": "\u200bIn addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. These changes included aggregate reductions to Medicare payments to providers of 2% per fiscal year that became effective on April 1, 2013 and, due to subsequent legislative amendments to the statute, including the BBA and the Infrastructure Investment and Jobs Act, will stay in effect through 2032 unless additional Congressional action is taken. The American Taxpayer Relief Act of 2012, which was signed into law in January 2013, among other things, further reduced Medicare payments to several providers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Any similar new laws may result in additional reductions in Medicare and other health care funding, which could have a material adverse effect on our ability to earn revenue from arrangements with our potential third-party partners for our drug candidates.\u200bWe expect that the Affordable Care Act, as well as other health care reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that our potential third-party partners receive for any approved drug candidate. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other health care reforms may prevent our potential third-party partners from being able to generate revenue, attain profitability, or commercialize our drug candidates, if approved, which in turn may impact our ability to earn revenue from arrangements with such third-party partners for our drug candidates. \u200bLegislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for drugs. In addition, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. In July 2021, the Biden administration released an executive order, \u201cPromoting Competition in the American Economy,\u201d with multiple provisions aimed at prescription drugs. In response to Biden\u2019s executive order, on September 9, 2021, U.S. Department of Health and Human Services, or HHS, released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. In addition, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs and biologics covered under Medicare and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry. Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. It is unclear whether this executive order or similar policy initiatives will be implemented in the future. On December 7, 2023, the Biden administration announced an initiative to control the price of prescription drugs through the use of march-in rights under the Bayh-Dole Act. On December 8, 2023, the National Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an agency can use when deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that will continue under the new framework. It is unclear whether these or similar policy initiatives will be implemented in the future. The effect of reducing prices and reimbursement for certain of our drug candidates, if approved, could significantly impact our business and consolidated results of operations. In addition, the IRA may meaningfully influence our and pharmaceutical industry business strategies. In particular, it may reduce the attractiveness of investment in small molecule and biologic innovation. \u200bAt the state level, legislatures have become increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain drug access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. For example, on January 5, 2024, the FDA approved Florida\u2019s proposal to import certain drugs from Canada for specific state healthcare programs. It is unclear if and how this program will be implemented and whether it will be subject challenges in the United States or Canada. Other states have also submitted proposals that are pending review by the FDA. Any such approved importation plans, if implemented, may result in lower drug prices for products covered by those programs. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, 46",
            "type": "paragraph"
        },
        {
            "id": 42,
            "context": "or what the impact of such changes on obtaining marketing approvals for our drug candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA\u2019s approval process may significantly delay or prevent marketing approval, as well as subject our potential third-party partners to more stringent drug labeling and post-marketing testing and other requirements. These risks may compromise our ability to earn revenue from arrangements with such third-party partners for our drug candidates.\u200bGovernments outside the United States tend to impose strict price controls, which may adversely affect our revenue.\u200bIn some countries, particularly the countries of the European Union, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a drug. To obtain coverage and reimbursement or pricing approval in some countries, our potential third-party partners may be required to conduct a clinical trial that compares the cost-effectiveness of our drug candidate to other available procedures. If reimbursement of our drug candidates is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our potential third-party partners may not able to generate revenue, which in turn may adversely affect our ability to earn revenue from arrangements with such third-party partners for our drug candidates. \u200bIf we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.\u200bWe are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. \u200bAlthough we maintain workers\u2019 compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials.\u200bIn addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our development or manufacturing efforts. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.\u200bWe are subject to stringent and evolving U.S. and foreign laws, regulations, and rules, contractual obligations, industry standards, policies and other obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions; litigation (including class claims) and mass arbitration demands; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; and other adverse business consequences.\u200bIn the ordinary course of business, we collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, process) personal data and other sensitive information, including proprietary and confidential business data, trade secrets, intellectual property, personnel data, data from participants in our clinical trials, and other sensitive third-party data (collectively, sensitive data). Our data processing activities subject us to numerous data privacy and security obligations, such as various laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements, and other obligations relating to data privacy and security. \u200bIn the United States, federal, state, and local governments have enacted numerous data privacy and security laws, including data breach notification laws, personal data privacy laws, consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws). In the past few years, numerous U.S. states\u201447",
            "type": "paragraph"
        },
        {
            "id": 43,
            "context": "including California, Virginia, Colorado, Connecticut, and Utah\u2014have enacted comprehensive privacy laws that impose certain obligations on covered businesses, including providing specific disclosures in privacy notices and affording residents with certain rights concerning their personal data. As applicable, such rights may include the right to access, correct, or delete certain personal data, and to opt-out of certain data processing activities, such as targeted advertising, profiling, and automated decision-making. The exercise of these rights may impact our business operations. Certain states also impose stricter requirements for processing certain personal data, including sensitive information, such as conducting data privacy impact assessments. These state laws allow for statutory fines for noncompliance. For example, the California Consumer Privacy Act of 2018, as amended by the California Privacy Rights Act of 2020 (\u201cCPRA\u201d) (collectively, \u201cCCPA\u201d), applies to personal data of consumers, business representatives, and employees who are California residents, and requires businesses to provide specific disclosures in privacy notices and honor requests of such individuals to exercise certain privacy rights. The CCPA provides for fines of up to $7,500 per intentional violation and allows private litigants affected by certain data breaches to recover significant statutory damages. Although the CCPA exempts some data processed in the context of clinical trials, the CCPA increases compliance costs and potential liability with respect to other personal data we maintain about California residents. Similar laws are being considered in several other states, as well as at the federal and local levels, and we expect more states to pass similar laws in the future. While these states, like the CCPA, also exempt some data processed in the context of clinical trials, these developments may further complicate compliance efforts, and increase legal risk and compliance costs for us and the third parties upon whom we rely. \u200bIn addition to \u201ccomprehensive\u201d state privacy laws like CCPA, we are or may become subject to new state laws governing the privacy of consumer health data. For example, Washington\u2019s My Health My Data Act broadly defines consumer health data, places restrictions on processing consumer health data (including imposing stringent requirements for consents), provides consumers certain rights with respect to their health data, and creates a private right of action to allow individuals to sue for violations of the law. Other states are considering and may adopt similar laws. \u200bOutside the United States, an increasing number of laws, regulations, and industry standards may govern data privacy and security. For example, the European Union\u2019s General Data Protection Regulation (\u201cEU GDPR\u201d) and the United Kingdom\u2019s GDPR (\u201cUK GDPR\u201d) impose strict requirements for processing personal data. For example, under GDPR, companies may face temporary or definitive bans on data processing and other corrective actions; fines of up to 20 million Euros under the EU GDPR, 17.5 million pounds sterling under the UK GDPR or, in each case, 4% of annual global revenue, whichever is greater; or private litigation related to processing of personal data brought by classes of data subjects or consumer protection organizations authorized at law to represent their interests.\u200bIn addition, we may be unable to transfer personal data from Europe and other jurisdictions to the United States or other countries due to data localization requirements or limitations on cross-border data flows. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, the European Economic Area (EEA) and the United Kingdom (UK) have significantly restricted the transfer of personal data to the United States and other countries whose privacy laws it generally believes are inadequate. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross-border data transfer laws. Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the United States in compliance with law, such as the EEA\u2019s standard contractual clauses, the UK\u2019s International Data Transfer Agreement / Addendum, and the EU-U.S. Data Privacy Framework and the UK extension thereto (which allows for transfers to relevant U.S.-based organizations who self-certify compliance and participate in the Framework), these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the United States. If there is no lawful manner for us to transfer personal data from the EEA, the UK, or other jurisdictions to the United States, or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our data processing activities to other jurisdictions (such as Europe) at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business. Additionally, companies that transfer personal data out of the EEA and UK to other jurisdictions, particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activities groups. Some European regulators have ordered certain companies to suspend or permanently cease certain transfers of personal data out of Europe for allegedly violating the GDPR\u2019s cross-border data transfer limitations. \u200bIn addition to data privacy and security laws, we are contractually subject to industry standards adopted by industry groups and may become subject to such obligations in the future. We are also bound by other contractual obligations related to data privacy and security, and our efforts to comply with such obligations may not be successful. 48",
            "type": "paragraph"
        },
        {
            "id": 44,
            "context": "\u200bWe publish privacy policies and make other statements regarding data privacy and security. If these policies or statements are found to be deficient, lacking in transparency, deceptive, unfair, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators, or other adverse consequences. \u200bObligations related to data privacy and security (and consumers\u2019 data privacy expectations) are quickly changing, becoming increasingly stringent, and creating uncertainty. Additionally, these obligations may be subject to differing applications and interpretations, which may be inconsistent or conflict among jurisdictions. Preparing for and complying with these obligations requires us to devote significant resources and may necessitate changes to our services, information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. \u200bWe may at times fail (or be perceived to have failed) in our efforts to comply with our data privacy and security obligations. Moreover, despite our efforts, our personnel or third parties on whom we rely may fail to comply with such obligations, which could negatively impact our business operations. If we or the third parties on which we rely fail, or are perceived to have failed, to address or comply with applicable data privacy and security obligations, we could face significant consequences, including but not limited to: government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar); litigation (including class-action claims) and mass arbitration demands; additional reporting requirements and/or oversight; bans on processing personal data; and orders to destroy or not use personal data. In particular, plaintiffs have become increasingly more active in bringing privacy-related claims against companies, including class claims and mass arbitration demands. Some of these claims allow for the recovery of statutory damages on a per violation basis, and, if viable, carry the potential for significant statutory damages, depending on the volume of data and the number of violations. Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: loss of customers; or stoppages in our business operations (including clinical trials); inability to process personal data or to operate in certain jurisdictions; limited ability to develop our drug candidates; expenditure of time and resources to defend any claim or inquiry; adverse publicity; or substantial changes to our business model or operations. \u200bWe are subject to governmental economic sanctions and export and import controls that could impair our potential third-party partners\u2019 ability to compete in international markets or subject us or our potential third-party partners to liability if we or they are not in compliance with applicable laws.\u200bAs a U.S. company, we are subject to U.S. import and export controls and economic sanctions laws and regulations, and we are required to import and export our drug candidates, technology and services in compliance with those laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, the International Traffic in Arms Regulations, and economic embargo and trade sanction programs administered by the U.S. Treasury Department\u2019s Office of Foreign Assets Control. \u200bU.S. economic sanctions and export control laws and regulations prohibit the shipment of certain products and services to countries, governments and persons targeted by U.S. sanctions. While we are currently taking precautions to prevent doing any business, directly or indirectly, with countries, governments and persons targeted by U.S. sanctions and to ensure that our drug candidates are not exported or used by countries, governments and persons targeted by U.S. sanctions, such measures may be circumvented. \u200bFurthermore, if we or our potential third-party partners export our drug candidates, the exports may require authorizations, including a license, a license exception or other appropriate government authorization. Complying with export control and sanctions regulations may be time-consuming and may result in the delay or loss of sales opportunities. Failure to comply with export control and sanctions regulations may expose us or our potential third-party partners to government investigations and penalties. \u200bIf we are found to be in violation of U.S. sanctions or import or export control laws, it could result in civil and criminal, monetary and non-monetary penalties, including possible incarceration for those individuals responsible for the violations, the loss of export or import privileges and reputational harm.\u200b49",
            "type": "paragraph"
        },
        {
            "id": 45,
            "context": "We and our potential third-party partners are subject to anti-corruption and anti-money laundering laws with respect to our and their operations and non-compliance with such laws can subject us to criminal and/or civil liability and harm our business.\u200bWe and our potential third-party partners are subject to the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. \u00a7 201, the U.S. Travel Act, the USA PATRIOT Act and possibly other anti-bribery and anti-money laundering laws in countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees and third-party intermediaries from authorizing, offering or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector. We or our potential third-party partners may engage third-party intermediaries in connection with the development or commercialization of our drug candidates, if approved, and to obtain necessary permits, licenses and other regulatory approvals. We, our potential third-party partners or the third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners and agents, even if we do not explicitly authorize such activities. \u200bNoncompliance with anti-corruption and anti-money laundering laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage and other collateral consequences. Responding to any action will likely result in a materially significant diversion of management\u2019s attention and resources and significant defense costs and other professional fees.\u200bRisks Related to Employee Matters and Managing Our Growth\u200bOur future success depends on our ability to retain key executives and to attract, retain and motivate qualified personnel.\u200bWe are highly dependent on the management, development, clinical, financial, and business development expertise of Dr. Neal Walker, our Interim Chief Executive Officer and President, Kevin Balthaser, our Chief Financial Officer, Dr. Joseph Monahan, our Chief Scientific Officer, and James Loerop, our Chief Business Officer, as well as the other members of our scientific and clinical teams. Although we have entered into employment agreements with our executive officers, each of them may currently terminate their employment with us or resign at any time. We do not maintain \u201ckey person\u201d insurance for any of our key executives. \u200bRecruiting and retaining qualified scientific, manufacturing and clinical personnel will also be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of our development objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop and partner drug candidates. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our development strategy. Our consultants and advisors may have commitments under employment, consulting or advisory contracts with other entities that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited. \u200bOur employees, independent contractors, consultants, third-party partners, principal investigators, CROs and vendors may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements.\u200bWe are exposed to the risk that our employees, independent contractors, consultants, third-party partners, principal investigators, CROs and vendors may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates FDA regulations, including those laws requiring the reporting of true, complete and accurate information to the FDA, manufacturing standards, federal and state health care laws and regulations, and laws that require the true, complete 50",
            "type": "paragraph"
        },
        {
            "id": 46,
            "context": "| \u25cf | the commencement, enrollment and/or results of any preclinical studies and clinical trials we may conduct, or changes in the development status of our drug candidates; |\n| \u25cf | any delay in our regulatory filings for any of our drug candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority\u2019s review of such filings, including without limitation the FDA\u2019s issuance of a \u201crefusal to file\u201d letter or a request for additional information; |\n| \u25cf | adverse results from, delays in or termination of clinical trials; |\n| \u25cf | adverse regulatory decisions, including failure of any of our drug candidates to receive marketing approval; |\n| \u25cf | unanticipated serious safety concerns related to the use of any drug candidate or previously sold commercial product; |\n| \u25cf | changes in financial estimates by us or by any securities analysts who might cover our stock; |\n| \u25cf | conditions or trends in our industry; |\n| \u25cf | changes in the structure of health care payment systems; |\n| \u25cf | changes in the market valuations of similar companies; |\n| \u25cf | stock market price and volume fluctuations of comparable companies and, in particular, those that operate in the biotechnology industry; |\n| \u25cf | publication of research reports about us or our industry or positive or negative recommendations or withdrawal of research coverage by securities analysts; |\n| \u25cf | announcements by us or our competitors of significant acquisitions, strategic partnerships or divestitures; |\n| \u25cf | announcements of investigations or regulatory scrutiny of our operations or lawsuits filed against us; |\n| \u25cf | investors\u2019 general perception of our company and our business; |\n| \u25cf | recruitment or departure of key personnel; |\n| \u25cf | overall performance of the equity markets; |\n| \u25cf | trading volume of our common stock; |",
            "type": "table"
        },
        {
            "id": 47,
            "context": "| \u25cf | disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies; |\n| \u25cf | significant lawsuits, including patent or stockholder litigation; |\n| \u25cf | general political and economic conditions; and |\n| \u25cf | other events or factors, many of which are beyond our control. |",
            "type": "table"
        },
        {
            "id": 48,
            "context": "| \u25cf | only one of our three classes of directors is elected each year; |\n| \u25cf | stockholders are not entitled to remove directors other than by a 66 2/3% vote and only for cause; |\n| \u25cf | stockholders are not permitted to take actions by written consent; |\n| \u25cf | stockholders cannot call a special meeting of stockholders; and |\n| \u25cf | stockholders must give advance notice to nominate directors or submit proposals for consideration at stockholder meetings. |",
            "type": "table"
        },
        {
            "id": 49,
            "context": "may be limited. Although we have experienced Section 382 ownership changes between 2012 and 2023, we have concluded that we should have sufficient ability to utilize NOLs accumulated during the periods tested. In addition, we may have experienced ownership changes since 2023 and may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside of our control. If we determine that an ownership change has occurred and our ability to use our historical NOL and tax credit carryforwards is materially limited, it might harm our future operating results by effectively increasing our future tax obligations.\u200bWe do not anticipate paying any cash dividends on our common stock in the foreseeable future and our stock may not appreciate in value.\u200bWe have not declared or paid cash dividends on our common stock to date. We currently intend to retain our future earnings, if any, to fund the development and growth of our business. There is no guarantee that shares of our common stock will appreciate in value or that the price at which our stockholders have purchased their shares will be able to be maintained.\u200bExclusive forum provisions in our amended and restated certificate of incorporation and amended and restated bylaws could limit our stockholders\u2019 ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.\u200bOur amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim for breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws or (iv) any action asserting a claim governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated bylaws provide the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation and our amended and restated bylaws. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.\u200bOur amended and restated certificate of incorporation and amended and restated bylaws further provide any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the foregoing provisions. These exclusive forum provisions may limit a stockholder\u2019s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business.\u200bGeneral Risk Factors\u200bIf our information technology systems, those of third parties upon which we rely, or our data are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; and other adverse consequences.\u200bIn the ordinary course of our business, we and the third parties upon which we rely process sensitive data, and, as a result, we and the third parties upon which we rely face a variety of evolving threats that could cause security incidents. Cyber-attacks, malicious internet-based activity, online and offline fraud, and other similar activities threaten the confidentiality, integrity, and availability of our sensitive data and information technology systems, and those of the third 54",
            "type": "paragraph"
        },
        {
            "id": 50,
            "context": "parties upon which we rely. Such threats are prevalent and continue to rise, are increasingly difficult to detect, and come from a variety of sources, including traditional computer \u201chackers,\u201d threat actors, \u201chacktivists,\u201d organized criminal threat actors, personnel (such as through theft or misuse), sophisticated nation states, and nation-state-supported actors. \u200bSome actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to develop our drug candidates and provide our services. \u200bWe and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), denial-of-service attacks, credential stuffing, credential harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, attacks enhanced or facilitated by AI, telecommunications failures, earthquakes, fires, floods, and other similar threats. \u200bIn particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, ability to develop our drug candidates or provide our services, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. \u200bRemote work has become more common and has increased risks to our information technology systems and data, as more of our employees utilize network connections, computers, and devices outside our premises or network, including working at home, while in transit and in public locations. Additionally, future or past business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities\u2019 systems and technologies. Furthermore, we may discover security issues that were not found during due diligence of such acquired or integrated entities, and it may be difficult to integrate companies into our information technology environment and security program.\u200bIn addition, our reliance on third-party service providers could introduce new cybersecurity risks and vulnerabilities, including supply-chain attacks and other threats to our business operations. We rely on third-party service providers and technologies to operate critical business systems to process sensitive data in a variety of contexts, including, without limitation, cloud-based infrastructure, data center facilities, SaaS platforms, encryption and authentication technology, employee email and other functions. We also rely on third-party service providers to provide other products and services, or otherwise to operate our business. Our ability to monitor these third parties\u2019 information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties\u2019 infrastructure in our supply chain or our third-party partners\u2019 supply chains have not been compromised.\u200bWhile we have implemented security measures designed to protect against security incidents, there can be no assurance that these measures will be effective. We take steps designed to detect, mitigate, and remediate vulnerabilities in our information systems (such as our hardware and/or software). We may not, however, detect and remediate all such vulnerabilities including on a timely basis. Further, we may experience delays in developing and deploying remedial measures and patches designed to address identified vulnerabilities. Vulnerabilities could be exploited and result in a security incident.\u200bAny of the previously identified or similar threats could cause a security incident or other interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive data or our information technology systems, or those of the third parties upon whom we rely. A security incident or other interruption could disrupt our ability (and that of third parties upon whom we rely) to operate our business. 55",
            "type": "paragraph"
        },
        {
            "id": 51,
            "context": "\u200bWe may expend significant resources or modify our business activities to try to protect against security incidents. Additionally, certain data privacy and security obligations may require us to implement and maintain specific security measures or industry-standard or reasonable security measures to protect our information technology systems and sensitive data.\u200bApplicable data privacy and security obligations may require us to notify relevant stakeholders, including affected individuals, customers, regulators, and investors, of security incidents. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences. \u200bIf we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences, such as government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive data (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; diversion of management attention; interruptions in our operations (including availability of data); financial loss; and other similar harms. Security incidents and attendant consequences may prevent or cause customers to stop using our services, deter new customers from using our services, and negatively impact our ability to grow and operate our business. \u200bOur contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.\u200bIn addition to experiencing a security incident, third parties may gather, collect, or infer sensitive data about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position.\u200bAn active trading market for our common stock may not be sustained.\u200bAlthough our common stock is listed on The Nasdaq Global Select Market, we cannot assure you that an active trading market for our shares will be sustained. If an active market for our common stock is not sustained, it may be difficult for investors in our common stock to sell shares without depressing the market price for the shares or to sell the shares at all. \u200bIf equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline.\u200bThe trading market for our common stock is influenced by the research and reports that equity research analysts publish about us or our business, our market and our competitors. Equity research analysts may elect not to initiate or continue to provide research coverage of our common stock, and such lack of research coverage may adversely affect the market price of our common stock. Even if we have equity research analyst coverage, we will not have any control over the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline. \u200bEnvironmental, social and governance matters may impact our business and reputation.\u200bIncreasingly, in addition to the importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance, or ESG, matters, which are considered to contribute to the long-term sustainability of companies\u2019 performance.\u200b56",
            "type": "paragraph"
        },
        {
            "id": 52,
            "context": "A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the company\u2019s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the company\u2019s board of directors in supervising various sustainability issues. In addition to the topics typically considered in such assessments, in the healthcare industry, issues of the public\u2019s ability to access medicines are of particular importance.\u200bIn light of investors\u2019 increased focus on ESG matters, there can be no certainty that we will manage such issues successfully. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, stock price, financial condition, or results of operations, including the sustainability of our business over time.\u200bUnfavorable conditions, including inflationary pressure, in the global economy could limit our ability to grow our business and negatively affect our operating results.\u200bGeneral worldwide economic conditions have experienced significant instability in recent years including the recent global economic uncertainty and financial market conditions. For example, inflation rates, particularly in the United States and United Kingdom, have increased recently to levels not seen in years, and increased inflation may result in increases in our operating costs (including our labor costs), reduced liquidity and limits on our ability to access credit or otherwise raise capital. In addition, the Federal Reserve has raised, and may again raise, interest rates in response to concerns about inflation, which coupled with reduced government spending and volatility in financial markets may have the effect of further increasing economic uncertainty and heightening these risks. Additionally, financial markets around the world have experienced volatility in connection with geopolitical conflicts. These conditions make it extremely difficult for us to accurately forecast and plan future business activities.\u200bThe issuance of additional stock in connection with financings, acquisitions, investments, our equity incentive plan or otherwise will dilute all other stockholders.\u200bOur certificate of incorporation authorizes us to issue up to 200,000,000 shares of common stock and up to 10,000,000 shares of preferred stock with such rights and preferences as may be determined by our board of directors. Subject to compliance with applicable rules and regulations, we may issue our shares of common stock or securities convertible into our common stock from time to time in connection with a financing, acquisition, investment, our equity incentive plan or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and cause the trading price of our common stock to decline. \u200bChanges in tax laws or regulations that are applied adversely to us may have a material adverse effect on our business, cash flow, financial condition or results of operations.\u200bNew income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business operations and financial performance. For example, the Inflation Reduction Act provides for a minimum tax equal to 15% of the adjusted financial statement income of certain large corporations, as well as a 1% excise tax on certain share buybacks by public corporations that would be imposed on such corporations. In addition, it is uncertain if and to what extent various states will conform to newly enacted federal tax legislation. Changes in corporate tax rates, the realization of net deferred tax assets relating to our operations, the taxation of foreign earnings, and the deductibility of expenses could have a material impact on the value of our deferred tax assets, could result in significant one-time charges, and could increase our future U.S. tax expense.\u200bWe incur significant costs and demands upon management as a result of being a public company.\u200bAs a public company listed in the United States, we incur, and will continue to incur, particularly now that we no longer qualify as a \u201csmaller reporting company,\u201d significant legal, accounting and other costs. These costs could negatively affect our financial results. In addition, changing laws, regulations and standards relating to corporate governance and public disclosure, including regulations implemented by the SEC and The Nasdaq Stock Market, may increase legal and financial compliance costs and make some activities more time-consuming. These laws, regulations and standards are subject to varying interpretations and, as a result, their application in practice may evolve over time as new guidance is 57",
            "type": "paragraph"
        },
        {
            "id": 53,
            "context": "provided by regulatory and governing bodies. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management\u2019s time and attention from revenue-generating activities to compliance activities. If notwithstanding our efforts to comply with new laws, regulations and standards, we fail to comply, regulatory authorities may initiate legal proceedings against us and our business may be harmed.\u200bFailure to comply with these rules might also make it more difficult for us to obtain some types of insurance, including director and officer liability insurance, and we might be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, on committees of our board of directors or as members of senior management.\u200b\u200b",
            "type": "paragraph"
        },
        {
            "id": 54,
            "context": "Item 1B. Unresolved Staff Comments\n\u200b\nNone.\n\u200b\n\u200b\nItem 2. Properties\n\u200b\nWe lease 11,564 square feet of space for our headquarters in Wayne, Pennsylvania, which we use for our therapeutics business. The lease has a term through February 2029.\n\u200b We also sublease 26,694 square feet of office and laboratory space in St. Louis, Missouri, which we use for our therapeutics and contract research businesses. The sublease has an initial term through June 2029. We have the option to extend the initial term for two additional five-year periods.",
            "type": "paragraph"
        },
        {
            "id": 55,
            "context": "\u200b\n59\nWe believe that our facilities are suitable and adequate to meet our current needs. \u200b\u200b\nItem 3. Legal Proceedings\n\u200b From time to time we are subject to litigation and claims arising in the ordinary course of business. We are not currently a party to any material legal proceedings and we are not aware of any other pending or threatened legal proceeding against us that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.",
            "type": "paragraph"
        },
        {
            "id": 56,
            "context": "\u200b\n\u200b\nItem 4. Mine Safety Disclosures\n\u200b\nNot applicable.\n\u200b\n\u200b\n60\n\u200bPART II\u200b\nItem 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity\nSecurities\n\u200b\nMarket Information for Common Stock\n\u200b\nOur common stock is listed on the Nasdaq Global Select Market under the symbol \u201cACRS.\u201d\n\u200b\nDividend Policy\n\u200b We have never declared or paid any dividends on our common stock. We anticipate that we will retain all of our future earnings, if any, for use in the operation and expansion of our business and do not anticipate paying cash dividends in the foreseeable future.",
            "type": "paragraph"
        },
        {
            "id": 57,
            "context": "\u200b\nStockholders\n\u200b As of January 31, 2024, we had 70,925,042 shares of common stock outstanding held by 49 holders of record. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.",
            "type": "paragraph"
        },
        {
            "id": 58,
            "context": "\u200b\nRecent Sales of Unregistered Securities\n\u200b\nNone.\n\u200b\nPurchases of Equity Securities by the Issuer and Affiliated Parties\n\u200b\nNone.\n\u200b\nStock Performance Graph\n\u200b The graph below compares the cumulative total stockholder return for the period December 31, 2018 through December 31, 2023 for (i) our common stock, (ii) the Nasdaq Biotechnology Index and (iii) the Nasdaq Composite Index. The graph assumes an investment of $100 on December 31, 2018 in each of our common stock, the Nasdaq Biotechnology Index and the Nasdaq Composite Index and the reinvestment of dividends, if any, although we have never declared or paid any dividends on our common stock. The stock price performance shown on the graph below is based on historical data and is not indicative of future stock price performance.",
            "type": "paragraph"
        },
        {
            "id": 59,
            "context": "\u200b The graph and table below shall not be deemed \u201csoliciting material\u201d or to be \u201cfiled\u201d with the SEC for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act or the Exchange Act.",
            "type": "paragraph"
        },
        {
            "id": 60,
            "context": "61\n\n| \u200b | 12/31/18 | 12/31/19 | 12/31/20 | 12/31/21 | 12/31/22 | 12/31/23 | \u200b |\n| Aclaris Therapeutics, Inc. | \u200b | $ | 100.00 | \u200b | $ | 25.58 | \u200b | $ | 87.55 | \u200b | $ | 196.75 | \u200b | $ | 213.13 | \u200b | $ | 14.21 | \u200b |\n| Nasdaq Composite Index | \u200b | $ | 100.00 | \u200b | $ | 136.69 | \u200b | $ | 198.10 | \u200b | $ | 242.03 | \u200b | $ | 163.28 | \u200b | $ | 236.17 | \u200b |\n| Nasdaq Biotechnology Index | \u200b | $ | 100.00 | \u200b | $ | 125.11 | \u200b | $ | 158.17 | \u200b | $ | 158.20 | \u200b | $ | 142.19 | \u200b | $ | 148.72 | \u200b |",
            "type": "table"
        },
        {
            "id": 61,
            "context": "Item 6.\n[Reserved]\n\u200b\n\u200b\n\u200b\n\u200b\n\u200b\n62\nItem 7. Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations\n\u200b You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the consolidated financial statements and the related notes to those statements included later in this Annual Report. In addition to historical financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, beliefs and expectations that involve risks and uncertainties. Our actual results and the timing of events could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report, particularly in Part I, Item 1A. \u201cRisk Factors,\u201d and \u201cSpecial Note Regarding Forward-Looking Statements.\u201d",
            "type": "paragraph"
        },
        {
            "id": 62,
            "context": "\u200b\nOverview\n\u200b We are a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. Our proprietary KINect drug discovery platform combined with our preclinical development capabilities allows us to identify and advance potential drug candidates that we may develop independently or in collaboration with third parties. In addition to identifying and developing our novel drug candidates, we are pursuing strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our novel drug candidates. We also provide contract research services to third parties enabled by our early-stage research and development expertise. In January 2024, we announced that we are undertaking a strategic review of our business.",
            "type": "paragraph"
        },
        {
            "id": 63,
            "context": "\u200b\nATI-1777, an Investigational Topical \u201cSoft\u201d JAK 1/3 Inhibitor\n\u200b ATI-1777 is an investigational topical \u201csoft\u201d JAK 1/3 inhibitor for the potential treatment of atopic dermatitis and potentially other dermatologic conditions. \u201cSoft\u201d JAK inhibitors are designed to be topically applied and active in the skin, but rapidly metabolized and inactivated when they enter the bloodstream, which may result in low systemic exposure.",
            "type": "paragraph"
        },
        {
            "id": 64,
            "context": "\u200b In January 2024, we announced positive top-line results from our Phase 2b study of ATI-1777 in patients with mild to severe atopic dermatitis (ATI-1777-AD-202). ATI-1777-AD-202 was a Phase 2b, multicenter, randomized, double-blind, vehicle-controlled, parallel-group clinical trial to evaluate the efficacy, safety, tolerability and pharmacokinetics, or PK, of multiple concentrations (0.5%, 1% and 2%) of twice daily, or BID, treatment with ATI-1777 and a single concentration (2%) of once daily, or QD, treatment with ATI-1777. The trial randomized 250 patients with mild, moderate or severe atopic dermatitis, including adults and children as young as 12 years old, across 30 clinical trial sites in the United States. The study met the primary efficacy endpoint, the percent change from baseline in the Eczema Area and Severity Index, or EASI, score at week 4, with statistical significance for patients treated with ATI-1777 2% BID compared to patients treated with vehicle (69.7% versus 58.7% in the pooled vehicle group, p=0.035). No meaningful safety findings were observed and ATI-1777 was well tolerated.",
            "type": "paragraph"
        },
        {
            "id": 65,
            "context": "We intend to seek a development and commercialization partner for this program.\nATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor ATI-2138 is an investigational oral covalent ITK/JAK3 inhibitor for the potential treatment of T cell-mediated autoimmune diseases. The ITK/JAK3 compound interrupts T cell signaling through the combined inhibition of ITK/JAK3 pathways in lymphocytes.",
            "type": "paragraph"
        },
        {
            "id": 66,
            "context": "In September 2023, we announced positive results from our Phase 1 multiple ascending dose, or MAD, trial of ATI-2138 (ATI-2138-PKPD-102). ATI-2138-PKPD-201 was a two-week Phase 1 placebo-controlled, randomized, MAD trial to investigate the safety, tolerability, PK, and pharmacodynamics of ATI-2138 in healthy volunteers. The study enrolled 60 healthy subjects across 6 dosing cohorts ranging from 10 to 80 mg of total daily doses, with eight active and two placebo controlled per arm. Data from the trial demonstrated that ATI-2138 was generally well tolerated at all doses tested in the trial and had dose proportional PK. Additionally, ATI-2138 demonstrated a dose-dependent inhibition of both ITK and JAK3 exploratory pharmacodynamic biomarkers, with near maximal inhibition achieved at the 30 mg total daily dose. No serious adverse events were reported.",
            "type": "paragraph"
        },
        {
            "id": 67,
            "context": "We are assessing the most effective development pathway, including the lead indication, for ATI-2138.\n63 Zunsemetinib, an Investigational Oral MK2 Inhibitor\u200bZunsemetinib, or ATI-450, is an investigational oral, novel, small molecule selective MK2 inhibitor for the potential treatment of metastatic breast cancer and pancreatic ductal adenocarcinoma. We plan to support Washington University in St. Louis in its investigator-initiated Phase 1b/2 trials of zunsemetinib in patients with MBC and PDAC. We expect these studies to be primarily funded by grants awarded to Washington University.\u200bDiscovery Programs and KINect Drug Discovery Platform\u200bWe conduct small molecule drug discovery and preclinical development research through KINect, our proprietary drug discovery platform. Our KINect platform enables us to identify potential drug candidates through a unique combination of our proprietary chemical library of kinase inhibitors, our novel approaches to inhibitor modalities, our expertise in SBDD, and our custom kinase assays. \u200bOur focus has been on difficult to drug kinase targets that exhibit some level of clinical, genetic and/or pharmacological disease validation. Our approach involves the following mechanisms: (1) reversible and irreversible covalent inhibitors, (2) molecular glue/complex targeted inhibitors and (3) targeted protein degraders. These novel approaches are currently being utilized to prosecute additional validated, difficult to drug kinase targets with the goal of demonstrating potential platform utility.\u200bWe are actively progressing several discovery programs focused on delivering the next wave of drug candidates from our KINect platform. Our discovery efforts center on targeting kinases that play pivotal roles in various inflammatory, autoimmune, and oncology pathways. We intend to evaluate both internal and external development options, including strategic partnerships, for these assets.\u200bDiscontinued Programs\u200bWe were previously developing zunsemetinib as a potential treatment for various immuno-inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and rheumatoid arthritis. In March 2023, we announced that our Phase 2a study of zunsemetinib in patients with hidradenitis suppurativa did not meet its primary or second efficacy endpoints, and in November 2023, we announced that our Phase 2b study of zunsemetinib in patients with rheumatoid arthritis did not meet its primary or second efficacy endpoints. Following the results of these trials, in 2023 we discontinued further development of our MK2 inhibitor programs in immuno-inflammatory diseases, including halting enrollment in our Phase 2a study of zunsemetinib in patients with psoriatic arthritis.\u200bWe were previously exploring the use of ATI-2231, our second MK2 inhibitor, as a potential treatment for oncology diseases, but decided to pursue this with zunsemetinib due to its more advanced clinical development package.\u200bFinancial Overview\u200bSince our inception, we have incurred significant net losses. Our net loss was $88.5 million for the year ended December 31, 2023 and $86.9 million for the year ended December 31, 2022. As of December 31, 2023, we had an accumulated deficit of $770.8 million. We expect to incur significant expenses and operating losses for the foreseeable future as we advance our drug candidates from discovery through preclinical and clinical development. In addition, our drug candidates, even if they are approved by regulatory agencies for marketing, may not achieve commercial success. We may also not be successful in pursuing strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates. Furthermore, we have incurred and expect to continue to incur significant costs associated with operating as a public company, including legal, accounting, investor relations and other expenses. As a result, we will need substantial additional funding to support our continuing operations.\u200bWe have historically financed our operations primarily with sales of equity securities and incurring indebtedness in the form of loans from commercial lenders. In the near term, we expect to finance our operations through these and other capital sources, including potential partnerships with other companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on commercially acceptable terms, or at all. If we fail to raise capital or enter into such agreements as, and when needed, we may have to significantly delay, scale back or discontinue the development of one or more of our drug candidates. 64",
            "type": "paragraph"
        },
        {
            "id": 68,
            "context": "\u200bImpact of Macroeconomic Conditions on Our Business\u200bUnfavorable conditions in the economy both in the United States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, including rising inflation, the U.S. Federal Reserve raising interest rates and geopolitical conflicts, have led to economic uncertainty globally. The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed. For further discussion of the potential impacts of macroeconomic events on our business, financial condition, and operating results, see the section titled \u201cRisk Factors.\u201d\u200bAcquisition and License Agreements\u200bLicense Agreement with Sun Pharmaceutical Industries, Inc.\u200bIn December 2023, we entered into an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc., or Sun Pharma. Under the license agreement, we granted Sun Pharma exclusive rights under certain patents that we exclusively license from a third party. The patents relate to the use of deuruxolitinib, Sun Pharma\u2019s JAK inhibitor, or other isotopic forms of ruxolitinib, to treat alopecia areata or androgenetic alopecia. Under the license agreement, Sun Pharma has agreed to pay us an upfront payment, regulatory and commercial milestone payments, and a mid single-digit tiered royalty calculated as a percentage of Sun Pharma\u2019s net sales. We have separate contractual obligations under which we have agreed to pay to third parties a portion of the consideration we may receive under the license agreement.\u200bUpon execution of the agreement, we received an upfront payment of $15.0 million from Sun Pharma, a portion of which was payable to third parties. \u200bLicense Agreement with Pediatrix Therapeutics, Inc. \u200bIn November 2022, we entered into a license agreement with Pediatrix Therapeutics, Inc., or Pediatrix, under which we granted Pediatrix the exclusive rights to develop, manufacture and commercialize ATI-1777 in Greater China. Pediatrix has agreed to pay us an upfront payment, development, regulatory and commercial milestone payments, and a tiered royalty ranging from a low-to-high single digit percentage of net sales of ATI-1777 by Pediatrix in Greater China. A portion of consideration received from Pediatrix is payable to the former Confluence equity holders as described below under the caption \u201c\u2014Agreement and Plan of Merger with Confluence.\u201d \u200bUpon execution of the agreement, we received an upfront payment of $5.0 million from Pediatrix, a portion of which was payable to the former Confluence equity holders.\u200bLicense Agreement with Eli Lilly and Company \u200bIn August 2022, we entered into a non-exclusive patent license agreement with Eli Lilly and Company, or Lilly. Under the license agreement, we granted Lilly non-exclusive rights under certain patents and patent applications that we exclusively license from a third party. The patents and patent applications relate to the use of baricitinib, Lilly\u2019s JAK inhibitor, to treat alopecia areata. Under the license agreement, Lilly has agreed to pay us an upfront payment, regulatory and commercial milestone payments, anniversary payments, and a low single-digit royalty calculated as a percentage of Lilly\u2019s net sales of baricitinib for the treatment of alopecia areata. We have separate contractual obligations under which we have agreed to pay to third parties an amount equal to any regulatory and commercial milestone payments we receive under the Lilly license agreement, as well as a portion of the upfront consideration and a portion of the royalties we may receive under the license agreement.\u200b During the years ended December 31, 2023 and 2022, respectively, we recorded licensing revenue under this agreement of $12.7 million and $17.8 million from Lilly, a portion of which was payable to third parties. \u200bAsset Purchase Agreement with EPI Health, LLC\u200bIn October 2019, we sold RHOFADE (oxymetazoline hydrochloride) cream, 1%, or RHOFADE, to EPI Health, LLC, or EPI Health, pursuant to an asset purchase agreement. In July 2023, EPI Health filed a voluntary petition for relief 65",
            "type": "paragraph"
        },
        {
            "id": 69,
            "context": "under Chapter 11 of the United States Bankruptcy Code. Through the bankruptcy process, EPI Health and its parent company, Novan, Inc., sold the RHOFADE assets to a third party, which excluded our asset purchase agreement with EPI Health and the outstanding amounts due. The sale was approved by the bankruptcy court in September 2023. \u200bAs a result of the bankruptcy proceedings, we recorded an allowance for doubtful accounts resulting in $1.3 million of bad debt expense for the year ended December 31, 2023, representing all amounts that were due and outstanding by EPI Health.\u200bAgreement and Plan of Merger with Confluence\u200bIn 2017, we entered into an Agreement and Plan of Merger, or the Confluence Agreement, with Confluence Life Sciences, Inc. (now known as Aclaris Life Sciences, Inc.), or Confluence, Aclaris Life Sciences, Inc., our wholly-owned subsidiary, or Merger Sub, and Fortis Advisors LLC, as representative of the equity holders of Confluence. Pursuant to the terms of the Confluence Agreement, Merger Sub merged with and into Confluence, with Confluence surviving as our wholly-owned subsidiary. \u200bUnder the Confluence Agreement, we have agreed to pay the former Confluence equity holders aggregate remaining contingent consideration of up to $75.0 million based upon the achievement of specified regulatory and commercial milestones set forth in the Confluence Agreement. In addition, we have agreed to pay the former Confluence equity holders future royalty payments calculated as a low single-digit percentage of annual net sales, subject to specified reductions, limitations and other adjustments, until the date that all of the patent rights for that product have expired, as determined on a country-by-country and product-by-product basis or, in specified circumstances, ten years from the first commercial sale of such product. In addition to the payments described above, if we sell, license or transfer any of the intellectual property acquired from Confluence pursuant to the Confluence Agreement to a third party, we will be obligated to pay the former Confluence equity holders a portion of any consideration received from such sale, license or transfer in specified circumstances. \u200bRestructuring\u200bIn December 2023, our Board of Directors approved a reduction of our workforce by approximately 46%, which we expect to be substantially completed by June 2024. This action was taken in order to streamline operations, reduce costs and preserve capital. As a result, we terminated certain employees, or terminated employees, and gave notice to additional employees, or noticed employees, who were asked to provide transition services through termination dates ranging between one to thirteen months from the date notice was given. The terminated employees were entitled to receive cash severance payments and other benefits. The noticed employees are entitled to receive cash severance payments and other benefits, which are contingent upon providing additional services to us.\u200bDuring the year ended December 31, 2023, we recorded a restructuring charge of $3.1 million which represents a one-time termination benefit for impacted employees with retention periods less than the sixty-day minimum retention period, which was triggered immediately upon either terminating or giving notice to the impacted employees. An estimated charge between $1.9 million and $2.2 million is expected to be incurred for additional termination costs, including severance and other benefits, over the next 12 months.\u200bComponents of Our Results of Operations\u200bRevenue\u200bContract Research\u200bWe earn revenue from the provision of laboratory services. Contract research revenue is generally evidenced by contracts with clients which are on an agreed upon fixed-price, fee-for-service basis and are generally billed on a monthly basis in arrears for services rendered. \u200bLicensing\u200bLicensing revenue primarily consists of upfront consideration, royalties and milestone payments earned pursuant to license and acquisition agreements with third parties, as described above. 66",
            "type": "paragraph"
        },
        {
            "id": 70,
            "context": "| \u25cf | employee-related expenses, which include salaries, benefits and stock-based compensation; |\n| \u25cf | outsourced professional scientific services; |\n| \u25cf | depreciation of laboratory equipment; |\n| \u25cf | facility-related costs; and |\n| \u25cf | laboratory materials and supplies used to support the services provided. |\n| \u25cf | expenses incurred under agreements with contract research organizations, or CROs, as well as clinical trial sites and consultants that conduct our clinical trials and preclinical studies, and investigator-initiated trials; |\n| \u25cf | manufacturing scale-up expenses and the cost of acquiring and manufacturing active pharmaceutical ingredients and preclinical and clinical trial materials, including domestic technology transfer expenses; |\n| \u25cf | quality assurance and quality control costs; |\n| \u25cf | outsourced professional scientific development services; |\n| \u25cf | medical affairs expenses related to our drug candidates; |\n| \u25cf | employee-related expenses, which include salaries, benefits and stock-based compensation; |\n| \u25cf | expenses relating to regulatory activities, including filing fees paid to regulatory agencies; and |\n| \u25cf | laboratory materials and supplies used to support our research activities. |\n| \u25cf | the number of clinical sites included in the trials; |\n| \u25cf | the length of time required to enroll suitable subjects; |\n| \u25cf | the number of subjects that ultimately participate in the trials; |\n| \u25cf | the number of doses subjects receive; |\n| \u25cf | the duration of subject follow-up; and |\n| \u25cf | the results of our clinical trials. |",
            "type": "table"
        },
        {
            "id": 71,
            "context": "\u200bOur expenditures are subject to additional uncertainties, including the preparation of regulatory filings for our drug candidates. We may obtain unexpected results from our clinical trials or other development activities. We may elect to discontinue, delay or modify the development, including clinical trials, of some drug candidates or focus on others. A change in the outcome of any of these variables with respect to the development of a drug candidate could mean a significant change in the costs and timing associated with the development of that drug candidate. For example, if the FDA or other regulatory authorities were to require us to conduct clinical trials beyond those that we currently anticipate, or if we experience significant delays in enrollment in any of our clinical trials, we could be required to expend significant additional financial resources and time on the completion of clinical development. \u200bGeneral and Administrative \u200bGeneral and administrative expenses consist principally of salaries and related costs, including stock-based compensation, for personnel in executive, administrative, finance and legal functions. General and administrative expenses also include facility-related costs, patent filing and prosecution costs, professional fees for legal, auditing and tax services, investor relations costs, business development costs, insurance costs and travel expenses.\u200bLicensing\u200bLicensing expenses consist of third-party contractual obligations incurred under license and acquisition agreements with third parties, as described above.\u200bRevaluation of Contingent Consideration\u200bRevaluation of contingent consideration consists of changes in the fair value of our contingent consideration liability between reporting dates.\u200bIntangible Asset Impairment\u200bIntangible asset impairment consists of changes to the fair value of our in-process research and development, or IPR&D, intangible asset.\u200bOther Income (Expense), Net\u200bOther income (expense), net primarily consists of interest earned on our cash, cash equivalents and marketable securities and in prior periods included interest expense related to debt obligations. \u200bCritical Accounting Estimates\u200bThis discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reported period. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and judgments on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. \u200bWhile our significant accounting policies are described in more detail in the notes to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements. \u200bIntangible Assets\u200bOur intangible assets include both definite-lived and indefinite-lived assets. Our definite-lived intangible assets consist of a drug discovery platform acquired through the acquisition of Confluence. Definite-lived intangible assets are 68",
            "type": "paragraph"
        },
        {
            "id": 72,
            "context": "amortized over their estimated useful life based on the pattern over which the intangible assets are consumed or otherwise used up. If that pattern cannot be reliably determined, the straight-line method of amortization is used. Our indefinite-lived intangible assets consisted of an IPR&D drug candidate also acquired through the acquisition of Confluence. IPR&D assets are considered indefinite-lived until the completion or abandonment of the associated research and development efforts. The cost of IPR&D assets is either amortized over their estimated useful life beginning when the underlying drug candidate is approved and launched commercially, or expensed immediately if development of the drug candidate is abandoned. \u200bDefinite-lived intangible assets are tested for impairment when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. Indefinite-lived intangible assets are tested for impairment at least annually, which we perform during the fourth quarter, or when indicators of an impairment are present. We recognize an impairment loss when and to the extent that the estimated fair value of an intangible asset is less than its carrying value. The fair value of an intangible asset is dependent on significant unobservable inputs including the estimated future cash flows of the asset.\u200bDuring the quarter ended December 31, 2023, we performed an impairment analysis on the IPR&D intangible asset due to our decision to discontinue further development of the drug candidate in immuno-inflammatory diseases. Our impairment analysis resulted in a fair value of the IPR&D intangible asset which was less than the carrying value. As a result, we recorded an impairment charge of $6.6 million, the full balance of the IPR&D intangible asset. \u200bContingent Consideration\u200bWe record a contingent consideration liability related to future potential payments resulting from the acquisition of Confluence based upon significant unobservable inputs including the achievement of regulatory and commercial milestones, as well as estimated future sales levels and the discount rates applied to calculate the present value of the potential payments. Significant judgement is involved in determining the appropriateness of these assumptions. These assumptions are considered Level 3 inputs. Revaluation of our contingent consideration liability can result from changes to one or more of these assumptions. These assumptions are highly dependent on the outcome and timing of the development of certain of our drug candidates. We evaluate the fair value estimate of our contingent consideration liability on a quarterly basis with changes, if any, recorded as income or expense in our consolidated statement of operations. Any such changes could have a material impact on our financial results.\u200bThe fair value of contingent consideration is estimated using a probability-weighted expected payment model for regulatory milestone payments and a Monte Carlo simulation model for commercial milestone and royalty payments and then applying a risk-adjusted discount rate to calculate the present value of the potential payments. Significant assumptions used in our estimates include the probability of achieving regulatory milestones and commencing commercialization, which are based on an asset\u2019s current stage of development and a review of existing clinical data. The probability of success assumption was 35% at December 31, 2023. Additionally, estimated future sales levels and the risk-adjusted discount rate applied to the potential payments are also significant assumptions used in calculating the fair value. The discount rate ranged between 7.3% and 8.6% depending on the year of each potential payment.\u200bDuring the year ended December 31, 2023, we removed estimated sales of zunsemetinib for moderate to severe rheumatoid arthritis, moderate to severe hidradenitis suppurativa and moderate to severe psoriatic arthritis, following our decision to discontinue further development of our MK2 inhibitor programs in immuno-inflammatory diseases. These changes, partially offset by lower discount rates resulting from lower risk-free rates and changes in credit spreads, as well as the passage of time, resulted in an overall decrease of $26.9 million during the year ended December 31, 2023.\u200bStock-Based Compensation\u200bWe measure the compensation expense of stock-based awards granted to employees and directors using the grant date fair value of the award. We have issued stock options and restricted stock unit, or RSU, awards with service-based vesting conditions, as well as with performance-based vesting conditions. We have not issued awards that include market-based conditions. For service-based awards, we recognize stock-based compensation expense on a straight-line basis over the requisite service period. For performance-based awards, we recognize stock-based compensation expense on a straight-line basis over the requisite service period beginning in the period that it becomes probable the performance conditions will occur. At each balance sheet date, we evaluate whether any performance conditions related to a performance-based award have changed. The effect of any change in performance conditions would be recognized as a cumulative catch-up adjustment in the period such change occurs, and any remaining unrecognized compensation expense would be recognized 69",
            "type": "paragraph"
        },
        {
            "id": 73,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ended December 31, | \u200b | \u200b | \u200b |\n| (In thousands) | 2023 | 2022 | Change |\n| Revenues: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Contract research | \u200b | \u200b | $ | 3,035 | \u200b | $ | 4,395 | \u200b | $ | (1,360) |\n| Licensing | \u200b | \u200b | \u200b | 28,214 | \u200b | \u200b | 25,100 | \u200b | \u200b | 3,114 |\n| Other | \u200b | \u200b | \u200b | \u2014 | \u200b | \u200b | 257 | \u200b | \u200b | (257) |\n| Total revenue | \u200b | \u200b | \u200b | 31,249 | \u200b | \u200b | 29,752 | \u200b | \u200b | 1,497 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Costs and expenses: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Cost of revenue | \u200b | \u200b | \u200b | 3,423 | \u200b | \u200b | 4,023 | \u200b | \u200b | (600) |\n| Research and development | \u200b | \u200b | 98,384 | \u200b | 77,813 | \u200b | 20,571 |\n| General and administrative | \u200b | \u200b | 32,412 | \u200b | 25,133 | \u200b | 7,279 |\n| Licensing | \u200b | \u200b | \u200b | 14,658 | \u200b | \u200b | 7,937 | \u200b | \u200b | 6,721 |\n| Revaluation of contingent consideration | \u200b | \u200b | \u200b | (26,900) | \u200b | \u200b | 4,700 | \u200b | \u200b | (31,600) |\n| Intangible asset impairment | \u200b | \u200b | \u200b | 6,629 | \u200b | \u200b | \u2014 | \u200b | \u200b | 6,629 |\n| Total costs and expenses | \u200b | \u200b | 128,606 | \u200b | 119,606 | \u200b | 9,000 |\n| Loss from operations | \u200b | \u200b | (97,357) | \u200b | (89,854) | \u200b | (7,503) |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Other income, net | \u200b | \u200b | 8,509 | \u200b | 2,946 | \u200b | 5,563 |\n| Loss before income taxes | \u200b | \u200b | \u200b | (88,848) | \u200b | \u200b | (86,908) | \u200b | \u200b | (1,940) |\n| Income tax benefit | \u200b | \u200b | \u200b | (367) | \u200b | \u200b | \u2014 | \u200b | \u200b | (367) |\n| Net loss | \u200b | \u200b | $ | (88,481) | \u200b | $ | (86,908) | \u200b | $ | (1,573) |",
            "type": "table"
        },
        {
            "id": 74,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ended | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | December 31, | \u200b | \u200b | \u200b |\n| (In thousands) | \u200b | \u200b | 2023 | 2022 | \u200b | Change |\n| Zunsemetinib | $ | 36,461 | $ | 28,133 | $ | 8,328 |\n| ATI-1777 | \u200b | \u200b | \u200b | 12,129 | \u200b | \u200b | 12,113 | \u200b | \u200b | 16 |\n| ATI-2138 | \u200b | \u200b | \u200b | 12,143 | \u200b | \u200b | 7,704 | \u200b | \u200b | 4,439 |\n| ATI-2231 | \u200b | \u200b | \u200b | 1,575 | \u200b | \u200b | 4,828 | \u200b | \u200b | (3,253) |\n| Discovery | \u200b | \u200b | 6,881 | \u200b | 4,564 | \u200b | 2,317 |\n| Other research and development | \u200b | \u200b | \u200b | 3,417 | \u200b | \u200b | 1,564 | \u200b | \u200b | 1,853 |\n| Personnel | \u200b | \u200b | \u200b | 18,977 | \u200b | \u200b | 15,162 | \u200b | \u200b | 3,815 |\n| Stock-based compensation | \u200b | \u200b | \u200b | 6,801 | \u200b | \u200b | 3,745 | \u200b | \u200b | 3,056 |\n| Total research and development expenses | \u200b | \u200b | $ | 98,384 | \u200b | $ | 77,813 | \u200b | $ | 20,571 |",
            "type": "table"
        },
        {
            "id": 75,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ended | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | December 31, | \u200b | \u200b | \u200b |\n| (In thousands) | \u200b | \u200b | 2023 | 2022 | \u200b | Change |\n| Personnel | $ | 8,016 | $ | 6,028 | $ | 1,988 |\n| Professional and legal fees | \u200b | \u200b | \u200b | 5,534 | \u200b | \u200b | 4,319 | \u200b | \u200b | 1,215 |\n| Facility and support services | \u200b | \u200b | 3,023 | \u200b | 2,302 | \u200b | 721 |\n| Other general and administrative | \u200b | \u200b | \u200b | 2,240 | \u200b | \u200b | 2,341 | \u200b | \u200b | (101) |\n| Stock-based compensation | \u200b | \u200b | \u200b | 12,285 | \u200b | \u200b | 10,143 | \u200b | \u200b | 2,142 |\n| Bad debt | \u200b | \u200b | \u200b | 1,314 | \u200b | \u200b | \u2014 | \u200b | \u200b | 1,314 |\n| Total general and administrative expenses | \u200b | \u200b | $ | 32,412 | \u200b | $ | 25,133 | \u200b | $ | 7,279 |",
            "type": "table"
        },
        {
            "id": 76,
            "context": "Professional and legal fees\u200b The increase in professional and legal fees, including accounting, investor relations and corporate communication costs, during the year ended December 31, 2023 compared to the year ended December 31, 2022 was primarily driven by an increase in patent and accounting related expenses.\u200bFacility and support services \u200bThe increase in facility and support services, including general office expenses, information technology costs and other expenses, during the year ended December 31, 2023 compared to the year ended December 31, 2022 was primarily driven by an increase in rent expense due to leasing additional office and laboratory space during the year ended December 31, 2023, as well as an increase in information technology costs.\u200bBad debt\u200bBad debt expenses were related to our determination that amounts due to us as of December 31, 2023 pursuant to the asset purchase agreement with EPI Health are uncertain as a result of the bankruptcy filing by EPI Health, which was initiated in July 2023. \u200bLicensing\u200bThe increase in licensing expenses during the year ended December 31, 2023 compared to the year ended December 31, 2022 was primarily driven by amounts payable to third parties during the year ended December 31, 2023 in connection with amounts earned under the Sun Pharma agreement and an increase in amounts payable to third parties in connection with amounts earned under the Lilly agreement. \u200bRevaluation of Contingent Consideration\u200bThe fair value of our contingent consideration liability decreased during the year ended December 31, 2023 mainly due to the removal of estimated sales of zunsemetinib for moderate to severe rheumatoid arthritis, moderate to severe hidradenitis suppurativa and moderate to severe psoriatic arthritis, following our decision to discontinue further development of our MK2 inhibitor programs in immuno-inflammatory diseases. This decrease was partially offset by lower discount rates resulting from lower risk-free rates and changes in credit spreads, as well as the passage of time.\u200bThe fair value of our contingent consideration liability increased during the year ended December 31, 2022 mainly due to an increase in future sales level assumptions for zunsemetinib and the passage of time.\u200bIntangible Asset Impairment\u200bDuring the quarter ended December 31, 2023, we performed an impairment analysis on the IPR&D intangible asset due to our decision to discontinue further development of the drug candidate for immuno-inflammatory diseases. Our impairment analysis resulted in a fair value of the IPR&D intangible asset which was less than the carrying value. As a result, we recorded an impairment charge of $6.6 million, the full balance of the IPR&D intangible asset. \u200bOther Income, net\u200bOther income, net increased during the year ended December 31, 2023 compared to the year ended December 31, 2022 primarily due to higher interest income on investment portfolio balances.\u200b73",
            "type": "paragraph"
        },
        {
            "id": 77,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 |\n| Cash and cash equivalents beginning balance | \u200b | $ | 45,277 | \u200b | $ | 27,349 |\n| Net cash used in operating activities | \u200b | (78,325) | \u200b | (67,567) |\n| Net cash provided by investing activities | \u200b | 46,220 | \u200b | 12,628 |\n| Net cash provided by financing activities | \u200b | \u200b | 26,706 | \u200b | \u200b | 72,867 |\n| Cash and cash equivalents ending balance | \u200b | $ | 39,878 | \u200b | $ | 45,277 |",
            "type": "table"
        },
        {
            "id": 78,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 |\n| Net loss | \u200b | $ | (88,481) | \u200b | $ | (86,908) |\n| Non-cash adjustments to reconcile net loss to net cash used in operating activities | \u200b | 767 | \u200b | 20,536 |\n| Change in accounts payable and accrued expenses | \u200b | \u200b | 10,518 | \u200b | \u200b | 960 |\n| Change in accounts receivable | \u200b | \u200b | 186 | \u200b | \u200b | 139 |\n| Change in prepaid expenses and other assets | \u200b | (1,315) | \u200b | (2,294) |\n| Net cash used in operating activities | \u200b | $ | (78,325) | \u200b | $ | (67,567) |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 |\n| Purchases of property and equipment | \u200b | $ | (1,309) | \u200b | $ | (605) |\n| Purchases of marketable securities | \u200b | (135,675) | \u200b | (164,753) |\n| Proceeds from sales and maturities of marketable securities | \u200b | \u200b | 183,204 | \u200b | \u200b | 177,986 |\n| Net cash provided by investing activities | \u200b | $ | 46,220 | \u200b | $ | 12,628 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 |\n| Proceeds from issuance of common stock under the at-the-market sales agreement, net of issuance costs | \u200b | $ | 26,714 | \u200b | $ | 72,744 |\n| Payments of employee withholding taxes related to restricted stock unit award vesting | \u200b | \u200b | (102) | \u200b | \u200b | (34) |\n| Proceeds from exercise of employee stock options and the issuance of stock | \u200b | 94 | \u200b | 157 |\n| Net cash provided by financing activities | \u200b | $ | 26,706 | \u200b | $ | 72,867 |",
            "type": "table"
        },
        {
            "id": 79,
            "context": "| \u25cf | the number and development requirements of the drug candidates that we may pursue; |\n| \u25cf | the scope, progress, results and costs of preclinical development, laboratory testing and conducting preclinical and clinical trials for our drug candidates; |\n| \u25cf | the costs, timing and outcome of regulatory review of our drug candidates; |\n| \u25cf | the extent to which we in-license or acquire additional drug candidates and technologies; |\n| \u25cf | the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; |\n| \u25cf | our ability to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates; and |\n| \u25cf | our ability to earn revenue as a result of licenses to, or partnerships or other arrangements with, third parties. |",
            "type": "table"
        },
        {
            "id": 80,
            "context": "Leases\u200bWe occupy space for our headquarters in Wayne, Pennsylvania under a lease agreement which has a term through February 2029. We also occupy office and laboratory space in St. Louis, Missouri under a sublease agreement which has a term through June 2029. \u200bOur aggregate remaining lease payment obligation for these two spaces was $4.6 million as of December 31, 2023.\u200bAgreement and Plan of Merger \u2013 Confluence\u200bUnder the Confluence Agreement, we agreed to pay the former Confluence equity holders aggregate remaining contingent consideration of up to $75.0 million based upon the achievement of specified regulatory and commercial milestones set forth in the Confluence Agreement. In addition, we have agreed to pay the former Confluence equity holders future royalty payments calculated as a low single-digit percentage of annual net sales, subject to specified reductions, limitations and other adjustments, until the date that all of the patent rights for that product have expired, as determined on a country-by-country and product-by-product basis or, in specified circumstances, ten years from the first commercial sale of such product. In addition to the payments described above, if we sell, license or transfer any of the intellectual property acquired from Confluence pursuant to the Confluence Agreement to a third party, we will be obligated to pay the former Confluence equity holders a portion of any consideration received from such sale, license or transfer in specified circumstances. \u200bR&D Obligations\u200bWe enter into contracts in the normal course of business with CROs, contract manufacturing organizations and other service providers for clinical trials, preclinical studies and testing, manufacturing and other services and products for operating purposes. These contracts generally provide for termination upon notice, and therefore we believe that our non-cancelable obligations under these agreements are not material.\u200bSegment Information\u200bWe have two reportable segments, therapeutics and contract research. The therapeutics segment is focused on identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment earns revenue from the provision of laboratory services.\u200bRecently Issued Accounting Pronouncements\u200bIn November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2023-07, \u201cSegment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.\u201d This standard requires disclosure of significant segment expenses and other segment items by reportable segment. This ASU becomes effective for annual periods beginning in 2024 and interim periods in 2025. We are assessing the impact of this ASU and upon adoption expect that any impact would be limited to additional segment expense disclosures in the footnotes to the our consolidated financial statements.\u200bIn December 2023, the FASB issued ASU No. 2023-09, \u201cIncome Taxes (Topic 740): Improvements to Income Tax Disclosures.\u201d This standard enhances disclosures related to income taxes, including the rate reconciliation and information on income taxes paid. This ASU becomes effective January 1, 2025. We are currently assessing the impact of this ASU.\u200b\u200b77",
            "type": "paragraph"
        },
        {
            "id": 81,
            "context": "Item 7A. Quantitative and Qualitative Disclosures about Market Risk\n\u200b Our cash equivalents and marketable securities consist of money market funds, asset-backed debt securities, commercial paper, corporate debt securities, foreign government agency debt securities, U.S. government debt securities and U.S. government agency debt securities. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates. Our marketable securities are subject to interest rate risk and will fall in value if market interest rates increase. However, due to the short-term nature and low-risk profile of our investment portfolio, we do not expect that an immediate 10% change in market interest rates would have a material effect on the fair market value of our investment portfolio. We have the ability to hold our marketable securities until maturity, and therefore we would not expect our operating results or cash flows to be affected to any significant degree by the effect of a change in market interest rates on our investments.",
            "type": "paragraph"
        },
        {
            "id": 82,
            "context": "\u200b\nForeign currency risk\n\u200b Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in exchange rates. Our primary exposure to currency risk is foreign government agency debt securities. We do not enter into any derivative financial instruments to manage our exposure to foreign currency risk. Due to the conservative nature of our investment portfolio and other financial instruments, we do not believe an immediate 10% change in currency rates would have a material effect on the fair market value of our portfolio.",
            "type": "paragraph"
        },
        {
            "id": 83,
            "context": "\u200b\nInflation Risk\n\u200b Inflation generally affects us by increasing our cost of labor. Although inflation has increased generally in the United States in recent months, we do not believe that inflation has had a material effect on our business, financial condition or results of operations during the year ended December 31, 2023.",
            "type": "paragraph"
        },
        {
            "id": 84,
            "context": "\u200b\n\u200b\n78\nItem 8. Financial Statements and Supplementary Data\n\u200b\nINDEX TO CONSOLIDATED FINANCIAL STATEMENTS\n\u200b\n\n| \u200b |\n| Report of Independent Registered Public Accounting Firm (PCAOB ID 238 ) | 80 |\n| \u200b | \u200b |\n| Consolidated Balance Sheets as of December 31, 2023 and 2022 | 83 |\n| \u200b | \u200b |\n| Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021 | 84 |\n| \u200b | \u200b |\n| Consolidated Statements of Stockholders\u2019 Equity for the years ended December 31, 2023, 2022 and 2021 | 85 |\n| \u200b | \u200b |\n| Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021 | 86 |\n| \u200b | \u200b |\n| Notes to Consolidated Financial Statements | 87 |",
            "type": "table"
        },
        {
            "id": 85,
            "context": "\u200b\n\u200b\n\u200b\n79 Report of Independent Registered Public Accounting Firm \u200bTo the Board of Directors and Stockholders of Aclaris Therapeutics, Inc.Opinions on the Financial Statements and Internal Control over Financial ReportingWe have audited the accompanying consolidated balance sheets of Aclaris Therapeutics, Inc. and its subsidiaries (the \u201cCompany\u201d) as of December 31, 2023 and 2022, and the related consolidated statements of operations and comprehensive loss, of stockholders\u2019 equity and of cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the \u201cconsolidated financial statements\u201d). We also have audited the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.Basis for OpinionsThe Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management\u2019s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company\u2019s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.Definition and Limitations of Internal Control over Financial ReportingA company\u2019s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company\u2019s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely 80",
            "type": "paragraph"
        },
        {
            "id": 86,
            "context": "detection of unauthorized acquisition, use, or disposition of the company\u2019s assets that could have a material effect on the financial statements.Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.Critical Audit MattersThe critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.\u200bFair Value of the Contingent Consideration Liability \u200bAs described in Notes 2 and 3 to the consolidated financial statements, the Company\u2019s contingent consideration balance was $6.2 million as of December 31, 2023. The Company records a contingent consideration liability related to future potential payments resulting from the acquisition of Confluence based upon significant unobservable inputs including the achievement of regulatory and commercial milestones, as well as estimated future sales levels and the discount rates applied to calculate the present value of the potential payments. Management evaluates fair value estimates of the contingent consideration liability on a quarterly basis using a probability-weighted expected payment model for regulatory milestone payments and a Monte Carlo simulation model for commercial milestone and royalty payments and then applying a risk-adjusted discount rate to calculate the present value of the potential payment. Changes in the fair value of the contingent consideration are recorded as income or expense in the Company\u2019s consolidated statement of operations and comprehensive loss. Significant assumptions used in management\u2019s estimates include the probability of achieving regulatory milestones and commencing commercialization, which are based upon an asset\u2019s current stage of development and review of existing clinical data.\u200bThe principal considerations for our determination that performing procedures relating to the fair value of the contingent consideration liability is a critical audit matter are (i) the significant judgment by management when developing the fair value estimate, which in turn led to (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating management\u2019s significant assumptions related to the probability of achieving regulatory milestones and commencing commercialization. In addition, the audit effort involved the use of professionals with specialized skill and knowledge. Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management\u2019s contingent consideration evaluation, including controls over the valuation of the Company\u2019s contingent consideration liability. These procedures also included, among others, (i) testing management\u2019s process for developing the fair value of the contingent consideration liability, (ii) evaluating the appropriateness of the probability-weighted expected payment and Monte Carlo simulation valuation models, (iii) testing the completeness and accuracy of the underlying data used in the models, and (iv) evaluating the reasonableness of the significant assumptions used by management related to the probability of achieving regulatory milestones and commencing commercialization. Evaluating management\u2019s assumptions related to the probability of achieving regulatory milestones and commencing commercialization involved evaluating whether the assumptions were reasonable considering the agreements associated with the transaction as well as the consistency with industry information, the stage of product development and whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company\u2019s probability-weighted expected payment and Monte Carlo simulation valuation models. \u200b\u200b81",
            "type": "paragraph"
        },
        {
            "id": 87,
            "context": "/s/ PricewaterhouseCoopers LLP Philadelphia, Pennsylvania February 27, 2024We have served as the Company\u2019s auditor since 2015.\u200b\u200b\u200b82\n\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | December 31, | \u200b | December 31, |\n| \u200b | 2023 | 2022 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Assets | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Current assets: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Cash and cash equivalents | \u200b | $ | 39,878 | \u200b | $ | 45,277 |\n| Short-term marketable securities | \u200b | 79,228 | \u200b | 172,294 |\n| Accounts receivable, net | \u200b | \u200b | 298 | \u200b | \u200b | 484 |\n| Prepaid expenses and other current assets | \u200b | 9,452 | \u200b | 13,495 |\n| Total current assets | \u200b | 128,856 | \u200b | 231,550 |\n| Marketable securities | \u200b | 62,771 | \u200b | 12,242 |\n| Property and equipment, net | \u200b | 1,620 | \u200b | 1,099 |\n| Intangible assets | \u200b | \u200b | 269 | \u200b | \u200b | 6,973 |\n| Other assets | \u200b | 3,889 | \u200b | 2,732 |\n| Total assets | \u200b | $ | 197,405 | \u200b | $ | 254,596 |\n| Liabilities and Stockholders\u2019 Equity | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Current liabilities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Accounts payable | \u200b | $ | 8,878 | \u200b | $ | 10,351 |\n| Accrued expenses | \u200b | 19,446 | \u200b | 8,701 |\n| Current portion of lease liabilities | \u200b | \u200b | 426 | \u200b | \u200b | 684 |\n| Discontinued operations | \u200b | \u200b | 2,202 | \u200b | \u200b | 2,202 |\n| Total current liabilities | \u200b | 30,952 | \u200b | 21,938 |\n| Other liabilities | \u200b | \u200b | 3,074 | \u200b | 1,570 |\n| Contingent consideration | \u200b | \u200b | 6,200 | \u200b | \u200b | 33,100 |\n| Deferred tax liability | \u200b | \u2014 | \u200b | 367 |\n| Total liabilities | \u200b | 40,226 | \u200b | 56,975 |\n| Commitments and contingencies (Note 17) | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Stockholders\u2019 Equity: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Preferred stock, $ 0.00001 par value; 10,000,000 shares authorized and no shares issued or outstanding at December 31, 2023 and December 31, 2022 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 |\n| Common stock, $ 0.00001 par value; 200,000,000 and 100,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 70,894,889 and 66,688,647 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | \u200b | 1 | \u200b | 1 |\n| Additional paid\u2011in capital | \u200b | 928,080 | \u200b | 880,832 |\n| Accumulated other comprehensive loss | \u200b | ( 106 ) | \u200b | ( 897 ) |\n| Accumulated deficit | \u200b | ( 770,796 ) | \u200b | ( 682,315 ) |\n| Total stockholders\u2019 equity | \u200b | 157,179 | \u200b | 197,621 |\n| Total liabilities and stockholders\u2019 equity | \u200b | $ | 197,405 | \u200b | $ | 254,596 |",
            "type": "table"
        },
        {
            "id": 88,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended | \u200b |\n| \u200b | \u200b | December 31, | \u200b |\n| \u200b | 2023 | 2022 | 2021 | \u200b |\n| Revenues: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Contract research | \u200b | $ | 3,035 | \u200b | $ | 4,395 | \u200b | $ | 5,830 | \u200b |\n| Licensing | \u200b | \u200b | 28,214 | \u200b | \u200b | 25,100 | \u200b | \u200b | 809 | \u200b |\n| Other | \u200b | \u200b | \u2014 | \u200b | \u200b | 257 | \u200b | \u200b | 122 | \u200b |\n| Total revenue | \u200b | \u200b | 31,249 | \u200b | \u200b | 29,752 | \u200b | \u200b | 6,761 | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Costs and expenses: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Cost of revenue | \u200b | \u200b | 3,423 | \u200b | \u200b | 4,023 | \u200b | \u200b | 4,713 | \u200b |\n| Research and development | 98,384 | \u200b | 77,813 | \u200b | 43,813 | \u200b |\n| General and administrative | 32,412 | \u200b | 25,133 | \u200b | 23,619 | \u200b |\n| Licensing | \u200b | \u200b | 14,658 | \u200b | \u200b | 7,937 | \u200b | \u200b | \u2014 | \u200b |\n| Revaluation of contingent consideration | \u200b | \u200b | ( 26,900 ) | \u200b | \u200b | 4,700 | \u200b | \u200b | 24,339 | \u200b |\n| Intangible asset impairment | \u200b | \u200b | 6,629 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b |\n| Total costs and expenses | 128,606 | \u200b | 119,606 | \u200b | 96,484 | \u200b |\n| Loss from operations | ( 97,357 ) | \u200b | ( 89,854 ) | \u200b | ( 89,723 ) | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Other income (expense), net | 8,509 | \u200b | 2,946 | \u200b | ( 1,142 ) | \u200b |\n| Loss before income taxes | \u200b | \u200b | ( 88,848 ) | \u200b | \u200b | ( 86,908 ) | \u200b | \u200b | ( 90,865 ) | \u200b |\n| Income tax benefit | \u200b | \u200b | ( 367 ) | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b |\n| Net loss | \u200b | $ | ( 88,481 ) | \u200b | $ | ( 86,908 ) | \u200b | $ | ( 90,865 ) | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Net loss per share, basic and diluted | \u200b | $ | ( 1.27 ) | \u200b | $ | ( 1.33 ) | \u200b | $ | ( 1.60 ) | \u200b |\n| Weighted average common shares outstanding, basic and diluted | \u200b | 69,808,855 | \u200b | 65,213,944 | \u200b | \u200b | 56,730,583 | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Other comprehensive loss: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Unrealized gain (loss) on marketable securities, net of tax of $ 0 | \u200b | $ | 791 | \u200b | $ | ( 673 ) | \u200b | $ | ( 229 ) | \u200b |\n| Foreign currency translation adjustment | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 99 | \u200b |\n| Total other comprehensive gain (loss) | \u200b | 791 | \u200b | ( 673 ) | \u200b | ( 130 ) | \u200b |\n| Comprehensive loss | \u200b | $ | ( 87,690 ) | \u200b | $ | ( 87,581 ) | \u200b | $ | ( 90,995 ) | \u200b |",
            "type": "table"
        },
        {
            "id": 89,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | Accumulated | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Common Stock | \u200b | Additional | \u200b | Other | \u200b | \u200b | \u200b | Total |\n| \u200b | \u200b | \u200b | \u200b | Par | \u200b | Paid\u2011in | \u200b | Comprehensive | \u200b | Accumulated | \u200b | Stockholders\u2019 |\n| \u200b | Shares | Value | Capital | Loss | Deficit | Equity |\n| Balance at December 31, 2020 | \u200b | 45,109,314 | \u200b | $ | \u2014 | \u200b | $ | 542,286 | \u200b | $ | ( 94 ) | \u200b | $ | ( 504,542 ) | \u200b | $ | 37,650 | \u200b |\n| Issuance of common stock in connection with exercise of stock options and warrants and vesting of restricted stock units | \u200b | 1,714,269 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 1,574 ) | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | ( 1,574 ) | \u200b |\n| Issuance of common stock in connection with public offerings, net of offering costs of $ 15,910 | \u200b | 14,404,863 | \u200b | \u200b | 1 | \u200b | \u200b | 238,199 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 238,200 | \u200b |\n| Unrealized loss on marketable securities | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 229 ) | \u200b | \u200b | \u2014 | \u200b | ( 229 ) | \u200b |\n| Foreign currency translation adjustment | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 99 | \u200b | \u200b | \u2014 | \u200b | \u200b | 99 | \u200b |\n| Stock-based compensation expense | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 14,060 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 14,060 | \u200b |\n| Net loss | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 90,865 ) | \u200b | ( 90,865 ) | \u200b |\n| Balance at December 31, 2021 | 61,228,446 | \u200b | $ | 1 | \u200b | $ | 792,971 | \u200b | $ | ( 224 ) | \u200b | $ | ( 595,407 ) | \u200b | $ | 197,341 | \u200b |\n| Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units | \u200b | 621,492 | \u200b | \u200b | \u2014 | \u200b | \u200b | 163 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 163 | \u200b |\n| Issuance of common stock under at-the-market sales agreement, net of offering costs of $ 2,341 | \u200b | 4,838,709 | \u200b | \u200b | \u2014 | \u200b | \u200b | 72,659 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 72,659 | \u200b |\n| Unrealized loss on marketable securities | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 673 ) | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 673 ) | \u200b |\n| Stock-based compensation expense | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 15,039 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 15,039 | \u200b |\n| Net loss | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 86,908 ) | \u200b | \u200b | ( 86,908 ) | \u200b |\n| Balance at December 31, 2022 | \u200b | 66,688,647 | \u200b | $ | 1 | \u200b | $ | 880,832 | \u200b | $ | ( 897 ) | \u200b | $ | ( 682,315 ) | \u200b | $ | 197,621 | \u200b |\n| Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units | \u200b | 806,242 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 8 ) | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 8 ) | \u200b |\n| Issuance of common stock under at-the-market sales agreement, net of offering costs of $ 826 | \u200b | 3,400,000 | \u200b | \u200b | \u2014 | \u200b | \u200b | 26,714 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 26,714 | \u200b |\n| Unrealized gain on marketable securities | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 791 | \u200b | \u200b | \u2014 | \u200b | \u200b | 791 | \u200b |\n| Stock-based compensation expense | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 20,542 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 20,542 | \u200b |\n| Net loss | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 88,481 ) | \u200b | \u200b | ( 88,481 ) | \u200b |\n| Balance at December 31, 2023 | \u200b | 70,894,889 | \u200b | $ | 1 | \u200b | $ | 928,080 | \u200b | $ | ( 106 ) | \u200b | $ | ( 770,796 ) | \u200b | $ | 157,179 | \u200b |",
            "type": "table"
        },
        {
            "id": 90,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| \u200b | 2023 | 2022 | \u200b | 2021 |\n| Cash flows from operating activities: | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Net loss | \u200b | $ | ( 88,481 ) | \u200b | $ | ( 86,908 ) | \u200b | $ | ( 90,865 ) |\n| Adjustments to reconcile net loss to net cash used in operating activities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Depreciation and amortization | \u200b | 863 | \u200b | 797 | \u200b | \u200b | 923 |\n| Stock-based compensation expense | \u200b | 20,542 | \u200b | 15,039 | \u200b | \u200b | 14,060 |\n| Revaluation of contingent consideration | \u200b | \u200b | ( 26,900 ) | \u200b | \u200b | 4,700 | \u200b | \u200b | 24,339 |\n| Loss on extinguishment of debt | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 752 |\n| Intangible asset impairment charge | \u200b | \u200b | 6,629 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 |\n| Deferred taxes | \u200b | \u200b | ( 367 ) | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 |\n| Changes in operating assets and liabilities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Accounts receivable | \u200b | \u200b | 186 | \u200b | \u200b | 139 | \u200b | \u200b | 149 |\n| Prepaid expenses and other assets | \u200b | ( 1,315 ) | \u200b | ( 2,294 ) | \u200b | \u200b | ( 5,617 ) |\n| Accounts payable | \u200b | ( 1,473 ) | \u200b | 368 | \u200b | \u200b | 3,655 |\n| Accrued expenses | \u200b | 11,991 | \u200b | 592 | \u200b | \u200b | 470 |\n| Net cash used in operating activities | \u200b | ( 78,325 ) | \u200b | ( 67,567 ) | \u200b | \u200b | ( 52,134 ) |\n| Cash flows from investing activities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Purchases of property and equipment | \u200b | ( 1,309 ) | \u200b | ( 605 ) | \u200b | \u200b | ( 308 ) |\n| Purchases of marketable securities | \u200b | ( 135,675 ) | \u200b | ( 164,753 ) | \u200b | \u200b | ( 235,153 ) |\n| Proceeds from sales and maturities of marketable securities | \u200b | 183,204 | \u200b | 177,986 | \u200b | \u200b | 67,829 |\n| Net cash provided by (used in) investing activities | \u200b | 46,220 | \u200b | 12,628 | \u200b | \u200b | ( 167,632 ) |\n| Cash flows from financing activities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Proceeds from issuance of common stock in connection with public offerings, net of issuance costs | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 238,200 |\n| Proceeds from issuance of common stock under the at-the-market sales agreement, net of issuance costs | \u200b | \u200b | 26,714 | \u200b | \u200b | 72,744 | \u200b | \u200b | \u2014 |\n| Repayment of debt | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 11,483 ) |\n| Payments of employee withholding taxes related to restricted stock unit award vesting | \u200b | \u200b | ( 102 ) | \u200b | \u200b | ( 34 ) | \u200b | \u200b | ( 3,124 ) |\n| Proceeds from exercise of employee stock options and the issuance of stock | \u200b | \u200b | 94 | \u200b | \u200b | 157 | \u200b | \u200b | 1,459 |\n| Net cash provided by financing activities | \u200b | 26,706 | \u200b | 72,867 | \u200b | \u200b | 225,052 |\n| Net (decrease) increase in cash and cash equivalents | \u200b | ( 5,399 ) | \u200b | 17,928 | \u200b | \u200b | 5,286 |\n| Cash and cash equivalents at beginning of period | \u200b | 45,277 | \u200b | 27,349 | \u200b | \u200b | 22,063 |\n| Cash and cash equivalents at end of period | \u200b | $ | 39,878 | \u200b | $ | 45,277 | \u200b | $ | 27,349 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Supplemental disclosure of non-cash investing and financing activities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Additions to property and equipment included in accounts payable | \u200b | $ | \u2014 | \u200b | $ | 24 | \u200b | $ | 143 |",
            "type": "table"
        },
        {
            "id": 91,
            "context": "ACLARIS THERAPEUTICS, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS\u200b\u200b 1. Organization and Nature of Business\u200bOverview\u200bAclaris Therapeutics, Inc. was incorporated under the laws of the State of Delaware in 2012. In August 2017, Confluence Life Sciences, Inc. (now known as Aclaris Life Sciences, Inc.) (\u201cConfluence\u201d) was acquired by Aclaris Therapeutics, Inc. and became a wholly owned subsidiary thereof. Aclaris Therapeutics, Inc. and its wholly owned subsidiaries are referred to collectively as the \u201cCompany.\u201d \u200bThe Company is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The Company\u2019s proprietary KINect drug discovery platform combined with its preclinical development capabilities allows the Company to identify and advance potential drug candidates that it may develop independently or in collaboration with third parties. In addition to identifying and developing its novel drug candidates, the Company is pursuing strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize its novel drug candidates. The Company also provides contract research services to third parties enabled by its early-stage research and development expertise.\u200bLiquidity\u200bThe Company\u2019s consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities in the ordinary course of business. As of December 31, 2023, the Company had cash, cash equivalents and marketable securities of $ 181.9 million and an accumulated deficit of $ 770.8 million. Since inception, the Company has incurred net losses and negative cash flows from its operations. Prior to the acquisition of Confluence in August 2017, the Company had never generated revenue. There can be no assurance that profitable operations will ever be achieved, and, if achieved, will be sustained on a continuing basis. In addition, development activities, including clinical and preclinical testing of the Company\u2019s drug candidates, will require significant additional financing. The future viability of the Company is dependent on its ability to successfully develop its drug candidates and to generate revenue from identifying and consummating transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize its development assets or to raise additional capital to finance its operations. The Company will require additional capital to develop its drug candidates and to support its discovery efforts. \u200bAdditional funds may not be available on a timely basis, on commercially acceptable terms, or at all, and such funds, if raised, may not be sufficient to enable the Company to continue to implement its long-term business strategy. The Company's ability to raise additional capital may be adversely impacted by potentially worsening global economic conditions caused by a variety of factors including geopolitical tensions, rising interest rates and inflationary pressures. If the Company is unable to raise sufficient additional capital or generate revenue from transactions with potential third-party partners for the development and/or commercialization of its drug candidates, it may need to substantially curtail planned operations. The Company\u2019s failure to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. \u200bIn accordance with Accounting Standards Codification (\u201cASC\u201d) Subtopic 205-40, Disclosure of Uncertainties about an Entity\u2019s Ability to Continue as a Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company\u2019s ability to continue as a going concern within one year after the date that its consolidated financial statements are issued. As of the report date, the Company does not believe that substantial doubt exists about its ability to continue as a going concern. The Company believes its existing cash, cash equivalents and marketable securities are sufficient to fund its operating and capital expenditure requirements for a period greater than 12 months from the date of issuance of these consolidated financial statements. 87",
            "type": "paragraph"
        },
        {
            "id": 92,
            "context": "\u200b 2. Summary of Significant Accounting Policies\u200b Basis of Presentation\u200bThe accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (\u201cGAAP\u201d). The consolidated financial statements of the Company include the accounts of the operating parent company, Aclaris Therapeutics, Inc., and its wholly owned subsidiaries. All intercompany transactions have been eliminated. Based upon the Company\u2019s revenue, the Company believes that gross profit does not provide a meaningful measure of profitability and, therefore, has not included a line item for gross profit on the consolidated statement of operations. \u200b Reclassifications\u200bCertain prior year amounts have been reclassified to conform to the current year financial statement presentation. \u200b Discontinued Operations\u200bIn September 2019, the Company announced the completion of a strategic review and its decision to refocus its resources on its immuno-inflammatory development programs and to actively seek partners for its commercial products. \u200bAs of December 31, 2023 and 2022, the Company had $ 2.2 million in accrued expenses reported as discontinued operations in the Company\u2019s consolidated balance sheet. \u200b Use of Estimates\u200bThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, contingent consideration and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. Actual results could differ from the Company\u2019s estimates. \u200b Revenue Recognition\u200bThe Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers. Under ASC Topic 606, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. \u200bTo determine revenue recognition in accordance with ASC Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) performance obligations are satisfied. At contract inception, the Company assesses the goods or services promised within a contract with a customer to identify the performance obligations, and to determine if they are distinct. The Company recognizes the revenue that is allocated to each distinct performance obligation when (or as) that performance obligation is satisfied. The Company only recognizes revenue when collection of the consideration it is entitled to under a contract with a customer is probable.\u200bContract Research\u200bThe Company earns contract research revenue from the provision of laboratory services. Contract research revenue is generally evidenced by contracts with clients which are on an agreed upon fixed-price, fee-for-service basis and are generally billed on a monthly basis in arrears for services rendered. Revenue related to these contracts is generally recognized as the laboratory services are performed, based upon the rates specified in the contracts. Under ASC Topic 606, the Company elected to apply the \u201cright to invoice\u201d practical expedient when recognizing contract research revenue 88",
            "type": "paragraph"
        },
        {
            "id": 93,
            "context": "and as such, recognizes revenue in the amount which it has the right to invoice. ASC Topic 606 also provides an optional exemption, which the Company has elected to apply, from disclosing remaining performance obligations when revenue is recognized from the satisfaction of the performance obligation in accordance with the \u201cright to invoice\u201d practical expedient.\u200bLicensing Revenue\u200bLicenses of Intellectual Property \u2013 The Company recognizes revenue received from non-refundable, upfront fees related to the licensing of intellectual property when the intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the license has been transferred to the customer, and the customer is able to use and benefit from the license. \u200bMilestone and Royalty Payments \u2013 The Company considers any future potential milestones and sales-based royalties to be variable consideration. The Company recognizes revenue from development, regulatory and anniversary milestone payments as they are achieved. The Company recognizes revenue from commercial milestones and royalty payments as the sales occur. \u200b Cash Equivalents\u200bThe Company considers all short-term, highly liquid investments with original maturities of three months or less at acquisition date to be cash equivalents. Cash equivalents, which have consisted of money market funds and commercial paper, are stated at fair value. \u200b Marketable Securities\u200bMarketable securities with original maturities of greater than three months and remaining maturities of less than one year from the balance sheet date are classified as short-term. Marketable securities with remaining maturities of greater than one year from the balance sheet date are classified as long-term.\u200bThe Company classifies all marketable securities as available-for-sale securities. The Company\u2019s marketable securities are measured and reported at fair value using either quoted prices in active markets for identical securities or quoted prices in markets that are not active for identical or similar securities. Unrealized gains and losses are reported as a separate component of stockholders\u2019 equity. The cost of securities sold is determined on a specific identification basis, and realized gains and losses, if any, are included in other expense, net within the consolidated statement of operations and comprehensive loss. If any adjustment to fair value reflects a decline in the value of the investment, the Company considers available evidence to evaluate the extent to which the decline is \u201cother than temporary\u201d and reduces the investment to fair value through a charge to the statement of operations and comprehensive loss. \u200b Property and Equipment\u200bProperty and equipment are stated at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the useful life of the asset. Computer equipment is depreciated over three years . Laboratory equipment is depreciated over three to five years . Furniture and fixtures are depreciated over five years . Leasehold improvements are depreciated over the shorter of the lease term or their useful life. Expenditures for repairs and maintenance of assets are charged to expense as incurred. Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from continuing operations. \u200b Impairment of Long-Lived Assets\u200bLong-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized 89",
            "type": "paragraph"
        },
        {
            "id": 94,
            "context": "when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value, determined based on discounted cash flows. \u200b Intangible Assets\u200bIntangible assets include both definite-lived and indefinite-lived assets. Definite-lived intangible assets consist of a drug discovery platform the Company acquired through the acquisition of Confluence. Definite-lived intangible assets are amortized over their estimated useful life based on the pattern over which the intangible assets are consumed or otherwise used up. If that pattern cannot be reliably determined, the straight-line method of amortization is used. Indefinite-lived intangible assets consisted of an in-process research and development (\u201cIPR&D\u201d) drug candidate acquired through the acquisition of Confluence. IPR&D assets are considered indefinite-lived until the completion or abandonment of the associated research and development efforts. The cost of IPR&D is either amortized over its estimated useful life beginning when the underlying drug candidate is approved and launched commercially, or expensed immediately if development of the drug candidate is abandoned or otherwise impaired.\u200bDefinite-lived intangible assets are tested for impairment when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. Indefinite-lived intangible assets are tested for impairment at least annually, which the Company performs during the fourth quarter, or when indicators of an impairment are present. The Company recognizes impairment losses when and to the extent that the estimated fair value of an intangible asset is less than its carrying value. \u200bDuring the quarter ended December 31, 2023, the Company performed an impairment analysis on the IPR&D intangible asset due to the Company\u2019s decision to discontinue further development of the drug candidate in immuno-inflammatory diseases. The Company\u2019s impairment analysis resulted in a fair value of the IPR&D intangible asset which was less than the carrying value. As a result, the Company recorded an impairment charge of $ 6.6 million, the full balance of the IPR&D intangible asset. \u200b Leases\u200bLeases represent a company\u2019s right to use an underlying asset and a corresponding obligation to make payments to a lessor for the right to use those assets. The Company evaluates leases at their inception to determine if they are an operating lease or a finance lease. A lease is accounted for as a finance lease if it meets one of the following five criteria: the lease has a purchase option that is reasonably certain of being exercised, the present value of the future cash flows are substantially all of the fair market value of the underlying asset, the lease term is for a significant portion of the remaining economic life of the underlying asset, the title to the underlying asset transfers at the end of the lease term, or if the underlying asset is of such a specialized nature that it is expected to have no alternative uses to the lessor at the end of the term. Leases that do not meet the finance lease criteria are accounted for as an operating lease. \u200bThe Company recognizes assets and liabilities for leases at their inception based upon the present value of all payments due under the lease. The Company uses an incremental borrowing rate to determine the present value of operating leases. The Company determines incremental borrowing rates by referencing collateralized borrowing rates for debt instruments with terms similar to the respective lease. The Company recognizes expense for operating leases on a straight-line basis over the term of each lease. The Company includes estimates for any residual value guarantee obligations under its leases in lease liabilities recorded on its consolidated balance sheet. \u200bRight-of-use assets are included in other assets on the Company\u2019s consolidated balance sheet for operating leases. Obligations for lease payments are included in current portion of lease liabilities and other liabilities on the Company\u2019s consolidated balance sheet for operating leases. \u200b Contingent Consideration\u200bThe Company records a contingent consideration liability related to future potential payments resulting from the acquisition of Confluence based upon significant unobservable inputs including the achievement of regulatory and commercial milestones, as well as estimated future sales levels and the discount rates applied to calculate the present value of the potential payments. Significant judgement is involved in determining the appropriateness of these assumptions. These assumptions are considered Level 3 inputs. Revaluation of the contingent consideration liability can 90",
            "type": "paragraph"
        },
        {
            "id": 95,
            "context": "result from changes to one or more of these assumptions. The Company evaluates the fair value estimate of the contingent consideration liability on a quarterly basis with changes, if any, recorded as income or expense in the consolidated statement of operations.\u200bThe fair value of contingent consideration is estimated using a probability-weighted expected payment model for regulatory milestone payments and a Monte Carlo simulation model for commercial milestone and royalty payments and then applying a risk-adjusted discount rate to calculate the present value of the potential payments. Significant assumptions used in the Company\u2019s estimates include the probability of achieving regulatory milestones and commencing commercialization, which are based on an asset\u2019s current stage of development and a review of existing clinical data. The probability of success assumption was 35 % at December 31, 2023. Additionally, estimated future sales levels and the risk-adjusted discount rate applied to the potential payments are also significant assumptions used in calculating the fair value. The discount rate ranged between 7.3 % and 8.6 % depending on the year of each potential payment. \u200b Research and Development Costs\u200bResearch and development costs are expensed as incurred. Research and development expenses include salaries, stock-based compensation and benefits of employees, and other operational costs related to the Company\u2019s research and development activities, including depreciation expenses and the cost of research and development contracts which the Company has entered into with outside vendors to conduct both preclinical studies and clinical trials. Significant judgment and estimates are made in determining the amount of research and development costs recognized in each reporting period. The Company analyzes the progress of its preclinical studies and clinical trials, completion of milestone events, invoices received and contracted costs when estimating research and development costs. Actual results could differ from the Company\u2019s estimates. The Company\u2019s historical estimates for research and development costs have not been materially different from the actual costs. \u200b Stock-Based Compensation\u200bThe Company measures the compensation expense of stock-based awards granted to employees and directors using the grant date fair value of the award. The Company has issued stock options and restricted stock unit (\u201cRSU\u201d) awards with service-based vesting conditions, as well as with performance-based vesting conditions. The Company has not issued awards that include market-based conditions. For service-based awards the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period, which is typically four years . For performance-based awards the Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period beginning in the period that it becomes probable the performance conditions will occur. At each balance sheet date, the Company evaluates whether any performance conditions related to a performance-based award have changed. The effect of any change in performance conditions would be recognized as a cumulative catch-up adjustment in the period such change occurs, and any remaining unrecognized compensation expense would be recognized on a straight-line basis over the remaining requisite service period. The impact of forfeitures is recognized in the period in which they occur. \u200bThe Company measures the compensation expense of stock-based awards granted to consultants using the grant date fair value of the award. The Company recognizes compensation expense over the period during which services are rendered by the consultant.\u200bThe Company classifies stock-based compensation expense in its statement of operations and comprehensive loss in the same manner in which the award recipient\u2019s payroll costs are classified or in which the award recipients\u2019 service payments are classified.\u200bThe fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Historically, the Company estimated expected volatility based on historical volatility of a set of peer companies, which are publicly traded. Starting in 2022, the Company estimated expected volatility based on its stock price's historical volatility, as the Company determined that it had adequate historical data regarding the volatility of its own publicly-traded stock price. The expected term of the Company\u2019s stock options has been determined using the \u201csimplified\u201d method for awards that qualify as \u201cplain vanilla\u201d options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. 91",
            "type": "paragraph"
        },
        {
            "id": 96,
            "context": "The Company uses an expected dividend yield of zero based on the fact that the Company has never paid cash dividends and does not expect to pay cash dividends in the future.\u200bThe fair value of each RSU is measured using the closing price of the Company\u2019s common stock on the date of grant. \u200b Patent Costs\u200bAll patent related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. \u200b Income Taxes\u200bThe Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements or in the Company\u2019s tax returns. Deferred taxes are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.\u200bThe Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more likely than not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves and unrecognized tax benefits that are considered appropriate, as well as the related net interest and penalties. \u200b Comprehensive Loss\u200bComprehensive loss includes net loss as well as other changes in stockholders\u2019 equity that result from transactions and economic events other than those with stockholders. Comprehensive loss is primarily comprised of net loss and unrealized gains (losses) on marketable securities.\u200b Net Loss per Share\u200bBasic net loss per share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed using the sum of the weighted average number of common shares outstanding during the period, plus the weighted average number of potential shares of common stock from the assumed exercise of stock options and warrants and the assumed vesting of RSUs, if dilutive. Since the Company was in a net loss position, basic and diluted net loss per share was the same for each of the periods presented. \u200b Fair Value Measurements\u200bCertain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial 92",
            "type": "paragraph"
        },
        {
            "id": 97,
            "context": "| \u25cf | Level 1 \u2014 Quoted prices in active markets for identical assets or liabilities. |\n| \u25cf | Level 2 \u2014 Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. |\n| \u25cf | Level 3 \u2014 Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. |",
            "type": "table"
        },
        {
            "id": 98,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | December 31, 2023 |\n| (In thousands) | Level 1 | Level 2 | Level 3 | Total |\n| Assets: | \u200b | \u200b | \u200b | \u200b |\n| Cash equivalents | \u200b | $ | 32,177 | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b | $ | 32,177 |\n| Marketable securities | \u200b | \u2014 | \u200b | \u200b | 141,999 | \u200b | \u200b | \u2014 | \u200b | \u200b | 141,999 |\n| Total assets | \u200b | $ | 32,177 | \u200b | $ | 141,999 | \u200b | $ | \u2014 | \u200b | $ | 174,176 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Liabilities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Contingent consideration | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b | $ | 6,200 | \u200b | $ | 6,200 |\n| Total liabilities | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b | $ | 6,200 | \u200b | $ | 6,200 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | December 31, 2022 |\n| (In thousands) | Level 1 | Level 2 | Level 3 | Total |\n| Assets: | \u200b | \u200b | \u200b | \u200b |\n| Cash equivalents | \u200b | $ | 38,516 | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b | $ | 38,516 |\n| Marketable securities | \u200b | \u2014 | \u200b | \u200b | 184,536 | \u200b | \u200b | \u2014 | \u200b | \u200b | 184,536 |\n| Total assets | \u200b | $ | 38,516 | \u200b | $ | 184,536 | \u200b | $ | \u2014 | \u200b | $ | 223,052 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Liabilities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Contingent consideration | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b | $ | 33,100 | \u200b | $ | 33,100 |\n| Total liabilities | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b | $ | 33,100 | \u200b | $ | 33,100 |",
            "type": "table"
        },
        {
            "id": 99,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | December 31, 2023 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | Gross | \u200b | Gross | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Book | \u200b | Unrealized | \u200b | Unrealized | \u200b | Fair |\n| (In thousands) | \u200b | Value | \u200b | Gain | \u200b | Loss | \u200b | Value |\n| Marketable securities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Corporate debt securities(1) | \u200b | $ | 52,362 | \u200b | $ | 65 | \u200b | $ | ( 142 ) | \u200b | $ | 52,285 |\n| Commercial paper | \u200b | \u200b | 12,345 | \u200b | \u200b | 2 | \u200b | \u200b | ( 1 ) | \u200b | \u200b | 12,346 |\n| Asset-backed debt securities(2) | \u200b | \u200b | 10,953 | \u200b | \u200b | 42 | \u200b | \u200b | ( 30 ) | \u200b | \u200b | 10,965 |\n| Foreign government agency debt securities(3) | \u200b | \u200b | 4,698 | \u200b | \u200b | 43 | \u200b | \u200b | \u2014 | \u200b | \u200b | 4,741 |\n| U.S. government and government agency debt securities(4) | \u200b | \u200b | 61,750 | \u200b | \u200b | 8 | \u200b | \u200b | ( 96 ) | \u200b | \u200b | 61,662 |\n| Total marketable securities | \u200b | $ | 142,108 | \u200b | $ | 160 | \u200b | $ | ( 269 ) | \u200b | $ | 141,999 |\n| (1) Included in Corporate debt securities is $ 28.0 million with maturity dates between one and two years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (2) Included in Asset-backed debt securities is $ 6.2 million with maturity dates between one and three years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (3) Included in Foreign government agency debt securities is $ 4.7 million with a maturity date between one and two years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (4) Included in U.S. government and government agency debt securities is $ 23.9 million with maturity dates between one and two years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | December 31, 2022 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | Gross | \u200b | Gross | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Book | \u200b | Unrealized | \u200b | Unrealized | \u200b | Fair |\n| (In thousands) | \u200b | Value | \u200b | Gain | \u200b | Loss | \u200b | Value |\n| Marketable securities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Corporate debt securities(1) | \u200b | $ | 40,626 | \u200b | $ | \u2014 | \u200b | $ | ( 251 ) | \u200b | $ | 40,375 |\n| Commercial paper | \u200b | \u200b | 79,598 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 79,598 |\n| Asset-backed debt securities(2) | \u200b | \u200b | 14,641 | \u200b | \u200b | 4 | \u200b | \u200b | ( 123 ) | \u200b | \u200b | 14,522 |\n| U.S. government and government agency debt securities(3) | \u200b | \u200b | 50,571 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 530 ) | \u200b | \u200b | 50,041 |\n| Total marketable securities | \u200b | $ | 185,436 | \u200b | $ | 4 | \u200b | $ | ( 904 ) | \u200b | $ | 184,536 |\n| (1) Included in Corporate debt securities is $ 4.8 million with maturity dates between one and five years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (2) Included in Asset-backed debt securities is $ 2.4 million with maturity dates between one and five years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (3) Included in U.S. government and government agency debt securities is $ 5.0 million with maturity dates between one and five years . | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | December 31, | \u200b | \u200b | December 31, |\n| (In thousands) | \u200b | 2023 | \u200b | 2022 |\n| Computer equipment | $ | 1,253 | $ | 1,381 |\n| Lab equipment | \u200b | \u200b | 3,154 | \u200b | \u200b | 2,010 |\n| Furniture and fixtures | \u200b | \u200b | 558 | \u200b | \u200b | 620 |\n| Leasehold improvements | \u200b | \u200b | 817 | \u200b | \u200b | 1,123 |\n| Property and equipment, gross | \u200b | 5,782 | \u200b | 5,134 |\n| Accumulated depreciation | \u200b | ( 4,162 ) | \u200b | ( 4,035 ) |\n| Property and equipment, net | \u200b | $ | 1,620 | \u200b | $ | 1,099 |",
            "type": "table"
        },
        {
            "id": 100,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | Gross Cost | \u200b | Accumulated Amortization |\n| \u200b | \u200b | \u200b | Remaining | \u200b | \u200b | December 31, | \u200b | \u200b | December 31, | \u200b | \u200b | December 31, | \u200b | \u200b | December 31, |\n| (In thousands, except years) | \u200b | Life (years) | 2023 | 2022 | 2023 | 2022 |\n| Other intangible assets | \u200b | \u200b | 3.6 | \u200b | $ | 751 | \u200b | $ | 751 | \u200b | $ | 482 | \u200b | $ | 407 |\n| In-process research and development | \u200b | \u200b | n/a | \u200b | \u200b | \u2014 | \u200b | \u200b | 6,629 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 |\n| Total intangible assets | \u200b | \u200b | \u200b | \u200b | $ | 751 | \u200b | $ | 7,380 | \u200b | $ | 482 | \u200b | $ | 407 |\n| \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ending |\n| (In thousands) | \u200b | December 31, |\n| 2024 | \u200b | 75 |\n| 2025 | \u200b | 75 |\n| 2026 | \u200b | \u200b | 75 |\n| 2027 | \u200b | \u200b | 44 |\n| Total | \u200b | $ | 269 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | December 31, | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 |\n| Employee compensation expenses | \u200b | $ | 3,910 | \u200b | $ | 5,295 |\n| Research and development expenses | \u200b | \u200b | 6,661 | \u200b | \u200b | 2,689 |\n| Licensing expenses | \u200b | \u200b | 5,478 | \u200b | \u200b | 500 |\n| Restructuring expenses (Note 15) | \u200b | \u200b | 3,112 | \u200b | \u200b | \u2014 |\n| Other | \u200b | 285 | \u200b | 217 |\n| Total accrued expenses | \u200b | $ | 19,446 | \u200b | $ | 8,701 |",
            "type": "table"
        },
        {
            "id": 101,
            "context": "8. Stockholders\u2019 Equity\u200bPreferred Stock\u200bAs of December 31, 2023 and 2022, the Company\u2019s amended and restated certificate of incorporation (the \u201cCharter\u201d) authorized the Company to issue 10,000,000 shares of undesignated preferred stock. There were no shares of preferred stock outstanding as of December 31, 2023 and 2022. \u200bCommon Stock\u200bOn June 1, 2023, at the 2023 Annual Meeting of Stockholders, the Company\u2019s stockholders approved an amendment to the Charter to increase the authorized number of shares of common stock from 100,000,000 shares to 200,000,000 shares. On June 1, 2023, the Company filed a Certificate of Amendment to the Charter with the Secretary of State of the State of Delaware, which became effective upon filing.\u200bAs of December 31, 2023 and 2022, the Company\u2019s Charter authorized the Company to issue 200,000,000 and 100,000,000 shares, respectively, of $ 0.00001 par value common stock. There were 70,894,889 and 66,688,647 shares of common stock issued and outstanding as of December 31, 2023 and 2022, respectively. \u200bEach share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company\u2019s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the board of directors, if any, subject to any preferential dividend rights of any series of preferred stock that may be outstanding. No dividends have been declared through December 31, 2023. \u200bWarrants\u200bThe Warrant issued to SVB in March 2020 had an initial exercise price of $ 0.956 per share, subject to adjustment as provided in the Warrant. The Warrant became immediately exercisable in full upon the funding of the term loan facility. The Company assigned a fair value of $ 0.4 million to the Warrant using a Black-Scholes valuation methodology, and also concluded that the Warrant was indexed to its own stock and therefore classified the Warrant as an equity instrument. In January 2021, SVB net exercised the Warrant in full, and the Company issued to SVB 388,119 shares of common stock.\u200bJanuary 2021 Public Offering\u200bIn January 2021, the Company closed a public offering in which it sold 6,306,271 shares of common stock at a price to the public of $ 17.50 per share, for aggregate gross proceeds of $ 110.4 million. The Company paid underwriting discounts and commissions of $ 6.6 million, and also incurred expenses of $ 0.4 million in connection with the offering. As a result, the net offering proceeds received by the Company, after deducting underwriting discounts, commissions and offering expenses, were $ 103.3 million.\u200bJune 2021 Public Offering\u200bIn June 2021, the Company closed a public offering in which it sold 8,098,592 shares of common stock at a price to the public of $ 17.75 per share, for aggregate gross proceeds of $ 143.8 million. The Company paid underwriting discounts and commissions of $ 8.6 million, and also incurred expenses of $ 0.3 million in connection with the offering. As a result, the net offering proceeds received by the Company, after deducting underwriting discounts, commissions and offering expenses, were $ 134.9 million.\u200bSales of Common Stock Pursuant to At-The-Market Facility\u200bIn April 2022, the Company sold 4.8 million shares of its common stock for aggregate gross proceeds of $ 75.0 million, pursuant to a sales agreement with SVB Securities LLC and Cantor Fitzgerald & Co., as sales agents, dated May 20, 2021. The Company paid selling commissions and other fees of $ 2.3 million in connection with the sale. \u200bIn April 2023, the Company sold 3.4 million shares of its common stock for aggregate gross proceeds of $ 27.5 million, pursuant to a sales agreement with SVB Securities LLC and Cantor Fitzgerald & Co., as sales agents, dated February 23, 2023. The Company paid selling commissions of $ 0.8 million in connection with the sale. \u200b 97",
            "type": "paragraph"
        },
        {
            "id": 102,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| \u200b | \u200b | 2023 | \u200b | \u200b | 2022 | \u200b | \u200b | 2021 |\n| Risk-free interest rate | 3.55 | % | \u200b | 2.22 | % | \u200b | 0.92 | % |\n| Expected term (in years) | 6.2 | \u200b | \u200b | 6.2 | \u200b | \u200b | 6.2 | \u200b |\n| Expected volatility | 77.73 | % | \u200b | 77.95 | % | \u200b | 76.60 | % |\n| Expected dividend yield | 0 | % | \u200b | 0 | % | \u200b | 0 | % |",
            "type": "table"
        },
        {
            "id": 103,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | Weighted | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | Weighted | \u200b | Average | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | Average | \u200b | Remaining | \u200b | Aggregate |\n| \u200b | \u200b | Number | \u200b | Exercise | \u200b | Contractual | \u200b | Intrinsic |\n| (In thousands, except share and per share data and years) | \u200b | of Shares | \u200b | Price | \u200b | Term | \u200b | Value |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | (in years) | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2020 | \u200b | 2,871,498 | \u200b | $ | 15.16 | 6.8 | \u200b | $ | 4,890 |\n| Granted | \u200b | 1,068,100 | \u200b | 23.44 | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Exercised | \u200b | ( 115,548 ) | \u200b | 12.63 | \u200b | \u200b | \u200b | \u200b | 1,373 |\n| Forfeited and cancelled | \u200b | ( 31,600 ) | \u200b | 23.26 | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2021 | \u200b | 3,792,450 | \u200b | $ | 17.50 | 6.8 | \u200b | $ | 13,710 |\n| Granted | \u200b | 2,548,750 | \u200b | 14.40 | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Exercised | \u200b | ( 88,172 ) | \u200b | 1.78 | \u200b | \u200b | \u200b | \u200b | 1,120 |\n| Forfeited and cancelled | \u200b | ( 1,085,864 ) | \u200b | 18.44 | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2022 | 5,167,164 | \u200b | $ | 16.04 | 7.2 | \u200b | $ | 15,288 |\n| Granted | 2,241,550 | \u200b | \u200b | 15.62 | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Exercised | \u200b | ( 71,092 ) | \u200b | \u200b | 1.31 | \u200b | \u200b | \u200b | \u200b | 473 |\n| Forfeited and cancelled | ( 918,167 ) | \u200b | \u200b | 16.85 | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2023 | 6,419,455 | \u200b | $ | 15.94 | \u200b | 7.1 | \u200b | $ | 14 |\n| Options vested and expected to vest as of December 31, 2023 | 6,419,455 | \u200b | $ | 15.94 | 7.1 | \u200b | $ | 14 |\n| Options exercisable as of December 31, 2023 | 2,879,529 | \u200b | $ | 16.55 | 5.1 | \u200b | $ | 14 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | Weighted | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | Average | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | Grant Date | \u200b | Aggregate |\n| \u200b | \u200b | Number | \u200b | Fair Value | \u200b | Intrinsic |\n| (In thousands, except share and per share data) | \u200b | of Shares | \u200b | Per Share | \u200b | Value |\n| Outstanding as of December 31, 2020 | \u200b | 2,244,157 | \u200b | $ | 3.83 | \u200b | \u200b | \u200b |\n| Granted | \u200b | 664,948 | \u200b | \u200b | 23.33 | \u200b | \u200b | \u200b |\n| Vested | \u200b | ( 1,340,042 ) | \u200b | \u200b | 3.18 | \u200b | $ | 31,492 |\n| Forfeited and cancelled | \u200b | ( 72,117 ) | \u200b | \u200b | 10.36 | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2021 | \u200b | 1,496,946 | \u200b | $ | 12.75 | \u200b | \u200b | \u200b |\n| Granted | \u200b | 936,563 | \u200b | \u200b | 14.43 | \u200b | \u200b | \u200b |\n| Vested | \u200b | ( 533,212 ) | \u200b | \u200b | 11.61 | \u200b | $ | 7,943 |\n| Forfeited and cancelled | \u200b | ( 379,567 ) | \u200b | \u200b | 13.40 | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2022 | \u200b | 1,520,730 | \u200b | $ | 14.02 | \u200b | \u200b | \u200b |\n| Granted | \u200b | 993,662 | \u200b | \u200b | 15.17 | \u200b | \u200b | \u200b |\n| Vested | \u200b | ( 745,279 ) | \u200b | \u200b | 11.72 | \u200b | $ | 8,262 |\n| Forfeited and cancelled | \u200b | ( 247,173 ) | \u200b | \u200b | 15.15 | \u200b | \u200b | \u200b |\n| Outstanding as of December 31, 2023 | \u200b | 1,521,940 | \u200b | $ | 15.72 | \u200b | \u200b | \u200b |",
            "type": "table"
        },
        {
            "id": 104,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ended |\n| \u200b | \u200b | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 | 2021 |\n| Cost of revenue | $ | 1,456 | $ | 1,151 | \u200b | $ | 981 |\n| Research and development | \u200b | \u200b | \u200b | 6,801 | \u200b | \u200b | 3,745 | \u200b | \u200b | 3,866 |\n| General and administrative | \u200b | \u200b | 12,285 | \u200b | 10,143 | \u200b | 9,213 |\n| Total stock-based compensation expense | \u200b | \u200b | $ | 20,542 | \u200b | $ | 15,039 | \u200b | $ | 14,060 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ended |\n| \u200b | \u200b | \u200b | December 31, |\n| (In thousands, except for share and per share data) | \u200b | 2023 | 2022 | 2021 | \u200b |\n| Numerator: | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Net loss | \u200b | \u200b | $ | ( 88,481 ) | \u200b | $ | ( 86,908 ) | \u200b | $ | ( 90,865 ) | \u200b |\n| Denominator: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Weighted average shares of common stock outstanding, basic and diluted | \u200b | \u200b | 69,808,855 | \u200b | 65,213,944 | \u200b | 56,730,583 | \u200b |\n| Net loss per share, basic and diluted | \u200b | \u200b | $ | ( 1.27 ) | \u200b | $ | ( 1.33 ) | \u200b | $ | ( 1.60 ) | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | December 31, | \u200b |\n| \u200b | \u200b | 2023 | \u200b | 2022 | \u200b | 2021 |\n| Options to purchase common stock | \u200b | 6,419,455 | \u200b | 5,167,164 | 3,792,450 | \u200b |\n| Restricted stock unit awards | \u200b | 1,521,940 | \u200b | 1,520,730 | \u200b | 1,496,946 | \u200b |\n| Total potential shares of common stock | \u200b | 7,941,395 | \u200b | 6,687,894 | 5,289,396 | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| \u200b | \u200b | December 31, |\n| (In thousands) | 2023 | 2022 | 2021 |\n| Operating lease expense | $ | 1,092 | $ | 1,013 | $ | 1,013 |",
            "type": "table"
        },
        {
            "id": 105,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | December 31, | \u200b | \u200b | December 31, |\n| (In thousands) | \u200b | 2023 | \u200b | 2022 |\n| Operating Leases: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Gross cost | \u200b | $ | 5,094 | \u200b | $ | 5,240 |\n| Accumulated amortization | \u200b | \u200b | ( 1,235 ) | \u200b | \u200b | ( 2,560 ) |\n| Other assets | \u200b | $ | 3,859 | \u200b | $ | 2,680 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Current portion of lease liabilities | \u200b | $ | 426 | \u200b | $ | 684 |\n| Other liabilities | \u200b | \u200b | 3,074 | \u200b | \u200b | 1,570 |\n| Total operating lease liabilities | \u200b | $ | 3,500 | \u200b | $ | 2,254 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended |\n| (In thousands, except for years and percentages) | \u200b | December 31, |\n| Supplemental Cash Flow Lease Information: | \u200b | 2023 | \u200b | 2022 | 2021 |\n| Operating cash flows from operating leases | \u200b | $ | 974 | \u200b | $ | 846 | \u200b | $ | 924 | \u200b |\n| Leased assets obtained in exchange for new operating lease liabilities | \u200b | $ | 2,010 | \u200b | $ | \u2014 | \u200b | $ | \u2014 | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Weighted-Average Remaining Lease Term (in years): | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Operating leases | \u200b | \u200b | 5.3 | \u200b | \u200b | 5.2 | \u200b | \u200b | 5.4 | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Weighted-Average Discount Rate: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Operating leases | \u200b | \u200b | 10.2 | % | \u200b | 10.1 | % | \u200b | 10.1 | % |",
            "type": "table"
        },
        {
            "id": 106,
            "context": "| \u200b | \u200b | \u200b | \u200b |\n| (In thousands) | \u200b | \u200b | Operating |\n| Year Ending December 31, | Leases |\n| 2024 | \u200b | $ | 766 |\n| 2025 | \u200b | \u200b | 847 |\n| 2026 | \u200b | \u200b | 868 |\n| 2027 | \u200b | \u200b | 890 |\n| 2028 | \u200b | \u200b | 912 |\n| Thereafter | \u200b | \u200b | 316 |\n| Total undiscounted lease payments | \u200b | \u200b | 4,598 |\n| Less: unrecognized interest | \u200b | \u200b | ( 1,098 ) |\n| Total lease liability | \u200b | $ | 3,500 |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended December 31, | \u200b |\n| (In thousands) | \u200b | 2023 | \u200b | 2022 | \u200b | 2021 | \u200b |\n| U.S. operations | \u200b | $ | ( 88,848 ) | \u200b | $ | ( 86,908 ) | \u200b | $ | ( 90,865 ) | \u200b |\n| Foreign operations | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b |\n| Loss before income taxes | \u200b | $ | ( 88,848 ) | \u200b | $ | ( 86,908 ) | \u200b | $ | ( 90,865 ) | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | Year Ended December 31, |\n| \u200b | \u200b | 2023 | \u200b | 2022 | 2021 |\n| Federal statutory income tax rate | ( 21.0 ) | % | ( 21.0 ) | % | ( 21.0 ) | % |\n| State taxes, net of federal benefit | \u200b | ( 1.7 ) | ( 2.3 ) | ( 7.7 ) | \u200b |\n| Impact of state rate changes | \u200b | 17.7 | \u200b | \u2014 | \u200b | \u2014 | \u200b |\n| Research and development tax credits | \u200b | ( 5.9 ) | ( 4.3 ) | ( 3.0 ) | \u200b |\n| Excess equity compensation tax benefit, net of officer limitation | \u200b | 0.6 | \u200b | 0.2 | \u200b | ( 3.9 ) | \u200b |\n| Revaluation of contingent consideration | \u200b | ( 6.3 ) | \u200b | 1.1 | \u200b | 5.6 | \u200b |\n| Non-deductible royalty payments | \u200b | 4.3 | \u200b | \u2014 | \u200b | \u2014 | \u200b |\n| Change in deferred tax asset valuation allowance | \u200b | 11.7 | \u200b | 26.3 | \u200b | 30.0 | \u200b |\n| Other | \u200b | 0.2 | \u2014 | \u2014 | \u200b |\n| Effective income tax rate | \u200b | ( 0.4 ) | % | \u2014 | % | \u2014 | % |",
            "type": "table"
        },
        {
            "id": 107,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | December 31, |\n| (In thousands) | \u200b | 2023 | \u200b | 2022 |\n| Deferred tax assets: | \u200b | \u200b | \u200b |\n| Net operating loss carryforwards | \u200b | $ | 119,155 | \u200b | $ | 120,554 | \u200b |\n| Capitalized start-up costs | \u200b | \u200b | 3,812 | \u200b | \u200b | 5,506 | \u200b |\n| Research and development tax credit carryforwards | \u200b | 20,505 | \u200b | 15,233 | \u200b |\n| Section 174 research and development capitalization | \u200b | \u200b | 30,984 | \u200b | \u200b | 19,639 | \u200b |\n| Capitalized research and development expense | \u200b | 2,359 | \u200b | 5,448 | \u200b |\n| Stock\u2011based compensation expense | \u200b | 18,055 | \u200b | 19,432 | \u200b |\n| Accrued compensation | \u200b | \u200b | 1,219 | \u200b | \u200b | 1,146 | \u200b |\n| Lease liabilities | \u200b | \u200b | 774 | \u200b | \u200b | 558 | \u200b |\n| Other | \u200b | 407 | \u200b | 534 | \u200b |\n| Total deferred tax assets | \u200b | 197,270 | \u200b | 188,050 | \u200b |\n| Deferred tax liabilities: | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| Property and equipment | \u200b | \u200b | ( 187 ) | \u200b | \u200b | ( 137 ) | \u200b |\n| Intangible asset | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 1,576 ) | \u200b |\n| Right-to-use assets | \u200b | \u200b | ( 853 ) | \u200b | \u200b | ( 651 ) | \u200b |\n| Other | \u200b | ( 1,106 ) | \u200b | ( 1,365 ) | \u200b |\n| Total deferred tax liabilities | \u200b | ( 2,146 ) | \u200b | ( 3,729 ) | \u200b |\n| Valuation allowance | \u200b | ( 195,124 ) | \u200b | ( 184,688 ) | \u200b |\n| Deferred tax liabilities, net | \u200b | $ | \u2014 | \u200b | $ | ( 367 ) | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | Year Ended December 31, |\n| (In thousands) | \u200b | \u200b | 2023 | \u200b | \u200b | 2022 | \u200b | \u200b | 2021 |\n| Valuation allowance at beginning of year | \u200b | $ | ( 184,688 ) | $ | ( 161,824 ) | $ | ( 134,559 ) | \u200b |\n| Decreases recorded as benefit to income tax provision | \u200b | \u2014 | \u200b | \u2014 | \u200b | \u2014 | \u200b |\n| Increases recorded to income tax provision | \u200b | ( 10,436 ) | \u200b | ( 22,864 ) | \u200b | ( 27,265 ) | \u200b |\n| Valuation allowance as of end of year | \u200b | $ | ( 195,124 ) | \u200b | $ | ( 184,688 ) | \u200b | $ | ( 161,824 ) | \u200b |",
            "type": "table"
        },
        {
            "id": 108,
            "context": "\u200bThe Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending income tax examinations. The Company\u2019s tax years are still open under statute from 2021 to the present. All open years may be examined to the extent that tax credit or NOLs are used in future periods. The Company\u2019s policy is to record interest and penalties related to income taxes as part of its income tax provision. The Company has no t recorded any amounts for unrecognized tax benefits as of December 31, 2023 and 2022. \u200b 13. Agreements Related to Intellectual Property\u200bLicense Agreement \u2013 Sun Pharmaceutical Industries, Inc.\u200bIn December 2023, the Company entered into an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc. (\u201cSun Pharma\u201d). Under the license agreement, the Company granted Sun Pharma exclusive rights under certain patents that the Company exclusively licenses from a third party. The patents relate to the use of deuruxolitinib, Sun Pharma\u2019s Janus kinase (\u201cJAK\u201d) inhibitor, or other isotopic forms of ruxolitinib, to treat alopecia areata or androgenetic alopecia. Under the license agreement, Sun Pharma has agreed to pay the Company an upfront payment, regulatory and commercial milestone payments, and a mid single-digit tiered royalty calculated as a percentage of Sun Pharma\u2019s net sales. The Company has separate contractual obligations under which the Company has agreed to pay to third parties a portion of the consideration it may receive under the license agreement.\u200bUpon execution of the agreement, the Company received an upfront payment of $ 15.0 million from Sun Pharma, a portion of which was payable to third parties.\u200bLicense Agreement \u2013 Pediatrix Therapeutics, Inc. \u200bIn November 2022, the Company entered into a license agreement with Pediatrix Therapeutics, Inc. (\u201cPediatrix\u201d), under which the Company granted Pediatrix the exclusive rights to develop, manufacture and commercialize ATI-1777 in Greater China. Pediatrix has agreed to pay the Company an upfront payment, development, regulatory and commercial milestone payments, and a tiered royalty ranging from a low-to-high single digit percentage of net sales of ATI-1777 by Pediatrix in Greater China. A portion of consideration received from Pediatrix is payable to the former Confluence equity holders as described below. \u200bUpon execution of the agreement, the Company received an upfront payment of $ 5.0 million from Pediatrix, a portion of which was payable to the former Confluence equity holders as described below.\u200bLicense Agreement \u2013 Eli Lilly and Company\u200bIn August 2022, the Company entered into a non-exclusive patent license agreement with Eli Lilly and Company (\u201cLilly\u201d). Under the license agreement, the Company granted Lilly non-exclusive rights under certain patents and patent applications that the Company exclusively licenses from a third party. The patents and patent applications relate to the use of baricitinib, Lilly\u2019s JAK inhibitor, to treat alopecia areata. Under the license agreement, Lilly has agreed to pay the Company an upfront payment, regulatory and commercial milestone payments, anniversary payments, and a low single-digit royalty calculated as a percentage of Lilly\u2019s net sales of baricitinib for the treatment of alopecia areata. The Company has separate contractual obligations under which the Company has agreed to pay to third parties an amount equal to any regulatory and commercial milestone payments it receives under the Lilly license agreement, as well as a portion of the upfront consideration and a portion of the royalties it may receive under the license agreement.\u200bDuring the years ended December 31, 2023 and 2022, the Company recorded licensing revenue under this agreement of $ 12.7 million and $ 17.8 million, respectively, from Lilly, a portion of which was payable to third parties. \u200bAsset Purchase Agreement \u2013 EPI Health, LLC\u200bIn October 2019, the Company sold RHOFADE (oxymetazoline hydrochloride) cream, 1 % (\u201cRHOFADE\u201d) to EPI Health, LLC (\u201cEPI Health\u201d) pursuant to an asset purchase agreement. In July 2023, EPI Health filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code. Through the bankruptcy process, EPI Health and its parent company, Novan, Inc., sold the RHOFADE assets to a third party, which excluded the Company\u2019s asset 104",
            "type": "paragraph"
        },
        {
            "id": 109,
            "context": "purchase agreement with EPI Health and the outstanding amounts due. The sale was approved by the bankruptcy court in September 2023. As a result of the bankruptcy proceedings, the Company recorded an allowance for doubtful accounts resulting in $ 1.3 million of bad debt expense for the year ended December 31, 2023, representing all amounts that were due and outstanding by EPI Health.\u200bAgreement and Plan of Merger \u2013 Confluence\u200bIn August 2017, the Company entered into an Agreement and Plan of Merger, pursuant to which it acquired Confluence (the \u201cConfluence Agreement\u201d). Under the Confluence Agreement, the Company agreed to pay the former Confluence equity holders aggregate remaining contingent consideration of up to $ 75.0 million based upon the achievement of specified regulatory and commercial milestones set forth in the Confluence Agreement. In addition, the Company agreed to pay the former Confluence equity holders future royalty payments calculated as a low single-digit percentage of annual net sales, subject to specified reductions, limitations and other adjustments, until the date that all of the patent rights for that product have expired, as determined on a country-by-country and product-by-product basis or, in specified circumstances, ten years from the first commercial sale of such product. In addition to the payments described above, if the Company sells, licenses or transfers any of the intellectual property acquired from Confluence pursuant to the Confluence Agreement to a third party, the Company will be obligated to pay the former Confluence equity holders a portion of any consideration received from such sale, license or transfer in specified circumstances.\u200bAs of December 31, 2023 and December 31, 2022, the balance of the Company\u2019s contingent consideration liability was $ 6.2 million and $ 33.1 million, respectively (see Note 3). \u200b 14. Retirement Savings Plan\u200bThe Company has a defined contribution savings plan under Section 401(k) of the Internal Revenue Code. This plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. Company contributions to the plan may be made at the discretion of the Company\u2019s board of directors. The Company has elected to match employee contributions to the 401(k) Plan up to 4 % of the employee\u2019s earnings, subject to certain limitations. Company contributions under the 401(k) Plan were $ 0.7 million, $ 0.5 million and $ 0.3 million for the years ended December 31, 2023, 2022 and 2021, respectively. \u200b 15. Restructuring Charges\u200bIn December 2023, the Company\u2019s board of directors approved a reduction of the Company\u2019s workforce by approximately 46%, which the Company expects to be substantially completed by June 2024. This action was taken in order to streamline operations, reduce costs and preserve capital. As a result, the Company terminated certain employees (\u201cterminated employees\u201d) and gave notice to additional employees (\u201cnoticed employees\u201d) who were asked to provide transition services through termination dates ranging between one to thirteen months from the date notice was given. The terminated employees were entitled to receive cash severance payments and other benefits. The noticed employees are entitled to receive cash severance payments and other benefits, which are contingent upon providing additional services to the Company. \u200bDuring the year ended December 31, 2023, the Company recorded a restructuring charge of $ 3.1 million which represents a one-time termination benefit for impacted employees with retention periods less than the sixty-day minimum retention period, which was triggered immediately upon either terminating or giving notice to the impacted employees. Of the $ 3.1 million of expenses incurred during the year ended December 31, 2023, $ 2.2 million, $ 0.9 million and $ 19 thousand were recorded in research and development expense, general and administrative expense and cost of revenue, respectively, in the consolidated statement of operations and comprehensive loss. The Company is expensing the cost of cash severance payments, other benefits and annual bonus payments for noticed employees with retention periods more than the minimum retention period over their respective service terms. \u200b 16. Segment Information\u200bThe Company has two reportable segments, therapeutics and contract research. The therapeutics segment is focused on identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases and earns revenue through licensing of the Company\u2019s intellectual property. The contract research segment earns revenue from the provision of laboratory services. All intersegment revenue has been eliminated in the Company\u2019s 105",
            "type": "paragraph"
        },
        {
            "id": 110,
            "context": "| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (In thousands) | \u200b | \u200b | \u200b | Contract | \u200b | Corporate | \u200b | Total |\n| Year Ended December 31, 2023 | \u200b | Therapeutics | \u200b | Research | \u200b | and Other | \u200b | Company |\n| Revenue from external customers | \u200b | $ | 28,214 | \u200b | $ | 3,035 | \u200b | $ | \u2014 | \u200b | $ | 31,249 |\n| Intercompany revenue | \u200b | \u200b | \u2014 | \u200b | \u200b | 16,543 | \u200b | \u200b | ( 16,543 ) | \u200b | \u200b | \u2014 |\n| Cost of revenue | \u200b | \u200b | \u2014 | \u200b | \u200b | 18,941 | \u200b | \u200b | ( 15,537 ) | \u200b | \u200b | 3,404 |\n| Research and development | \u200b | \u200b | 97,188 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 1,006 ) | \u200b | \u200b | 96,182 |\n| General and administrative | \u200b | \u200b | \u2014 | \u200b | \u200b | 4,561 | \u200b | \u200b | 26,940 | \u200b | \u200b | 31,501 |\n| Licensing | \u200b | \u200b | 14,658 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 14,658 |\n| Revaluation of contingent consideration | \u200b | \u200b | ( 26,900 ) | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 26,900 ) |\n| Intangible asset impairment | \u200b | \u200b | 6,629 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 6,629 |\n| Restructuring expense | \u200b | \u200b | 2,202 | \u200b | \u200b | 19 | \u200b | \u200b | 911 | \u200b | \u200b | 3,132 |\n| Loss from operations | \u200b | $ | ( 65,563 ) | \u200b | $ | ( 3,943 ) | \u200b | $ | ( 27,851 ) | \u200b | $ | ( 97,357 ) |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (In thousands) | \u200b | \u200b | \u200b | Contract | \u200b | Corporate | \u200b | Total |\n| Year Ended December 31, 2022 | \u200b | Therapeutics | \u200b | Research | \u200b | and Other | \u200b | Company |\n| Revenue from external customers | \u200b | $ | 25,356 | \u200b | $ | 4,396 | \u200b | $ | \u2014 | \u200b | $ | 29,752 |\n| Intercompany revenue | \u200b | \u200b | \u2014 | \u200b | \u200b | 12,609 | \u200b | \u200b | ( 12,609 ) | \u200b | \u200b | \u2014 |\n| Cost of revenue | \u200b | \u200b | \u2014 | \u200b | \u200b | 15,847 | \u200b | \u200b | ( 11,824 ) | \u200b | \u200b | 4,023 |\n| Research and development | \u200b | \u200b | 78,599 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 786 ) | \u200b | \u200b | 77,813 |\n| General and administrative | \u200b | \u200b | \u2014 | \u200b | \u200b | 3,505 | \u200b | \u200b | 21,628 | \u200b | \u200b | 25,133 |\n| Licensing | \u200b | \u200b | 7,937 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 7,937 |\n| Revaluation of contingent consideration | \u200b | \u200b | 4,700 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 4,700 |\n| Loss from operations | \u200b | $ | ( 65,880 ) | \u200b | $ | ( 2,347 ) | \u200b | $ | ( 21,627 ) | \u200b | $ | ( 89,854 ) |\n| \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b | \u200b |\n| (In thousands) | \u200b | \u200b | \u200b | Contract | \u200b | Corporate | \u200b | Total |\n| Year Ended December 31, 2021 | \u200b | Therapeutics | \u200b | Research | \u200b | and Other | \u200b | Company |\n| Revenue from external customers | \u200b | $ | 932 | \u200b | $ | 5,829 | \u200b | $ | \u2014 | \u200b | $ | 6,761 |\n| Intercompany revenue | \u200b | \u200b | \u2014 | \u200b | \u200b | 7,618 | \u200b | \u200b | ( 7,618 ) | \u200b | \u200b | \u2014 |\n| Cost of revenue | \u200b | \u200b | \u2014 | \u200b | \u200b | 11,885 | \u200b | \u200b | ( 7,172 ) | \u200b | \u200b | 4,713 |\n| Research and development | \u200b | \u200b | 44,259 | \u200b | \u200b | \u2014 | \u200b | \u200b | ( 446 ) | \u200b | \u200b | 43,813 |\n| General and administrative | \u200b | \u200b | \u2014 | \u200b | \u200b | 3,047 | \u200b | \u200b | 20,572 | \u200b | \u200b | 23,619 |\n| Revaluation of contingent consideration | \u200b | \u200b | 24,339 | \u200b | \u200b | \u2014 | \u200b | \u200b | \u2014 | \u200b | \u200b | 24,339 |\n| Loss from operations | \u200b | $ | ( 67,666 ) | \u200b | $ | ( 1,485 ) | \u200b | $ | ( 20,572 ) | \u200b | $ | ( 89,723 ) |",
            "type": "table"
        },
        {
            "id": 111,
            "context": "Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure\n\u200b\nNone.\n\u200b\n106\nItem 9A. Controls and Procedures\n\u200b\nEvaluation of Disclosure Controls and Procedures\n\u200b Under the supervision of and with the participation of our management, including our principal executive officer, and our principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of December 31, 2023, the end of the period covered by this Annual Report. The term \u201cdisclosure controls and procedures,\u201d as set forth in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms promulgated by the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company\u2019s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2023, our principal executive officer and principal financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.",
            "type": "paragraph"
        },
        {
            "id": 112,
            "context": "\u200b\nManagement\u2019s Report on Internal Control over Financial Reporting\n\u200b Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Management conducted an assessment of our internal control over financial reporting based on the framework established in 2013 by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control\u2014Integrated Framework. Based on the assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2023 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. Our independent registered public accounting firm, PricewaterhouseCoopers LLP, has issued an audit report with respect to our internal control over financial reporting, which appears in Part II, Item 8 of this Annual Report.",
            "type": "paragraph"
        },
        {
            "id": 113,
            "context": "\u200b\nChanges in Internal Control over Financial Reporting\n\u200b There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended December 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.",
            "type": "paragraph"
        },
        {
            "id": 114,
            "context": "\u200b\nLimitations on Effectiveness of Disclosure Controls and Procedures and Internal Control over Financial Reporting\n\u200b In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.",
            "type": "paragraph"
        },
        {
            "id": 115,
            "context": "\u200b\nItem 9B. Other Information\n\u200b\nDirector and Officer Trading Arrangements\n\u200b During the quarter ended December 31, 2023, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a \u201cRule 10b5-1 trading arrangement\u201d or a \u201cnon-Rule 10b5-1 trading arrangement\u201d (as each term is defined in Item 408 of Regulation S-K).",
            "type": "paragraph"
        },
        {
            "id": 116,
            "context": "107\nItem 10. Directors, Executive Officers and Corporate Governance\n\u200b\nThe information required by Item 10 is hereby incorporated by reference to the sections of the 2024 Proxy Statement under the captions \u201cInformation Regarding the Board of Directors and Corporate Governance,\u201d \u201cElection of Directors\u201d and \u201cManagement.\u201d\n\u200b\nItem 11. Executive Compensation\n\u200b\nThe information required by Item 11 is hereby incorporated by reference to the sections of the 2024 Proxy Statement under the captions \u201cExecutive Compensation\u201d and \u201cNon-Employee Director Compensation.\u201d\n\u200b\nItem 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters\n\u200b The information required by Item 12 is hereby incorporated by reference to the sections of the 2024 Proxy Statement under the captions \u201cSecurity Ownership of Certain Beneficial Owners and Management\u201d and \u201cSecurities Authorized for Issuance under Equity Compensation Plans.\u201d",
            "type": "paragraph"
        },
        {
            "id": 117,
            "context": "\u200b\nItem 13. Certain Relationships and Related Transactions, and Director Independence\n\u200b The information required by Item 13 is hereby incorporated by reference to the sections of the 2024 Proxy Statement under the captions \u201cTransactions with Related Persons\u201d and \u201cInformation Regarding the Board of Directors and Corporate Governance\u2014Independence of the Board of Directors.\u201d",
            "type": "paragraph"
        },
        {
            "id": 118,
            "context": "\u200b\nItem 14. Principal Accountant Fees and Services\n\u200b\nThe information required by Item 14 is hereby incorporated by reference to the sections of the 2024 Proxy Statement under the caption \u201cRatification of Selection of Independent Registered Public Accounting Firm.\u201d\n\u200b\n109\nPART IV\u200b\nItem 15. Exhibits and Financial Statement Schedules\n\u200b\n(a) The following documents are filed as part of this report:\n\u200b\n(1) Financial Statements\n\u200b\nOur consolidated financial statements are listed in the \u201cIndex to Consolidated Financial Statements\u201d under Part II. Item 8 of this Annual Report on Form 10-K.\n\u200b\n(2) Financial Statement Schedules\n\u200b\nFinancial statement schedules have been omitted in this report because they are not applicable, not required under the instructions, or the information required is set forth in the consolidated financial statements or related notes thereto.\n\u200b\n(3) Exhibits\n\u200b\nSee exhibits listed under part (b) below.\n\u200b\n(b) Exhibits\n\u200b\n\n| Exhibit | \u200b | \u200b |\n| Number | Description of Document |\n| 2.1# | \u200b | Agreement and Plan of Merger, dated as of August 3, 2017, by and among the Registrant, Aclaris Life Sciences, Inc., Confluence Life Sciences, Inc. and Fortis Advisors LLC (incorporated by reference to Exhibit 2.1 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on November 7, 2017). |\n| 3.1 | \u200b | Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on October 13, 2015). |\n| 3.2 | \u200b | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.2 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on August 7, 2023). |\n| 3.3 | \u200b | Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on June 24, 2020). |\n| 4.1* | \u200b | Description of Securities. |\n| 10.1+ | \u200b | Amended and Restated 2012 Equity Compensation Plan (incorporated by reference to Exhibit 10.7 to Amendment No. 1 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on September 4, 2015). |\n| 10.2+ | \u200b | Form of Stock Option Grant under Amended and Restated 2012 Equity Compensation Plan (incorporated by reference to Exhibit 10.8 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on August 17, 2015). |\n| 10.3+ | \u200b | 2015 Equity Incentive Plan (incorporated by reference to Exhibit 4.6 to the Registrant\u2019s Registration Statement on Form S-8 (File No. 333-207434), filed with the SEC on October 15, 2015). |\n| 10.4+ | \u200b | Form of Stock Option Grant Notice and Stock Option Agreement under 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.10 to Amendment No. 2 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on September 25, 2015). |\n| 10.5+ | \u200b | Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 to Amendment No. 2 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on September 25, 2015). |\n| 10.6+ | \u200b | Form of Performance Stock Option Grant Notice and Stock Option Agreement used in connection with the 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on March 18, 2019). |",
            "type": "table"
        },
        {
            "id": 119,
            "context": "110\n\n| 10.7+ | \u200b | Form of Performance Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.12 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on March 18, 2019). |\n| 10.8+ | \u200b | Aclaris Therapeutics, Inc. Inducement Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on August 1, 2017). |\n| 10.9+ | \u200b | Form of Stock Option Grant Notice and Stock Option Agreement used in connection with the Aclaris Therapeutics, Inc. Inducement Plan (incorporated herein by reference to Exhibit 10.2 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on August 1, 2017). |\n| 10.10+ | \u200b | Eighth Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.12 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023). |\n| 10.11+ | \u200b | Ninth Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.4 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on May 8, 2023). |\n| 10.12+ | \u200b | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.12 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on August 17, 2015). |\n| 10.13+ | \u200b | Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan (incorporated herein by reference to Exhibit 10.15 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 24, 2022). |\n| 10.14+ | \u200b | Amended and Restated Employment Agreement, effective as of July 1, 2023, by and between the Registrant and Joseph Monahan (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on June 12, 2023). |\n| 10.15+* | \u200b | Second Amended and Restated Employment Agreement, effective as of February 1, 2024, by and between the Registrant and Joseph Monahan. |\n| 10.16+ | \u200b | Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop (incorporated herein by reference to Exhibit 10.16 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 24, 2022). |\n| 10.17+ | \u200b | Amended and Restated Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Douglas Manion (incorporated herein by reference to Exhibit 10.23 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023). |\n| 10.18+* | \u200b | Separation Agreement, Waiver, and Release, dated as of February 4, 2024, by and between the Registrant and Douglas Manion. |\n| 10.19+ | \u200b | Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Kevin Balthaser (incorporated herein by reference to Exhibit 10.24 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023). |\n| 10.20+ | \u200b | Employment Agreement, dated as of June 27, 2022, by and between the Registrant and Gail Cawkwell (incorporated by reference to Exhibit 10.1 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on August 3, 2022). |\n| 10.21+ | \u200b | Letter Agreement, dated as of November 22, 2022, by and between the Registrant and Neal Walker (incorporated herein by reference to Exhibit 10.16 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023). |\n| 10.22+* | \u200b | Letter Agreement, dated as of January 31, 2024, by and between the Registrant and Neal Walker. |\n| 10.23\u02c4 | \u200b | Office Lease, dated May 26, 2023, by and between the Registrant and CBCC \u2013 Lee Road Acquisitions, LLC (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on June 1, 2023). |\n| 10.24 | \u200b | Sales Agreement, dated February 23, 2023, by and among the Registrant, SVB Securities LLC and Cantor Fitzgerald & Co. (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on February 23, 2023). |\n| 21.1* | \u200b | Subsidiaries of the Registrant. |\n| 23.1* | \u200b | Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm. |\n| 24.1* | \u200b | Power of Attorney (contained on signature page hereto). |\n| 31.1* | \u200b | Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |\n| 31.2* | \u200b | Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. |",
            "type": "table"
        },
        {
            "id": 120,
            "context": "| 32.1\u2020 | \u200b | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) and 15d-14(b) promulgated under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to section 906 of The Sarbanes-Oxley Act of 2002. |\n| 97.1* | \u200b | Aclaris Therapeutics, Inc. Incentive Compensation Recoupment Policy, adopted as of October 2, 2023. |\n| 101.INS | \u200b | XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |\n| 101.SCH | \u200b | Inline XBRL Taxonomy Extension Schema Document |\n| 101.CAL | \u200b | Inline XBRL Taxonomy Extension Calculation Linkbase Document |\n| 101.DEF | \u200b | Inline XBRL Taxonomy Extension Definition Linkbase Document |\n| 101.LAB | \u200b | Inline XBRL Taxonomy Extension Label Linkbase Document |\n| 101.PRE | \u200b | Inline XBRL Taxonomy Extension Presentation Linkbase Document |\n| 104 | \u200b | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |\n| * | Filed herewith. |\n| \u2020 | This certification is being furnished solely to accompany this Annual Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing. |\n| + | Indicates management contract or compensatory plan. |\n| # | Confidential treatment has been granted with respect to portions of this exhibit (indicated by asterisks) and those portions have been separately filed with the SEC. |\n| \u02c4 | Pursuant to Item 601(a)(5) of Regulation S-K promulgated by the SEC, certain exhibits and schedules to this agreement have been omitted. The Company hereby agrees to furnish supplementally to the SEC, upon its request, any or all of such omitted exhibits or schedules. |",
            "type": "table"
        },
        {
            "id": 121,
            "context": "| \u200b | ACLARIS THERAPEUTICS, INC. |\n| \u200b | \u200b |\n| Date: February 27, 2024 | By: | /s/ Neal Walker |\n| \u200b | \u200b | Neal Walker |\n| \u200b | \u200b | Interim President and Chief Executive Officer |\n| \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b |\n| Signature | Title | Date |\n| /s/ Neal Walker | \u200b | Interim President and Chief Executive Officer, and Chairman of the Board of Directors | \u200b | February 27, 2024 |\n| Neal Walker | \u200b | (Principal Executive Officer) | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Kevin Balthaser | \u200b | Chief Financial Officer | \u200b | February 27, 2024 |\n| Kevin Balthaser | \u200b | (Principal Financial Officer and Principal Accounting Officer) | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Christopher Molineaux | \u200b | Lead Independent Director | \u200b | February 27, 2024 |\n| Christopher Molineaux | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Anand Mehra, M.D. | \u200b | Director | \u200b | February 27, 2024 |\n| Anand Mehra, M.D. | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ William Humphries | \u200b | Director | \u200b | February 27, 2024 |\n| William Humphries | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Andrew Powell | \u200b | Director | \u200b | February 27, 2024 |\n| Andrew Powell | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Andrew Schiff | \u200b | Director | \u200b | February 27, 2024 |\n| Andrew Schiff | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Bryan Reasons | \u200b | Director | \u200b | February 27, 2024 |\n| Bryan Reasons | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Maxine Gowen | \u200b | Director | \u200b | February 27, 2024 |\n| Maxine Gowen | \u200b | \u200b | \u200b | \u200b |\n| \u200b | \u200b | \u200b | \u200b | \u200b |\n| /s/ Vincent Milano | \u200b | Director | \u200b | February 27, 2024 |\n| Vincent Milano | \u200b | \u200b | \u200b | \u200b |",
            "type": "table"
        }
    ],
    "html_tables": [
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:0.9pt;\"><td style=\"color:#ffffff;vertical-align:middle;width:17.13%;background:#432950;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Drug Candidate / Program</b></p></td><td style=\"color:#ffffff;vertical-align:middle;width:15.77%;background:#432950;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Target</b></p></td><td style=\"color:#ffffff;vertical-align:middle;width:16.51%;background:#432950;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Route of Administration</b></p></td><td style=\"color:#ffffff;vertical-align:middle;width:31.3%;background:#432950;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Indication</b></p></td><td style=\"color:#ffffff;vertical-align:middle;width:19.26%;background:#432950;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Development Phase</b></p></td></tr><tr style=\"height:0.9pt;\"><td colspan=\"5\" style=\"vertical-align:middle;width:100%;background:#fab714;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Immuno-Inflammatory</b></p></td></tr><tr style=\"height:0.9pt;\"><td style=\"vertical-align:middle;width:17.13%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">ATI-</b><b style=\"font-weight:bold;\">1</b><b style=\"font-weight:bold;\">777</b></p></td><td style=\"vertical-align:middle;width:15.77%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">\u201cSoft\u201d JAK 1/3 inhibitor</p></td><td style=\"vertical-align:middle;width:16.51%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Topical</p></td><td style=\"vertical-align:middle;width:31.3%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Atopic dermatitis</p></td><td style=\"vertical-align:middle;width:19.26%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Phase 2b Complete</p></td></tr><tr style=\"height:23pt;\"><td style=\"vertical-align:middle;width:17.13%;background:#fce3d3;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">ATI-2138</b></p></td><td style=\"vertical-align:middle;width:15.77%;background:#fce3d3;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">ITK/JAK3 inhibitor</p></td><td style=\"vertical-align:middle;width:16.51%;background:#fce3d3;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Oral</p></td><td style=\"vertical-align:middle;width:31.3%;background:#fce3d3;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">T cell-mediated autoimmune diseases</p></td><td style=\"vertical-align:middle;width:19.26%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Phase 1 Complete</p></td></tr><tr style=\"height:0.9pt;\"><td colspan=\"5\" style=\"vertical-align:middle;width:100%;background:#fab714;border-bottom:3.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Oncology</b></p></td></tr><tr style=\"height:0.9pt;\"><td rowspan=\"2\" style=\"vertical-align:middle;width:17.13%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Zunsemetinib</b></p></td><td rowspan=\"2\" style=\"vertical-align:middle;width:15.77%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">MK2 inhibitor</p></td><td rowspan=\"2\" style=\"vertical-align:middle;width:16.51%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Oral</p></td><td style=\"vertical-align:middle;width:31.3%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Metastatic breast cancer</p></td><td rowspan=\"2\" style=\"vertical-align:middle;width:19.26%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Phase 1*</p></td></tr><tr style=\"height:0.9pt;\"><td style=\"display:none;vertical-align:middle;width:17.13%;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 0pt 3.59pt 0pt;\"></td><td style=\"display:none;vertical-align:middle;width:15.77%;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 0pt 3.59pt 0pt;\"></td><td style=\"display:none;vertical-align:middle;width:16.51%;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 0pt 3.59pt 0pt;\"></td><td style=\"vertical-align:middle;width:31.3%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;border-top:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;\">Pancreatic cancer</p></td><td style=\"display:none;vertical-align:middle;width:19.26%;background:#fce3d3;border-bottom:1.0pt solid #ffffff;border-left:1.0pt solid #ffffff;border-right:1.0pt solid #ffffff;margin:0pt;padding:3.59pt 6.69pt 3.59pt 6.69pt;\"></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the FDA\u2019s good laboratory practice regulations;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">submission to the FDA of an IND which must take effect before clinical trials may begin; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">approval by an independent institutional review board, or IRB, representing each clinical site before clinical testing may be initiated at the clinical site; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">performance of adequate and well-controlled clinical trials in accordance with good clinical practice, or GCP, regulations to establish the safety and efficacy of the proposed drug product for each indication; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">preparation and submission to the FDA of an NDA; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">review of the NDA by an FDA advisory committee, if applicable; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product or its components are produced to assess compliance with current good manufacturing practices, or cGMP, and regulations to assure that the facilities, methods and controls are adequate to preserve the product\u2019s identity, strength, quality and purity; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">payment of user fees and securing FDA approval of the NDA; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">compliance with any post-approval requirements, including potential requirements for a risk evaluation and mitigation strategy and post-approval studies required by the FDA. </span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;\">Phase 1.</span><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\"> The drug is initially introduced into healthy human subjects and tested for safety, dosage tolerance, absorption, metabolism, distribution and elimination. In the case of some products for severe or life-threatening diseases, such as cancer, and especially when the product may be inherently too toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients who already have the condition. </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;\">Phase 2.</span><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\"> Clinical trials are performed on a limited patient population intended to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;\">Phase 3.</span><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\"> If a drug candidate is found to be potentially effective and to have an acceptable safety profile in Phase 2 clinical trials, the clinical trial program will be expanded to Phase 3 clinical trials to further evaluate dosage, clinical efficacy and safety in an expanded patient population at geographically dispersed clinical trial sites. These trials are intended to establish the overall risk-benefit ratio of the product and provide an adequate basis for product approval and labeling claims. </span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">refusal to approve pending applications; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">withdrawal of an approval; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">imposition of a clinical hold; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">warning letters; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">product seizures or detention, or refusal to permit the import or export of products; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">restrictions on the marketing or manufacturing of the product; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">total or partial suspension of production or distribution or product recalls; or</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">injunctions, fines, disgorgement, or civil or criminal penalties. </span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the scope, progress, results and costs of preclinical development, laboratory testing and conducting preclinical and clinical trials for our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the costs, timing and outcome of regulatory review of our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the extent to which we in-license or acquire drug candidates and technologies;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our ability to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our ability to earn revenue from licenses to, or partnerships or other arrangements with, third parties.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our drug discovery methods and our KINect platform may not be successful in identifying additional drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our discovery programs may initially show promise in identifying potential drug candidates, yet fail to yield drug candidates for clinical development; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">potential drug candidates may, on further study, be shown to have harmful side effects or other characteristics that indicate that they are unlikely to be drug candidates that will receive marketing approval and achieve market acceptance. </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">successful completion of preclinical studies and our clinical trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">successful development of manufacturing processes;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">receipt of timely approvals from applicable regulatory authorities;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the identification and consummation of transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the commercial launch of our drug candidates, if approved, by a potential third-party partner;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our potential third-party partners\u2019 ability to achieve acceptance of our drug candidates, if approved, by patients, the medical community and third-party payors, and willingness of patients to pay out of pocket for our drug candidates when third-party payor coverage and reimbursement is limited or unavailable;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our potential third-party partners\u2019 ability to achieve success in educating physicians and patients about the benefits, administration and use of our drug candidates, if approved;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the prevalence and severity of adverse events experienced with our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the availability, perceived advantages, cost, safety and efficacy of alternative treatments for the proposed indications of our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">obtaining and maintaining patent, trademark and trade secret protection and regulatory exclusivity for our drug candidates and otherwise protecting the intellectual property portfolio; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">maintaining compliance with regulatory requirements, including current good manufacturing practices, or cGMPs;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our potential third-party partners\u2019 ability to compete effectively with other treatment procedures; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our potential third-party partners\u2019 ability to maintain a continued acceptable safety, tolerability and efficacy profile of our drug candidates following marketing approval.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">regulators or IRBs may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">we may experience delays in reaching, or fail to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites or prospective contract research organizations, or CROs, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">clinical trials of our drug candidates may produce negative or inconclusive results, including failure to demonstrate statistical significance, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon drug development programs;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the number of patients required for clinical trials of our drug candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our drug candidates may have undesirable side effects or other unexpected characteristics, causing us or our investigators, regulators or IRBs to suspend or terminate the trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">regulators or IRBs may require that we or our investigators suspend or terminate clinical development for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the cost of clinical trials of our drug candidates may be greater than we anticipate; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the supply or quality of our drug candidates or other materials necessary to conduct clinical trials of our drug candidates may be insufficient or inadequate.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">be delayed in obtaining marketing approval for our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">not obtain marketing approval at all;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">obtain marketing approval for indications or patient populations that are not as broad as intended or desired;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">obtain marketing approval with labeling that includes significant use or distribution restrictions or safety warnings;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">be subject to additional post-marketing testing requirements; or</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">have the drug removed from the market after obtaining marketing approval.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the eligibility criteria for the trial in question;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the perceived risks and benefits of the drug candidate in the trial;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the availability of drugs approved to treat the disease in the trial;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the efforts to facilitate timely enrollment in clinical trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the patient referral practices of physicians;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the ability to monitor patients adequately during and after treatment; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the proximity and availability of clinical trial sites for prospective patients.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">we may need to abandon the development or limit the further development of our drug candidates, including in various populations and for certain indications; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">regulatory authorities may withdraw approval to market such product;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">regulatory authorities may require additional warnings on the labels;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">a medication guide outlining the risks of such side effects for distribution to patients may be required;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">we could be sued and held liable for harm caused to patients;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our reputation and physician or patient acceptance of our drug candidates, if approved, may suffer; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates would be harmed.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the efficacy, safety and potential advantages compared to alternative treatments;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our potential third-party partners\u2019 ability to offer the products for sale at competitive prices;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the convenience and ease of administration compared to alternative treatments;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the willingness of the target patient population to try new treatments and of physicians to prescribe these treatments;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the ability of our potential third-party partners to retain a sales force;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the strength of our potential third-party partners\u2019 marketing and distribution support;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the availability of third-party payor coverage and adequate reimbursement or the willingness of patients to pay for these products;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the prevalence and severity of any side effects; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">any restrictions on the use of our products together with other medications.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">decreased demand for any drug candidates that we may develop and, if approved, are commercialized by our potential third-party partners;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">injury to our reputation and significant negative media attention;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">withdrawal of clinical trial participants;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">significant costs to defend the related litigation;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">substantial monetary awards paid to trial participants or patients;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">loss of revenue;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">reduced resources of our management to pursue our business strategy; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our inability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">reliance on the third party for regulatory compliance and quality assurance;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the possible breach of the manufacturing agreement by the third party;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the possible misappropriation of our proprietary information, including our trade secrets and know-how;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the possible increase in costs by our third-party suppliers for the active pharmaceutical ingredients for our drug candidates; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners have significant discretion in determining the efforts and resources that they will apply to these arrangements;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners may not perform their obligations as expected;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners may not pursue development, marketing approval or commercialization of any drug candidates that achieve marketing approval or may elect not to continue or renew development or commercialization </span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"></td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">programs based on clinical trial results, changes in the partners\u2019 strategic focus or available funding, or external factors, such as an acquisition, that divert resources or create competing priorities;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a drug candidate, repeat or conduct new clinical trials or require a new formulation of a drug candidate for clinical testing;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners could independently develop, or develop with third parties, products that compete directly or indirectly with our drug candidates if the partners believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">drug candidates discovered in collaboration with us may be viewed by our collaborators as competitive with their own products or drug candidates, which may cause our partners to cease to devote resources to the development and/or commercialization of our drug candidates, if approved;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">a partner with marketing and distribution rights to one or more of our drug candidates that achieve marketing approval may not commit sufficient resources to the marketing and distribution of such drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">disagreements with partners, including disagreements over proprietary rights, contract interpretation or the preferred course of development or commercialization, might cause delays or termination of the research, development or commercialization of drug candidates, might lead to additional responsibilities for us with respect to drug candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners may not properly maintain or defend our or their intellectual property rights or may use our or their proprietary information in such a way as to invite litigation that could jeopardize or invalidate such intellectual property or proprietary information or expose us to potential litigation;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partners may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">partnerships may be terminated for the convenience of the partner and, if terminated, we could be required to raise additional capital to pursue further development and/or commercialization of the applicable drug candidates.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">we, our licensors or any potential third-party partners might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">we, our licensors or any potential third-party partners might not have been the first to file patent applications covering certain of our inventions;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">it is possible that our pending patent applications will not lead to issued patents;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">issued patents that we own or exclusively license may not provide us with any competitive advantages, or may be held invalid or unenforceable as a result of legal challenges;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, </span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">differing regulatory requirements in foreign countries;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the potential for so-called parallel importing, which is what happens when a local seller, faced with high or higher local prices, opts to import goods from a foreign market (with low or lower prices) rather than buying them locally;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">economic weakness, including inflation, or political instability in particular foreign economies and markets;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">foreign reimbursement, pricing and insurance regimes;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">foreign taxes, including withholding of payroll taxes;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">difficulties staffing and managing foreign operations;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">workforce uncertainty in countries where labor unrest is more common than in the United States;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">potential liability under the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, or comparable foreign regulations;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">challenges enforcing contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">logistical challenges resulting from distributing our drug candidates to foreign countries; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">business interruptions resulting from geo-political actions, including war and terrorism.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">restrictions on such drugs, manufacturers or manufacturing processes;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">restrictions on the labeling or marketing of a drug;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">restrictions on drug distribution or use;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">requirements to conduct post-marketing studies or clinical trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">warning letters;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">recall or withdrawal of the drugs from the market;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">refusal to approve pending applications or supplements to approved applications;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">clinical holds;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">fines, restitution or disgorgement of profits or revenue;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">suspension or withdrawal of marketing approvals;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">refusal to permit the import or export of our drugs;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">drug seizure; or</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">injunctions or the imposition of civil or criminal penalties.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under federal and state health care programs such as Medicare and Medicaid. Further, several courts have interpreted the statute\u2019s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal health care covered business, the Anti-Kickback Statute has been violated. The intent standard was further amended by the Affordable Care Act, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a </span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"></td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">violation. Moreover, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">federal civil and criminal false claims laws, including, without limitation, the federal civil False Claims Act (that can be enforced through civil whistleblower or qui tam actions), and the civil monetary penalties law, which impose criminal and civil penalties, against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, including the Medicare and Medicaid programs, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes criminal and civil liability for, among other things, executing a scheme to defraud any health care benefit program or making false statements relating to health care matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their respective implementing regulations, which impose obligations on covered health care providers, health plans, and health care clearinghouses, as well as their business associates that create, receive, maintain or transmit individually identifiable health information for or on behalf of a covered entity and their subcontractors that use, disclose, access, or otherwise process protected health information, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the federal Open Payments program, created under Section 6002 of the Affordable Care Act (commonly known as the Physician Payments Sunshine Act) and its implementing regulations, which requires specified manufacturers of drugs, devices, biologics or medical supplies for which payment is available under Medicare, Medicaid or the Children\u2019s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare &amp; Medicaid Services, or CMS, information related to \u201cpayments or other transfers of value\u201d made to physicians, which is defined to include doctors, dentists, optometrists, podiatrists and chiropractors, other health care professionals (such as physician assistants and nurse practitioners), and teaching hospitals, and for applicable manufacturers to report annually to CMS information regarding ownership and investment interests held by physicians and their immediate family members; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving health care items or services reimbursed by non-governmental third-party payors, including private insurers; state and foreign laws that require pharmaceutical companies to comply with the pharmaceutical industry\u2019s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to health care providers; state, local and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other health care providers or marketing expenditures; state laws that require drug manufacturers to report pricing information regarding certain drugs; and/or that require registration of certain employees engaged in marketing activities in the location; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the commencement, enrollment and/or results of any preclinical studies and clinical trials we may conduct, or changes in the development status of our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">any delay in our regulatory filings for any of our drug candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority\u2019s review of such filings, including without limitation the FDA\u2019s issuance of a \u201crefusal to file\u201d letter or a request for additional information;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">adverse results from, delays in or termination of clinical trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">adverse regulatory decisions, including failure of any of our drug candidates to receive marketing approval;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">unanticipated serious safety concerns related to the use of any drug candidate or previously sold commercial product;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">changes in financial estimates by us or by any securities analysts who might cover our stock;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">conditions or trends in our industry;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">changes in the structure of health care payment systems;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">changes in the market valuations of similar companies;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">stock market price and volume fluctuations of comparable companies and, in particular, those that operate in the biotechnology industry;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">publication of research reports about us or our industry or positive or negative recommendations or withdrawal of research coverage by securities analysts;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">announcements by us or our competitors of significant acquisitions, strategic partnerships or divestitures;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">announcements of investigations or regulatory scrutiny of our operations or lawsuits filed against us;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">investors\u2019 general perception of our company and our business;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">recruitment or departure of key personnel;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">overall performance of the equity markets;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">trading volume of our common stock;</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">significant lawsuits, including patent or stockholder litigation;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">general political and economic conditions; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">other events or factors, many of which are beyond our control.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">only one of our three classes of directors is elected each year;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">stockholders are not entitled to remove directors other than by a 66 2/3% vote and only for cause;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">stockholders are not permitted to take actions by written consent;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">stockholders cannot call a special meeting of stockholders; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">stockholders must give advance notice to nominate directors or submit proposals for consideration at stockholder meetings.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:40.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">12/31/18</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">12/31/19</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;width:7.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">12/31/20</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">12/31/21</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">12/31/22</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;width:7.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">12/31/23</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.5%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:40.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Aclaris Therapeutics, Inc.</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;width:6.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">100.00</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.77%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">25.58</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.71%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">87.55</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.73%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">196.75</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.73%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">213.13</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.75%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">14.21</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:40.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Nasdaq Composite Index</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;width:6.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">100.00</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">136.69</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.71%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">198.10</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">242.03</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">163.28</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">236.17</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:40.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Nasdaq Biotechnology Index</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;width:6.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">100.00</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">125.11</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.71%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">158.17</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">158.20</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">142.19</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:top;width:6.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">148.72</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">employee-related expenses, which include salaries, benefits and stock-based compensation;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">outsourced professional scientific services;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">depreciation of laboratory equipment;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">facility-related costs; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">laboratory materials and supplies used to support the services provided.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">expenses incurred under agreements with contract research organizations, or CROs, as well as clinical trial sites and consultants that conduct our clinical trials and preclinical studies, and investigator-initiated trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">manufacturing scale-up expenses and the cost of acquiring and manufacturing active pharmaceutical ingredients and preclinical and clinical trial materials, including domestic technology transfer expenses;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">quality assurance and quality control costs;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">outsourced professional scientific development services;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">medical affairs expenses related to our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">employee-related expenses, which include salaries, benefits and stock-based compensation;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">expenses relating to regulatory activities, including filing fees paid to regulatory agencies; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;\">laboratory materials and supplies used to support our research activities.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the number of clinical sites included in the trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the length of time required to enroll suitable subjects;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the number of subjects that ultimately participate in the trials;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the number of doses subjects receive;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the duration of subject follow-up; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the results of our clinical trials.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:21.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Change</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Revenues:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> Contract research</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 3,035</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 4,395</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">$</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (1,360)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Licensing </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 28,214</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 25,100</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 3,114</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Other </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> \u2014</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 257</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (257)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 31,249</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 29,752</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 1,497</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Costs and expenses:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Cost of revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 3,423</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 4,023</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (600)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Research and development</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 98,384</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 77,813</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 20,571</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">General and administrative</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 32,412</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 25,133</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 7,279</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Licensing</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 14,658</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 7,937</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 6,721</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (26,900)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 4,700</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (31,600)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Intangible asset impairment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 6,629</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> \u2014</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 6,629</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total costs and expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 128,606</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 119,606</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 9,000</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Loss from operations</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (97,357)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (89,854)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (7,503)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Other income, net</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 8,509</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 2,946</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 5,563</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Loss before income taxes</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (88,848)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (86,908)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (1,940)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Income tax benefit</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (367)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> \u2014</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (367)</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net loss</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (88,481)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (86,908)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">$</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (1,573)</b></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:59.01%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:59.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:22.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:59.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:22.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:59.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Change</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Zunsemetinib</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 36,461</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 28,133</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 8,328</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">ATI-1777</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 12,129</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 12,113</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 16</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">ATI-2138</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 12,143</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 7,704</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 4,439</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">ATI-2231</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 1,575</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 4,828</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (3,253)</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Discovery</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 6,881</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 4,564</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 2,317</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Other research and development</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 3,417</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 1,564</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 1,853</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Personnel</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 18,977</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 15,162</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 3,815</b></p></td></tr><tr><td style=\"vertical-align:middle;width:59.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Stock-based compensation</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 6,801</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 3,745</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 3,056</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:59.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total research and development expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 98,384</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 77,813</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.13%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 20,571</b></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:60.81%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:60.81%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:20.91%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:60.81%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:20.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:60.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Change</b></p></td></tr><tr><td style=\"vertical-align:middle;width:60.81%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Personnel</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 8,016</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 6,028</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 1,988</b></p></td></tr><tr><td style=\"vertical-align:middle;width:60.81%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Professional and legal fees</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 5,534</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 4,319</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 1,215</b></p></td></tr><tr><td style=\"vertical-align:middle;width:60.81%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Facility and support services</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 3,023</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 2,302</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 721</b></p></td></tr><tr><td style=\"vertical-align:middle;width:60.81%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Other general and administrative</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 2,240</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 2,341</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> (101)</b></p></td></tr><tr><td style=\"vertical-align:middle;width:60.81%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Stock-based compensation</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 12,285</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 10,143</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 2,142</b></p></td></tr><tr><td style=\"vertical-align:middle;width:60.81%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Bad debt </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 1,314</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> \u2014</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 1,314</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:60.81%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total general and administrative expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 32,412</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 25,133</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.63%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><b style=\"font-weight:bold;white-space:pre-wrap;\"> 7,279</b></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:24.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:24.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Cash and cash equivalents beginning balance</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 45,277</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 27,349</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net cash used in operating activities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (78,325)</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (67,567)</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net cash provided by investing activities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 46,220</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 12,628</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net cash provided by financing activities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 26,706</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 72,867</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Cash and cash equivalents ending balance</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 39,878</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 45,277</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:24.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:24.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Net loss</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (88,481)</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (86,908)</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Non-cash adjustments to reconcile net loss to net cash used in operating activities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 767</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 20,536</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Change in accounts payable and accrued expenses</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 10,518</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 960</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Change in accounts receivable</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 186</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 139</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Change in prepaid expenses and other assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (1,315)</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (2,294)</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\">Net cash used in operating activities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (78,325)</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (67,567)</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:24.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:24.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Purchases of property and equipment</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (1,309)</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (605)</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Purchases of marketable securities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (135,675)</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (164,753)</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Proceeds from sales and maturities of marketable securities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 183,204</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 177,986</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net cash provided by investing activities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 46,220</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.29%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 12,628</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:nowrap;width:73.54%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:24.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:24.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:73.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Proceeds from issuance of common stock under the at-the-market sales agreement, net of <br/>issuance costs</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 26,714</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 72,744</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Payments of employee withholding taxes related to restricted stock unit award vesting </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (102)</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"white-space:pre-wrap;\"> (34)</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Proceeds from exercise of employee stock options and the issuance of stock</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 94</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 157</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net cash provided by financing activities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 26,706</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"white-space:pre-wrap;\"> 72,867</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the number and development requirements of the drug candidates that we may pursue;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the scope, progress, results and costs of preclinical development, laboratory testing and conducting preclinical and clinical trials for our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the costs, timing and outcome of regulatory review of our drug candidates;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the extent to which we in-license or acquire additional drug candidates and technologies;</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; </span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our ability to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates; and</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:18pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">our ability to earn revenue as a result of licenses to, or partnerships or other arrangements with, third parties.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"></div></div></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;\"><a href=\"#ReportofIndependentRegisteredPublic\"><span style=\"font-style:normal;font-weight:normal;\">Report of Independent Registered Public Accounting Firm</span></a> (PCAOB ID  238 )</p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">80</p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;\"><a href=\"#BALANCESHEETS_777152\"><span style=\"font-style:normal;font-weight:normal;\">Consolidated Balance Sheets as of December 31, 2023 and 2022</span></a></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">83</p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;\"><a href=\"#OPERATIONS_222661\"><span style=\"font-style:normal;font-weight:normal;\">Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021</span></a></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">84</p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;\"><a href=\"#EQUITY_613918\"><span style=\"font-style:normal;font-weight:normal;\">Consolidated Statements of Stockholders\u2019 Equity for the years ended December 31, 2023, 2022 and 2021</span></a></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">85</p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;\"><a href=\"#CASHFLOWS_98655\"><span style=\"font-style:normal;font-weight:normal;\">Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021</span></a></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">86</p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:93.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;\"><a href=\"#CONSOLIDATEDFINANCIALSTATEMENTS_199129\"><span style=\"font-style:normal;font-weight:normal;\">Notes to Consolidated Financial Statements</span></a></p></td><td style=\"vertical-align:bottom;width:6.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">87</p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Assets</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Current assets:</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Cash and cash equivalents</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  39,878 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  45,277 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Short-term marketable securities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  79,228 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  172,294 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Accounts receivable, net</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  298 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  484 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Prepaid expenses and other current assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  9,452 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  13,495 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total current assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  128,856 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  231,550 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Marketable securities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  62,771 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  12,242 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Property and equipment, net</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,620 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,099 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Intangible assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  269 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,973 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Other assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,889 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,732 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  197,405 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  254,596 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Liabilities and Stockholders\u2019 Equity</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Current liabilities:</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Accounts payable</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  8,878 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  10,351 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Accrued expenses</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  19,446 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  8,701 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Current portion of lease liabilities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  426 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  684 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Discontinued operations</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,202 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,202 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total current liabilities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  30,952 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  21,938 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Other liabilities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,074 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,570 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,200 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  33,100 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Deferred tax liability</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  367 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total liabilities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  40,226 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  56,975 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Commitments and contingencies (Note 17)</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Stockholders\u2019 Equity:</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Preferred stock, $  0.00001   par value;   10,000,000   shares authorized and   no   shares issued or outstanding at December 31, 2023 and December 31, 2022</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"-sec-ix-hidden:Hidden_mm4u0WzPYUmPSJ_C_KVF7A;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\"> \u2014</span></span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"><span style=\"-sec-ix-hidden:Hidden_yCfKOPM_fkaeijOdeTo_Sw;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\"> \u2014</span></span></p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Common stock, $  0.00001   par value;  200,000,000  and  100,000,000  shares authorized at December 31, 2023 and December 31, 2022, respectively;   70,894,889   and  66,688,647  shares <span style=\"-sec-ix-hidden:Hidden_9rIxtmOxi0GcbSOW5C3yzA;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">issued</span></span> and <span style=\"-sec-ix-hidden:Hidden_Qz7wOYnzV0GlU718Jn2yqA;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">outstanding</span></span> at December 31, 2023 and December 31, 2022, respectively</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Additional paid\u2011in capital</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  928,080 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  880,832 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Accumulated other comprehensive loss</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 106 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 897 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Accumulated deficit</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 770,796 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 682,315 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total stockholders\u2019 equity</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  157,179 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  197,621 </p></td></tr><tr><td style=\"vertical-align:bottom;width:74.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total liabilities and stockholders\u2019 equity</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  197,405 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  254,596 </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.5975723%;padding-left:0pt;padding-right:0pt;width:101.19%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;width:37.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;width:37.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Revenues:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Contract research</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3,035 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  4,395 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  5,830 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Licensing </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  28,214 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  25,100 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  809 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Other </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  257 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  122 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  31,249 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  29,752 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6,761 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Costs and expenses:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Cost of revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3,423 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  4,023 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  4,713 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Research and development</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  98,384 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  77,813 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  43,813 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">General and administrative</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  32,412 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  25,133 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  23,619 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Licensing </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  14,658 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  7,937 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 26,900 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  4,700 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  24,339 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Intangible asset impairment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6,629 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total costs and expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  128,606 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  119,606 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  96,484 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Loss from operations</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 97,357 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 89,854 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 89,723 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Other income (expense), net</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  8,509 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  2,946 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,142 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Loss before income taxes</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 88,848 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Income tax benefit</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 367 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net loss</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 88,481 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net loss per share, basic and diluted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> (  1.27  )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> (  1.33  )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> (  1.60  )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Weighted average common shares outstanding, basic and diluted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">   69,808,855  </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">   65,213,944  </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">   56,730,583  </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Other comprehensive loss:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Unrealized gain (loss) on marketable securities, net of tax of $   0   </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  791 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 673 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 229 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Foreign currency translation adjustment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  99 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total other comprehensive gain (loss)</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  791 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 673 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 130 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Comprehensive loss</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 87,690 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 87,581 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 90,995 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:105.6%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Accumulated</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"4\" style=\"vertical-align:bottom;white-space:normal;width:13.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Common Stock</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Additional</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Other</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:8.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Total</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:4.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Par</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Paid</b><b style=\"font-weight:bold;\">\u2011</b><b style=\"font-weight:bold;\">in</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Comprehensive</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:8.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Accumulated</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Stockholders\u2019</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\"> Shares </b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:4.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Capital</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Loss</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:8.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Deficit</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Equity</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Balance at December 31, 2020</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  45,109,314 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  542,286 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 94 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 504,542 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  37,650 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Issuance of common stock in connection with exercise of stock options and warrants and vesting of restricted stock units</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  1,714,269 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,574 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,574 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Issuance of common stock in connection with public offerings, net of offering costs of $ 15,910  </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  14,404,863 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  1 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  238,199 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  238,200 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Unrealized loss on marketable securities </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 229 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 229 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Foreign currency translation adjustment </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  99 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  99 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Stock-based compensation expense</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  14,060 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  14,060 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"white-space:pre-wrap;\">Net loss </span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:7pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Balance at December 31, 2021</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  61,228,446 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  1 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  792,971 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 224 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 595,407 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  197,341 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  621,492 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  163 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  163 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Issuance of common stock under at-the-market sales agreement, net of offering costs of $ 2,341  </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,838,709 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  72,659 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  72,659 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Unrealized loss on marketable securities </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 673 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 673 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Stock-based compensation expense</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  15,039 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  15,039 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"white-space:pre-wrap;\">Net loss </span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Balance at December 31, 2022</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  66,688,647 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  1 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  880,832 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 897 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 682,315 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  197,621 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  806,242 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 8 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 8 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Issuance of common stock under at-the-market sales agreement, net of offering costs of $ 826 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  3,400,000 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  26,714 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  26,714 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Unrealized gain on marketable securities </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  791 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  791 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Stock-based compensation expense</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  20,542 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  20,542 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"white-space:pre-wrap;\">Net loss </span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 88,481 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 88,481 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:41.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Balance at December 31, 2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  70,894,889 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  1 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  928,080 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 106 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 770,796 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  157,179 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:0.83%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:31.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:31.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.92%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Cash flows from operating activities</b>:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Net loss</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 88,481 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Adjustments to reconcile net loss to net cash used in operating activities:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Depreciation and amortization</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  863 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  797 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  923 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Stock-based compensation expense</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  20,542 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  15,039 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  14,060 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 26,900 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  4,700 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  24,339 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Loss on extinguishment of debt</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  752 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Intangible asset impairment charge</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6,629 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Deferred taxes</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 367 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Changes in operating assets and liabilities:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Accounts receivable</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  186 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  139 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  149 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Prepaid expenses and other assets</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,315 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 2,294 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 5,617 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Accounts payable</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,473 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  368 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3,655 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\">Accrued expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  11,991 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  592 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  470 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Net cash used in operating activities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 78,325 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 67,567 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 52,134 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Cash flows from investing activities:</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Purchases of property and equipment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,309 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 605 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 308 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Purchases of marketable securities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 135,675 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 164,753 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 235,153 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Proceeds from sales and maturities of marketable securities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  183,204 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  177,986 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  67,829 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Net cash provided by (used in) investing activities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  46,220 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  12,628 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 167,632 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Cash flows from financing activities:</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Proceeds from issuance of common stock in connection with public offerings, net of issuance costs</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  238,200 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Proceeds from issuance of common stock under the at-the-market sales agreement, net of issuance costs</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  26,714 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  72,744 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Repayment of debt</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 11,483 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Payments of employee withholding taxes related to restricted stock unit award vesting</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 102 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 34 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 3,124 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Proceeds from exercise of employee stock options and the issuance of stock</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  94 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  157 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  1,459 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;\">Net cash provided by financing activities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  26,706 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  72,867 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  225,052 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Net (decrease) increase in cash and cash equivalents</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 5,399 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  17,928 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  5,286 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Cash and cash equivalents at beginning of period</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  45,277 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  27,349 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  22,063 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Cash and cash equivalents at end of period</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  39,878 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  45,277 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  27,349 </p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">Supplemental disclosure of non-cash investing and financing activities:</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;\">Additions to property and equipment included in accounts payable</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  24 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  143 </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">Level 1 \u2014 Quoted prices in active markets for identical assets or liabilities.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">Level 2 \u2014 Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.</span></td></tr></table><table style=\"border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;\"><tr><td style=\"width:36pt;\"></td><td style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\">\u25cf</td><td style=\"padding:0pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">Level 3 \u2014 Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"11\" style=\"vertical-align:bottom;white-space:nowrap;width:39.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, 2023</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Level 1</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Level 2</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Level 3</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Total</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Assets:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Cash equivalents</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  32,177 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  32,177 </p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Marketable securities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  141,999 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  141,999 </p></td></tr><tr><td style=\"vertical-align:middle;width:58.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total assets</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  32,177 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  141,999 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  174,176 </p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Liabilities:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,200 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,200 </p></td></tr><tr><td style=\"vertical-align:middle;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total liabilities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,200 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,200 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:57.95%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"11\" style=\"vertical-align:bottom;white-space:nowrap;width:39.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, 2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Level 1</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Level 2</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Level 3</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Total</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Assets:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Cash equivalents</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  38,516 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  38,516 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Marketable securities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  184,536 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  184,536 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total assets</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  38,516 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  184,536 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  223,052 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Liabilities:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  33,100 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  33,100 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total liabilities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  33,100 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  33,100 </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:56.96%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"11\" style=\"vertical-align:bottom;white-space:nowrap;width:41.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, 2023</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gross</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gross</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Book </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Unrealized</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Unrealized</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Fair</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gain</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Loss</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\">Marketable securities:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"font-size:10pt;\">Corporate debt securities</span><sup style=\"font-size:6pt;line-height:100%;top:0pt;vertical-align:top;\">(1)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  52,362 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  65 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 142 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  52,285 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Commercial paper</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  12,345 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  12,346 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"font-size:10pt;\">Asset-backed debt securities</span><sup style=\"font-size:6pt;line-height:100%;top:0pt;vertical-align:top;\">(2)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  10,953 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  42 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 30 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  10,965 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"font-size:10pt;\">Foreign government agency debt securities</span><sup style=\"font-size:6pt;line-height:100%;top:0pt;vertical-align:top;\">(3)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  4,698 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  43 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  4,741 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"font-size:10pt;\">U.S. government and government agency debt securities</span><sup style=\"font-size:6pt;line-height:100%;top:0pt;vertical-align:top;\">(4)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  61,750 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  8 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 96 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  61,662 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\">Total marketable securities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  142,108 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  160 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 269 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  141,999 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\"><sup style=\"font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;\">(1)</sup><span style=\"font-size:6pt;\"> Included in Corporate debt securities is </span><span style=\"font-size:6pt;\">$ 28.0 </span><span style=\"font-size:6pt;\"> million with maturity dates between </span><span style=\"-sec-ix-hidden:Hidden_Y5tEH3XK7kqT03DhKKR8cQ;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">two years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\"><sup style=\"font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;\">(2)</sup><span style=\"font-size:6pt;\"> Included in Asset-backed debt securities is </span><span style=\"font-size:6pt;\">$ 6.2 </span><span style=\"font-size:6pt;\"> million with maturity dates between </span><span style=\"-sec-ix-hidden:Hidden_tXdT4eF3mUGcX5vMpVtSNw;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">three years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\"><sup style=\"font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;\">(3)</sup><span style=\"font-size:6pt;\"> Included in Foreign government agency debt securities is </span><span style=\"font-size:6pt;\">$ 4.7 </span><span style=\"font-size:6pt;\"> million with a maturity date between </span><span style=\"-sec-ix-hidden:Hidden_IHonrYGnKUmQ1dW3QBf3tw;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">two years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.96%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\"><sup style=\"font-size:4.5pt;line-height:100%;top:0pt;vertical-align:top;\">(4)</sup><span style=\"font-size:6pt;\"> Included in U.S. government and government agency debt securities is </span><span style=\"font-size:6pt;\">$ 23.9 </span><span style=\"font-size:6pt;\"> million with maturity dates between </span><span style=\"-sec-ix-hidden:Hidden_6Ivbi7Tuj0uYcfdXoeky0g;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">two years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:56.92%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"11\" style=\"vertical-align:bottom;white-space:nowrap;width:41.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, 2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gross</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gross</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Book</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Unrealized</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Unrealized</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Fair</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gain</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Loss</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;\">Marketable securities:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"font-size:10pt;\">Corporate debt securities</span><sup style=\"font-size:6pt;line-height:100%;top:0pt;vertical-align:top;\">(1)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  40,626 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 251 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  40,375 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 18pt;\">Commercial paper</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  79,598 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  79,598 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 18pt;\">Asset-backed debt securities<sup style=\"font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;\">(2)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  14,641 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  4 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 123 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  14,522 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"font-size:10pt;\">U.S. government and government agency debt securities</span><sup style=\"font-size:6pt;line-height:100%;top:0pt;vertical-align:top;\">(3)</sup></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  50,571 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 530 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  50,041 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;\">Total marketable securities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  185,436 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  4 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 904 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  184,536 </p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;\"><span style=\"font-size:6pt;\">(1) Included in Corporate debt securities is </span><span style=\"font-size:6pt;\">$ 4.8 </span><span style=\"font-size:6pt;\"> million with maturity dates between </span><span style=\"-sec-ix-hidden:Hidden_0IiFZP9AzkuZSsPRp-pHEA;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">five years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0pt 6pt;\"><span style=\"font-size:6pt;\">(2) Included in Asset-backed debt securities is </span><span style=\"font-size:6pt;\">$ 2.4 </span><span style=\"font-size:6pt;\"> million with maturity dates between </span><span style=\"-sec-ix-hidden:Hidden_s6Gmqrg7aEOc_ArTanUcAw;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">five years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:56.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 5.75pt;\"><span style=\"font-size:6pt;\">(3) Included in U.S. government and government agency debt securities is </span><span style=\"font-size:6pt;\">$ 5.0 </span><span style=\"font-size:6pt;\"> million with maturity dates between </span><span style=\"-sec-ix-hidden:Hidden_1YxO_wtiTEi2hs9iPHwHzg;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:6pt;font-style:normal;font-weight:normal;\">one</span></span><span style=\"font-size:6pt;\"> and </span> <span style=\"font-size:6pt;\">five years</span> <span style=\"font-size:6pt;\">.</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:67.21%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:67.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:67.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:13.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:13.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Computer equipment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,253 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,381 </p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Lab equipment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,154 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,010 </p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Furniture and fixtures</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  558 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  620 </p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Leasehold improvements</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  817 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,123 </p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\">Property and equipment, gross</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,782 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,134 </p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Accumulated depreciation</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 4,162 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 4,035 )</p></td></tr><tr><td style=\"vertical-align:middle;width:67.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;\">Property and equipment, net</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,620 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,099 </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:41.71%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:41.71%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:23.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Gross Cost</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:nowrap;width:23.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Accumulated Amortization</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.71%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Remaining</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:41.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands, except years)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Life (years)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:middle;width:41.71%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Other intangible assets</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"> 3.6  </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  751 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  751 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  482 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  407 </p></td></tr><tr><td style=\"vertical-align:middle;width:41.71%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">In-process research and development</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">n/a</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,629 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:41.71%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total intangible assets</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.1%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  751 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  7,380 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  482 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  407 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:80%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:normal;width:79.97%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:79.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ending</b></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:79.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31,</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:79.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">2024</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  75 </p></td></tr><tr><td style=\"vertical-align:bottom;width:79.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">2025</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  75 </p></td></tr><tr><td style=\"vertical-align:bottom;width:79.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">2026</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  75 </p></td></tr><tr><td style=\"vertical-align:bottom;width:79.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">2027</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  44 </p></td></tr><tr><td style=\"vertical-align:bottom;width:79.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Total</p></td><td style=\"vertical-align:bottom;white-space:normal;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:13.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  269 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:71.2%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:71.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:71.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:middle;width:71.2%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Employee compensation expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,910 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,295 </p></td></tr><tr><td style=\"vertical-align:middle;width:71.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Research and development expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,661 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,689 </p></td></tr><tr><td style=\"vertical-align:middle;width:71.2%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Licensing expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,478 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  500 </p></td></tr><tr><td style=\"vertical-align:middle;width:71.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Restructuring expenses (Note 15)</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,112 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:middle;width:71.2%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Other</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  285 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  217 </p></td></tr><tr><td style=\"vertical-align:bottom;width:71.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total accrued expenses</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  19,446 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  8,701 </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:62.88%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.78%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:35.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:35.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Risk-free interest rate</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3.55 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  2.22 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  0.92 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Expected term (in years)</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6.2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6.2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6.2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Expected volatility</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  77.73 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  77.95 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  76.60 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td></tr><tr><td style=\"vertical-align:bottom;width:62.88%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Expected dividend yield</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  0 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  0 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  0 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Weighted</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Weighted</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Average</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Average</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Remaining</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.34%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Aggregate</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Number</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Exercise</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Contractual</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.34%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Intrinsic</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands, except share and per share data and years)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">of Shares</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Price</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Term</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">(in years)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2020</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,871,498 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  15.16 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6.8 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  4,890 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Granted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,068,100 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  23.44 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Exercised</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 115,548 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  12.63 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,373 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Forfeited and cancelled</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 31,600 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  23.26 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2021</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,792,450 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  17.50 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6.8 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  13,710 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Granted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,548,750 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  14.40 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Exercised</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 88,172 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1.78 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,120 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Forfeited and cancelled</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,085,864 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  18.44 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2022</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,167,164 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  16.04 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  7.2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  15,288 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Granted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,241,550 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  15.62 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Exercised</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 71,092 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1.31 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  473 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Forfeited and cancelled</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 918,167 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  16.85 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2023</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,419,455 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  15.94 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  7.1 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  14 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Options vested and expected to vest as of December 31, 2023</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,419,455 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  15.94 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  7.1 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  14 </p></td></tr><tr><td style=\"vertical-align:bottom;width:57.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Options exercisable as of December 31, 2023</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,879,529 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"vertical-align:top;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.39%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  16.55 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5.1 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  14 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Weighted</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Average</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Grant Date</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Aggregate</b></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Number</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Fair Value</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Intrinsic</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:61.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands, except share and per share data)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">of Shares</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Per Share</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Value</b></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2020</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  2,244,157 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3.83 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Granted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  664,948 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  23.33 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Vested </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,340,042 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3.18 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  31,492 </p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Forfeited and cancelled</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 72,117 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  10.36 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2021</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  1,496,946 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  12.75 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Granted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  936,563 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  14.43 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Vested </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 533,212 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  11.61 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  7,943 </p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Forfeited and cancelled</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 379,567 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  13.40 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2022</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  1,520,730 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  14.02 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Granted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  993,662 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  15.17 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Vested </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 745,279 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  11.72 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  8,262 </p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Forfeited and cancelled</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 247,173 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  15.15 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:61.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Outstanding as of December 31, 2023</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  1,521,940 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  15.72 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:85.25%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:62.56%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:7.97%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:2.41%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:7.97%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:2.41%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:7.97%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:62.56%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.56%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"> <span style=\"font-family:'Arial','Helvetica','sans-serif';\">\u00a0</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"> </p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"> </p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\"> </b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td></tr><tr><td style=\"vertical-align:middle;width:62.56%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Cost of revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;width:7.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  1,456 </p></td><td style=\"vertical-align:bottom;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;width:7.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  1,151 </p></td><td style=\"vertical-align:bottom;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;width:7.97%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  981 </p></td></tr><tr><td style=\"vertical-align:middle;width:62.56%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Research and development</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:7.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  6,801 </p></td><td style=\"vertical-align:bottom;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:7.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3,745 </p></td><td style=\"vertical-align:bottom;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:7.97%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3,866 </p></td></tr><tr><td style=\"vertical-align:middle;width:62.56%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">General and administrative</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;width:7.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  12,285 </p></td><td style=\"vertical-align:bottom;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;width:7.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  10,143 </p></td><td style=\"vertical-align:bottom;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;width:7.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  9,213 </p></td></tr><tr><td style=\"vertical-align:bottom;width:62.56%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total stock-based compensation expense</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  20,542 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  15,039 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  14,060 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:57.13%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:38.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:nowrap;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands, except for share and per share data)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:11.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Numerator:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Net loss</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 88,481 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Denominator:</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Weighted average shares of common stock outstanding, basic and diluted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  69,808,855 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  65,213,944 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  56,730,583 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:57.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Net loss per share, basic and diluted</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1.27 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"-sec-ix-hidden:Hidden_oPSXoTToi0iLfsD5oPcyeQ;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">$</span></span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1.33 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"-sec-ix-hidden:Hidden_eFrH5sUrLE-L76wY-mrhjw;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">$</span></span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1.60 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:66.04%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:66.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"3\" style=\"vertical-align:bottom;width:20.48%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;width:32.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:middle;width:66.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Options to purchase common stock</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,419,455 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,167,164 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,792,450 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:66.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Restricted stock unit awards</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,521,940 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,520,730 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,496,946 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total potential shares of common stock</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  7,941,395 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  6,687,894 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,289,396 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:63.17%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.39%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.96%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.18%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.2%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:63.17%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:normal;width:34.58%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:63.17%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:normal;width:34.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:63.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"> <span style=\"font-family:'Arial','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"> <span style=\"font-family:'Arial','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:10.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"> <span style=\"font-family:'Arial','Helvetica','sans-serif';\">\u00a0</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td></tr><tr><td style=\"vertical-align:middle;width:63.17%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Operating lease expense</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,092 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,013 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,013 </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:71.21%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:71.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:71.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:12.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:11.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:71.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Operating Leases:</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:71.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Gross cost</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,094 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,240 </p></td></tr><tr><td style=\"vertical-align:middle;width:71.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Accumulated amortization</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,235 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 2,560 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:71.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Other assets</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,859 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,680 </p></td></tr><tr><td style=\"vertical-align:bottom;width:71.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:71.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Current portion of lease liabilities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  426 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  684 </p></td></tr><tr><td style=\"vertical-align:middle;width:71.21%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"-sec-ix-hidden:Hidden_7PgL8prtdESJXmIj2qmCsA;\"><span style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;\">Other liabilities</span></span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,074 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,570 </p></td></tr><tr><td style=\"vertical-align:bottom;width:71.21%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total operating lease liabilities</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,500 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:10.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,254 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:middle;width:62.01%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"position:absolute;top:50%;transform:translate(0,-50%);width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:62.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td colspan=\"9\" style=\"vertical-align:bottom;white-space:nowrap;width:35.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands, except for years and percentages)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td colspan=\"9\" style=\"vertical-align:bottom;white-space:nowrap;width:35.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31, </b></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Supplemental Cash Flow Lease Information:</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">\u00a0</p></td><td colspan=\"3\" style=\"vertical-align:bottom;white-space:nowrap;width:11.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td></tr><tr><td style=\"vertical-align:middle;width:62.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Operating cash flows from operating leases</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  974 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  846 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  924 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:62.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Leased assets obtained in exchange for new operating lease liabilities</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  2,010 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:62.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Weighted-Average Remaining Lease Term (in years): </b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:62.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Operating leases</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> 5.3 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> 5.2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> 5.4 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:62.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:62.01%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Weighted-Average Discount Rate:</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:62.01%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Operating leases</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> 10.2 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.89%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> 10.1 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\"> 10.1 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:normal;width:82.95%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:82.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:11pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Operating</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ending December 31, </b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Leases</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">2024</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  766 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">2025</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  847 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">2026</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  868 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">2027</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  890 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">2028</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  912 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Thereafter</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  316 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total undiscounted lease payments</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  4,598 </p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Less: unrecognized interest</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">( 1,098 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:82.95%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Total lease liability</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.76%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:12.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;\">  3,500 </p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:102.74%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:normal;width:64.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:64.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"8\" style=\"vertical-align:bottom;white-space:normal;width:32.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended December 31,</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:64.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:normal;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:64.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">U.S. operations</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 88,848 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:64.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Foreign operations</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.04%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:64.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Loss before income taxes</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 88,848 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.08%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 86,908 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 90,865 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:normal;width:66.41%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"5\" style=\"vertical-align:bottom;white-space:normal;width:29.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended December 31,</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;white-space:normal;width:66.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Federal statutory income tax rate</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 21.0 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">% </p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 21.0 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">% </p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 21.0 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">State taxes, net of federal benefit</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1.7 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 2.3 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 7.7 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Impact of state rate changes</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  17.7 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Research and development tax credits</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 5.9 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 4.3 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 3.0 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Excess equity compensation tax benefit, net of officer limitation</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  0.6 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  0.2 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 3.9 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 6.3 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1.1 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5.6 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Non-deductible royalty payments</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  4.3 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Change in deferred tax asset valuation allowance</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  11.7 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  26.3 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  30.0 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Other</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  0.2 </p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:66.41%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Effective income tax rate</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:normal;width:7.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 0.4 )</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">% </p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:2.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">% </p></td><td style=\"vertical-align:bottom;white-space:normal;width:8.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:normal;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">%</p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"4\" style=\"vertical-align:bottom;white-space:nowrap;width:25.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">December 31,</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:70.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Deferred tax assets:</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Net operating loss carryforwards</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  119,155 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  120,554 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Capitalized start-up costs</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  3,812 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,506 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Research and development tax credit carryforwards</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  20,505 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  15,233 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Section 174 research and development capitalization</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  30,984 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  19,639 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Capitalized research and development expense</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  2,359 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  5,448 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Stock\u2011based compensation expense</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  18,055 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  19,432 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Accrued compensation</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,219 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  1,146 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Lease liabilities</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  774 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  558 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Other</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  407 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  534 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total deferred tax assets</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  197,270 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\">  188,050 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Deferred tax liabilities:</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Property and equipment</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 187 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 137 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Intangible asset</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,576 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Right-to-use assets</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 853 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 651 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Other</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,106 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 1,365 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Total deferred tax liabilities</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 2,146 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 3,729 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Valuation allowance</p></td><td style=\"vertical-align:bottom;width:0.64%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 195,124 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 184,688 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:70.92%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\">Deferred tax liabilities, net</p></td><td style=\"vertical-align:bottom;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:10.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 367 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;white-space:nowrap;width:63.76%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:63.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"7\" style=\"vertical-align:bottom;white-space:nowrap;width:31.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Year Ended December 31,</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;white-space:nowrap;width:63.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">2021</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\">\u00a0</p></td></tr><tr><td style=\"vertical-align:bottom;width:63.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Valuation allowance at beginning of year</p></td><td style=\"vertical-align:bottom;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 184,688 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 161,824 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 134,559 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:63.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Decreases recorded as benefit to income tax provision</p></td><td style=\"vertical-align:bottom;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:63.76%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\">Increases recorded to income tax provision</p></td><td style=\"vertical-align:bottom;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;\"><span style=\"margin-left:0pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 10,436 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 22,864 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 27,265 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:63.76%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Valuation allowance as of end of year</p></td><td style=\"vertical-align:bottom;width:1.8%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 195,124 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 184,688 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"> ( 161,824 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:0.73%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.57%;\"><tr style=\"height:1pt;\"><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><div style=\"height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;\"><div style=\"bottom:0pt;position:absolute;width:100%;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:1pt;visibility:hidden;\">\u200b</span></p></div></div></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.68%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Contract</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Corporate</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Total</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;\">Year Ended December 31, 2023</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Therapeutics</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Research</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">and Other</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Company</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Revenue from external customers</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  28,214 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  3,035 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  31,249 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Intercompany revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  16,543 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 16,543 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Cost of revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  18,941 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 15,537 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  3,404 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Research and development </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  97,188 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,006 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  96,182 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">General and administrative </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,561 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  26,940 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  31,501 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Licensing </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  14,658 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  14,658 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 26,900 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 26,900 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Intangible asset impairment</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  6,629 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">\u2014 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  6,629 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Restructuring expense</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  2,202 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  19 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  911 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  3,132 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Loss from operations</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 65,563 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 3,943 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 27,851 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 97,357 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.68%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Contract</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Corporate</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Total</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;\">Year Ended December 31, 2022</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Therapeutics</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Research</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">and Other</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Company</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Revenue from external customers</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  25,356 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,396 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  29,752 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Intercompany revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  12,609 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 12,609 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Cost of revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  15,847 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 11,824 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,023 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Research and development </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  78,599 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 786 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  77,813 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">General and administrative </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  3,505 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  21,628 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  25,133 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Licensing </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  7,937 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  7,937 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,700 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,700 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Loss from operations</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 65,880 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 2,347 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 21,627 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 89,854 )</p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;\">(In thousands)</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.19%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.68%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Contract</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Corporate</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.06%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Total</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\"><b style=\"font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;\">Year Ended December 31, 2021</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Therapeutics</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Research</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">and Other</b></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:bottom;white-space:nowrap;width:9.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Company</b></p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Revenue from external customers</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  932 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  5,829 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  6,761 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Intercompany revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  7,618 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 7,618 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Cost of revenue</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  11,885 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 7,172 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  4,713 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Research and development </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  44,259 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 446 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  43,813 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">General and administrative </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  3,047 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  20,572 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  23,619 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Revaluation of contingent consideration</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  24,339 </p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\"> \u2014</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;\">  24,339 </p></td></tr><tr><td style=\"vertical-align:bottom;width:56.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">Loss from operations</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 67,666 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 1,485 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 20,572 )</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;\">$</p></td><td style=\"vertical-align:bottom;white-space:nowrap;width:7.7%;background:#cceeff;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;\"> ( 89,723 )</p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Exhibit</b></p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:8pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:8pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Number</b></p></td><td style=\"vertical-align:top;width:2.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:8pt;margin:0pt;\">\u00a0</p></td><td style=\"vertical-align:top;width:88.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Description of Document</b></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">2.1#</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000155837017008320/acrs-20170930ex21d9ed579.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Agreement and Plan of Merger, dated as of August 3, 2017, by and among the Registrant, Aclaris Life Sciences, Inc., Confluence Life Sciences, Inc. and Fortis Advisors LLC (incorporated by reference to Exhibit 2.1 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on November 7, 2017).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">3.1</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000110465915070341/a15-21034_1ex3d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on October 13, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">3.2</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023013491/acrs-20230630xex3d2.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.2 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on August 7, 2023).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">3.3</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837020007743/tmb-20200623xex3d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on June 24, 2020)</span></a>.</p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">4.1*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex4d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Description of Securities.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.1+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000104746915007175/a2225848zex-10_7.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Amended and Restated 2012 Equity Compensation Plan (incorporated by reference to Exhibit 10.7 to Amendment No. 1 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on September 4, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.2+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000104746915006870/a2225650zex-10_8.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Stock Option Grant under Amended and Restated 2012 Equity Compensation Plan (incorporated by reference to Exhibit 10.8 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on August 17, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.3+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000110465915070883/a15-21110_1ex4d6.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">2015 Equity Incentive Plan (incorporated by reference to Exhibit 4.6 to the Registrant\u2019s Registration Statement on Form S-8 (File No. 333-207434), filed with the SEC on October 15, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.4+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000104746915007533/a2225995zex-10_10.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Stock Option Grant Notice and Stock Option Agreement under 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.10 to Amendment No. 2 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on September 25, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.5+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000104746915007533/a2225995zex-10_11.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 to Amendment No. 2 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on September 25, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.6+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:10.0pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000155837019002211/acrs-20181231ex10112f66b.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Performance Stock Option Grant Notice and Stock Option Agreement used in connection with the 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on March 18, 2019).</span></a></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.7+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:10.0pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000155837019002211/acrs-20181231ex1012720ee.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Performance Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.12 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on March 18, 2019).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.8+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000155837017005594/ex-10d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Aclaris Therapeutics, Inc. Inducement Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on August 1, 2017).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.9+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000155837017005594/ex-10d2.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Stock Option Grant Notice and Stock Option Agreement used in connection with the Aclaris Therapeutics, Inc. Inducement Plan (incorporated herein by reference to Exhibit 10.2 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on August 1, 2017).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.10+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023001829/acrs-20221231xex10d12.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Eighth Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.12 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.11+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023008382/acrs-20230331xex10d4.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Ninth Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.4 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on</span><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\"> </span><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">May 8, 2023).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.12+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"http://www.sec.gov/Archives/edgar/data/1557746/000104746915006870/a2225650zex-10_12.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Form of Indemnification Agreement (incorporated by reference to Exhibit 10.12 to the Registrant\u2019s Registration Statement on Form S-1 (File No. 333-206437), filed with the SEC on August 17, 2015).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.13+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837022001838/acrs-20211231xex10d15.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan (incorporated herein by reference to Exhibit 10.15 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 24, 2022).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.14+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023010987/acrs-20230609xex10d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">Amended and Restated Employment Agreement, effective as of July 1, 2023, by and between the Registrant and Joseph Monahan (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on June 12, 2023).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.15+*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d15.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Second Amended and Restated Employment Agreement, effective as of February 1, 2024, by and between the Registrant and Joseph Monahan.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.16+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837022001838/acrs-20211231xex10d16.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop (incorporated herein by reference to Exhibit 10.16 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 24, 2022).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.17+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023001829/acrs-20221231xex10d23.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Amended and Restated Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Douglas Manion (incorporated herein by reference to Exhibit 10.23 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.18+*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d18.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Separation Agreement, Waiver, and Release, dated as of February 4, 2024, by and between the Registrant and Douglas Manion.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.19+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023001829/acrs-20221231xex10d24.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Kevin Balthaser </span><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">(incorporated herein by reference to Exhibit 10.24 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023).</span></a></p></td></tr><tr style=\"height:19.45pt;\"><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.20+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837022011757/acrs-20220630xex10d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Employment Agreement, dated as of June 27, 2022, by and between the Registrant and Gail Cawkwell (incorporated by reference to Exhibit 10.1 to the Registrant\u2019s Quarterly Report on Form 10-Q (File No. 001-37581), filed with the SEC on August 3, 2022).</span></a></p></td></tr><tr style=\"height:12.25pt;\"><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.21+</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023001829/acrs-20221231xex10d16.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">Letter Agreement, dated as of November 22, 2022, by and between the Registrant and Neal Walker (incorporated herein by reference to Exhibit 10.16 to the Registrant\u2019s Annual Report on Form 10-K (File No. 001-37581), filed with the SEC on February 23, 2023).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.22+*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;background:#ffff00;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d22.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Letter Agreement, dated as of January 31, 2024, by and between the Registrant and Neal Walker.</span></a></p></td></tr><tr style=\"height:18.55pt;\"><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.23<sup style=\"font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;\">\u02c4</sup></p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"text-decoration-line:none;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837023010719/acrs-20230526xex10d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">Office Lease, dated May 26, 2023, by and between the Registrant and CBCC \u2013 Lee Road Acquisitions, LLC (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on June 1, 2023).</span></a></p></td></tr><tr style=\"height:18.55pt;\"><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">10.24</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"text-decoration-line:none;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000110465923024751/tm237408d1_ex10-1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;\">Sales Agreement, dated February 23, 2023, by and among the Registrant, SVB Securities LLC and Cantor Fitzgerald &amp; Co. (incorporated herein by reference to Exhibit 10.1 to the Registrant\u2019s Current Report on Form 8-K (File No. 001-37581), filed with the SEC on February 23, 2023)</span><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">21.1*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex21d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Subsidiaries of the Registrant.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">23.1*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex23d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">24.1*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"#SIGNATURES_591169\"><span style=\"font-style:normal;font-weight:normal;\">Power of Attorney (contained on signature page hereto).</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">31.1*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex31d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">31.2*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex31d2.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">32.1\u2020</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex32d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) and 15d-14(b) promulgated under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to section 906 of The Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">97.1*</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><a href=\"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex97d1.htm\" style=\"-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;\"><span style=\"font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;\">Aclaris Therapeutics, Inc. Incentive Compensation Recoupment Policy, adopted as of October 2, 2023.</span></a></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">101.INS</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">101.SCH</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">Inline XBRL Taxonomy Extension Schema Document</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">101.CAL</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">101.DEF</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">101.LAB</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">101.PRE</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td></tr><tr><td style=\"vertical-align:top;width:8.75%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;\">104</p></td><td style=\"vertical-align:top;width:2.46%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:88.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"background:#ffffff;\">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></p></td></tr></table><table style=\"border-collapse:collapse;border:0;\"><tr><td style=\"vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">*</p></td><td style=\"padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">Filed herewith.</p></td></tr></table><table style=\"border-collapse:collapse;border:0;\"><tr><td style=\"vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">\u2020</p></td><td style=\"padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">This certification is being furnished solely to accompany this Annual Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</p></td></tr></table><table style=\"border-collapse:collapse;border:0;\"><tr><td style=\"vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">+</p></td><td style=\"padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">Indicates management contract or compensatory plan.</p></td></tr></table><table style=\"border-collapse:collapse;border:0;\"><tr><td style=\"vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">#</p></td><td style=\"padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">Confidential treatment has been granted with respect to portions of this exhibit (indicated by asterisks) and those portions have been separately filed with the SEC.</p></td></tr></table><table style=\"border-collapse:collapse;border:0;\"><tr><td style=\"vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">\u02c4</p></td><td style=\"padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;\">Pursuant to Item 601(a)(5) of Regulation S-K promulgated by the SEC, certain exhibits and schedules to this agreement have been omitted. The Company hereby agrees to furnish supplementally to the SEC, upon its request, any or all of such omitted exhibits or schedules. </p></td></tr></table>",
        "<table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;\"><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><b style=\"font-weight:bold;\">ACLARIS THERAPEUTICS, INC.</b></p></td></tr><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td colspan=\"2\" style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"white-space:pre-wrap;\">Date: February 27, 2024</span></p></td><td style=\"vertical-align:top;width:3.84%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">By:</p></td><td style=\"vertical-align:top;width:46.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">/s/ Neal Walker</p></td></tr><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:3.84%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:46.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Neal Walker</p></td></tr><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:3.84%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:46.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Interim President and Chief Executive Officer</p></td></tr><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:3.84%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:46.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:top;width:50%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:3.84%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:46.15%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table><table style=\"border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;\"><tr><td style=\"vertical-align:bottom;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Signature</b></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;width:43.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Title</b></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">\u00a0</b></p></td><td style=\"vertical-align:bottom;width:20.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;\"><b style=\"font-weight:bold;\">Date</b></p></td></tr><tr style=\"height:5.2pt;\"><td style=\"vertical-align:bottom;width:30.59%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:3pt 0pt 0pt 0pt;\">/s/ Neal Walker</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:3pt 0pt 0pt 0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:43.47%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:3pt 0pt 0pt 0pt;\">Interim President and Chief Executive Officer, and Chairman of the Board of Directors</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:3pt 0pt 0pt 0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:3pt 0pt 0pt 0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:bottom;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Neal Walker</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-style:italic;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><i style=\"font-style:italic;\">(Principal Executive Officer)</i></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Kevin Balthaser</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Chief Financial Officer</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:top;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Kevin Balthaser</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-style:italic;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><i style=\"font-style:italic;\">(Principal Financial Officer and Principal Accounting Officer)</i></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:bottom;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;font-weight:bold;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Christopher Molineaux</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Lead Independent Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;\">Christopher Molineaux</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Anand Mehra, M.D.</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Anand Mehra, M.D.</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ William Humphries</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">William Humphries</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Andrew Powell</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Andrew Powell</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:10.1pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Andrew Schiff</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Andrew Schiff</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:10.1pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Bryan Reasons</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Bryan Reasons</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:10.1pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Maxine Gowen</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Maxine Gowen</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:10.1pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"font-size:8pt;visibility:hidden;\">\u200b</span></p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">/s/ Vincent Milano</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\">Director</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:bottom;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">February 27, 2024</p></td></tr><tr><td style=\"vertical-align:middle;width:30.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\">Vincent Milano</p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:middle;width:43.47%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:2.78%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td><td style=\"vertical-align:top;width:20.35%;margin:0pt;padding:0pt;\"><p style=\"font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;\"><span style=\"visibility:hidden;\">\u200b</span></p></td></tr></table>"
    ]
}